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ABSTRACT 
Objective:   To examine the association between process quality of inpatient care and 
risk-adjusted, thirty-day potentially preventable hospital readmission (PPR) rates.  
Data Sources/Study Setting:   This was an observational cross-sectional study of 
nonfederal acute-care hospitals located in two states California and Florida, discharging 
Medicare patients with a principal discharge diagnosis of heart failure, acute myocardial 
infarction, or pneumonia January through December 31, 2007.  Data were obtained from 
the Healthcare Cost and Utilization Project State Inpatient Database of the Agency for 
Healthcare Research and Quality, Centers for Medicare and Medicaid Services Hospital 
Compare database, and the American Hospital Association Annual Survey of Hospitals. 
Study Design:   The dependent variable of this study is condition-specific, 
risk-adjusted, thirty-day potentially preventable hospital readmission (PPR).  3M’s PPR 
software was utilized to determine whether a readmission was potentially preventable.  
The independent variable of this study is hospital performance for process quality of 
inpatient care, measured by hospital adherence to recommended processes of care.  We 
used multivariate hierarchical logistic models, clustered by hospitals, to examine the 
relationship between condition-specific, risk-adjusted, thirty-day PPR rates and process 
quality of inpatient care, after taking clinical and socio-demographic characteristics of 
patients and structural and operational characteristics of hospitals into account.  
Principal Findings:  Better performance on the process quality metrics was associated 
with better patient outcome (i.e., low thirty-day PPR rates) in pneumonia, but not 
generally in two cardiovascular conditions (i.e., heart failure and acute myocardial 
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infarction).  We found no evidence of an interaction between process quality metrics 
and condition-specific hospital volume with respect to 30-day PPR.  
Conclusion:  Adherence to the process quality metrics currently in use by CMS is 
associated with risk-adjusted, thirty-day PPR rates for patients with pneumonia, but not 
with cardiovascular conditions.  More evidence-based process quality metrics closely 
linked to 30-day PPR rates, particularly for cardiovascular conditions, need to be 
developed.    
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CHAPTER I: INTRODUCTION 
 
Background  
 A readmission is a return hospitalization to an acute care hospital that follows a 
prior admission from an acute care hospital.  Readmissions following discharge from 
acute care hospitals are frequent, costly, and sometimes life-threatening events.  Older 
people have substantially higher rates of hospital readmission than the general population.  
About 20 percent of Medicare fee-for-service beneficiaries who were discharged after 
hospitalization were readmitted within 30 days after discharge from hospitals, and 34 
percent were readmitted within 90 days [1].  Medicare expenditure for potentially 
preventable readmissions is as much as $12-17 billion a year [1, 2]. 
Readmission reflects gaps in care transition.  The transition from inpatient to 
outpatient setting is a critical and vulnerable point along the care continuum.  Many 
patients are discharged “quicker and sicker” than before, and they often are left 
unprepared at discharge.  Particularly, older patients with chronic and multiple 
comorbid conditions experience difficulties during the transition between inpatient and 
community setting because as burden of self-care responsibility is placed, if discharged to 
home, on patients or their family caregivers.  Family caregivers often lack necessary 
skills and knowledge to provide sustained care to the elderly patients with chronic and 
multiple comorbid conditions [3]. 
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The time period covered by a “readmission” can vary.  It can be a repeated 
admission within 7, 30, 90 days, or 1 year of discharge from the initial admission.  The 
lack of uniformity in defining readmission may yield inconsistent reports of the 
readmission rates in adult population.  The readmission timeframe directly affects the 
risk.  Hospitals have greater control over the clinical processes during the 
hospitalization and the discharge process.  The shorter readmission timeframe (7 to 30 
days) more closely reflects quality of care during the index hospitalization, while a longer 
timeframe (90+ days) reflects the effectiveness of community-based, chronic monitoring 
and maintenance systems [4].  The number of unpreventable readmissions tends to 
increase with an increasing readmission timeframe [5].    
Readmission rates vary substantially by hospitals and geographic areas.  One 
analysis suggests that the rate for the highest quartile of all-cause hospital readmission 
rates was 25%, compared to 13% in the lowest quartile [1].  Other studies reported 
variation in 30-day, all-cause readmission rates among hospitals for three common 
medical conditions, heart failure, acute myocardial infarction, and pneumonia [6, 7].  
The relative differences in 30-day, all-cause readmission rates across the 10th to 90th 
percentiles of hospital performance was 23.7% for heart failure (21.9% vs. 27.1%), 15% 
for acute myocardial infarction (18.4% vs. 21.2%), 24.4% for pneumonia (16.4% vs. 
20.4%) [6, 7].   
Readmission rates vary by geographic areas.  The 30-day readmission rate after 
discharge among Medicare beneficiaries was 45% higher in the five states with the 
highest rates (Maryland-22%, New Jersey 21.9%, Louisiana-21.9%, Illinois-21.7%, and 
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21.3%-West Virginia) than in the five states with the lowest rates (Idaho-13.3%, 
Utah-14.2%, Oregon-15.7%, Colorado-16.2%, and New Mexico-16.3%) [1].  Medicare 
beneficiaries who were admitted in Boston for five conditions (myocardial infarction, 
stroke, hip fracture, gastrointestinal bleeding, or potentially curative surgery for cancer) 
had a 64% higher readmission rate than those admitted in New Haven for these 
conditions [8].   
The substantial variation in readmission rates among hospitals and geographic 
areas suggests ample room for improvement.  Geographical variation in readmission 
rates may be partially explained by local capacity of health care systems or local 
physician practice patterns [6, 8, 9].  While we do not yet fully understand 
organizational characteristics explaining variation in readmission rates among hospitals, 
variation even after risk-adjustment among hospitals suggests that some hospital factors 
are at play.  A small but growing body of research indicates that hospital teaching status, 
ownership, cardiac capability, nurse staffing, hospital size, and hospital volume are 
associated with readmission rates [10-13].   
 Policymakers are anxious to reduce preventable readmissions because they may 
represent an opportunity to ensure quality of care and patient safety while lowering health 
care costs.  While not all readmissions are avoidable and unnecessary, many unplanned 
readmissions shortly after discharge are thought to be preventable; prior randomized 
controlled trials have shown that enhancing inpatient process care, such as 
comprehensive discharge planning and care coordination, reduce readmissions [14-17].  
Since July 2009, the Centers for Medicare & Medicaid Services (CMS) has posted 
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30-day all-cause readmission rates for heart failure, acute myocardial infarction, or 
pneumonia by hospitals for Medicare patients on its Hospital Compare web site.  
Beginning October 1, 2012, inpatient payments to hospitals will be reduced if a hospital 
experiences excessive readmissions within a specified period following discharge for a 
heart attack, heart failure, or pneumonia.   
 Hospital performance for potentially preventable hospital readmission rates is 
gaining momentum as a reportable quality indicator for pay-for-performance for hospitals.  
Several states, including New York, Florida, Texas, Maryland, Massachusetts, Colorado, 
and Hawaii, use potentially preventable readmission rates for public reporting.  
However, little attention has paid to the association between the potentially preventable 
hospital readmission rates and quality of inpatient care.  If potentially preventable 
readmission rates are to serve as a suitable marker of hospital performance, we need to 
make sure that hospital performance for quality of inpatient care is inversely related to 
preventable hospital readmission rates.  While previous studies that examined the 
association between quality of inpatient care and mortality rates as a clinical outcome 
found a modest inverse association [18-22], no prior work to date has investigated the 
link between potentially preventable readmission rates and hospital performance for 
quality of inpatient care.   
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Purpose of Study 
 This study contributes to the understanding of factors associated with the 
potentially preventable readmission rates.  The specific aim is to investigate, at the 
hospital level, whether hospital performance for process quality of inpatient care 
delivered during initial hospitalization is related to potentially preventable readmission 
rates.  The research questions examined are the following. 
Research Question 1 
 Our main focus is on the association between hospital level performance for 
process quality and potentially preventable readmission rates.  Is better process quality 
of inpatient care associated with lower potentially preventable readmission rates across 
hospitals?  Stated differently, are patients discharged from hospitals with better quality 
of inpatient care less likely to be readmitted for potentially preventable reasons?  
Because Question 1 has not been directly investigated in prior literature, we construct our 
hypothesis based on similar literature on other patient outcomes.  Specifically, we 
generate a hypothesis based on two lines of prior research that examined association 
between 1) readmission (but not preventable) and process quality at patient level and 2) 
mortality and process quality at hospital level.  Studies of the association between 
readmission and process quality at patient level have generally found an inverse 
association between readmission and process quality [23-27].  Studies that investigated 
the link between mortality and performance for process quality metrics at hospital level 
found an inverse association [18-22].  We extrapolate from these findings to 
hypothesize that hospitals’ performance for process quality of inpatient care is inversely 
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associated with potentially preventable rates of rehospitalization.  Because we lack data 
on process quality metrics at patient level, we rely on data aggregated at hospital level.  
Previous research that investigated an association between mortality and process quality 
metrics also used data on aggregated at the hospital level.  The hypothesized association 
is estimated after patients’ individual characteristics and other hospital factors are 
accounted for.   
Research Question 2 
 Hospital volume has been shown to be associated with better quality for many 
conditions [12, 28].  We are interested in investigating whether experience in caring for 
patients, measured by condition-specific hospital volume, moderates the hypothesized 
association between process quality of inpatient care and potentially preventable 
readmission rates.  We are looking for an interaction effect.  Among the hospitals, does 
the influence of process quality of inpatient care on potentially preventable readmission 
rates vary with hospital condition-specific volume?  Although high volume hospitals 
may have better process quality, we suspect that hospitals’ performance for process 
quality metrics may exert its influence differently in large volume and small volume 
hospitals.  We hypothesize that the magnitude of the postulated association between 
potentially preventable readmission rates and process quality of inpatient care is greater 
for low-volume hospitals than large-volume hospitals.  High-volume hospitals may 
provide care not captured in quality metrics, which might have benefit beyond the 
observed quality metrics in avoiding preventable readmissions.  For example, 
high-volume hospitals may have implemented care coordination programs or they may 
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provide care through specialized centers, such as a heart valve center.  Also, 
high-volume hospitals are more likely to be familiar with clinical practice guidelines of 
professional societies and are more likely to adhere to them to maintain a positive 
reputation.  Consequently, the magnitude of the association of the adherence to quality 
metrics with preventable readmission rates may be greater in low-volume hospitals than 
high-volume hospitals.   
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CHAPTER II: LITERATURE REVIEW 
Overview 
This dissertation examines the association between process quality of inpatient care and 
potentially preventable readmission rates.  This chapter will review the relevant 
literature concerning the factors associated with preventable hospital readmission.  
Related topics to be discussed include 1) patient-level factors predictive to preventable 
readmissions, 2) link between patient-level process quality of inpatient care and 
preventable readmissions, 3) link between hospital-level process quality of inpatient care 
and preventable readmissions, and 4) hospital-level factors associated with preventable 
readmissions.  Next, the conceptual model for the present study is presented. 
 
Patient-level factors associated with preventable readmissions 
 Prior research on early or unplanned readmissions has devoted much attention to 
the patient-specific risk factors including clinical, demographic, and social factors.  In 
general, it has been suggested that clinical factors have more influence on the risk of 
readmission than do demographic and social factors.  Clinical factors for early or 
unplanned readmission which have been identified and documented in prior studies 
include presence of comorbidities [1, 5, 29-46], severity of illness [5, 47-51], chronic 
conditions (relative to acute conditions) [52, 53], index hospitalization for medical 
conditions (relative to surgical procedure) [1, 5, 54], functional disability [1, 55, 56], 
mal-nutrition [57, 58], medication dosage change shortly before discharge [59], the prior 
hospital utilization (typically 12 month) [1, 29, 30, 37, 38, 41, 48, 51, 59-63], and 
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prolonged length of stay during index hospitalization [1, 10, 29, 35, 37, 38, 41, 48, 51, 55, 
62, 63].   
 Demographic factors matter in early or unplanned readmissions.  Demographic 
factors predictive of early or unplanned readmissions include increasing age [1, 5, 30, 
34-36, 38, 44, 45, 48, 51, 62, 64], male sex [1, 10, 29, 36, 44, 46, 48, 50, 61], Black race 
[1, 13, 36, 43, 49, 65], Hispanic race [66], and rural residence [10, 38, 52, 54].  While 
much attention has been paid to the patient risk factors, many of the clinical and 
demographic risk factors that have been identified are not considered modifiable.   
 Finally, several social factors are associated with an increased likelihood of early 
or unplanned readmissions.  Social risk factors which have been identified in prior 
studies include low socio-economic status [55, 67-69], Medicaid payer status [10, 34, 41, 
49, 65], Medicare payer status [41, 48, 65, 70], discharge to post-acute care facilities 
(relative to home) [35, 37, 49, 65], discharge against medical advice [48, 49], living alone 
[55, 71], lacking self-management skills [55], and lack of documented patient or family 
education [30].   
 
Link between patient-level process quality of inpatient care and preventable 
readmissions 
 Previous literature has documented that quality of inpatient care exerts an 
influence on the risk for early or unplanned readmission at patient level [23-27].  Ashton 
et al. (1995) performed a case-control study of 2513 male veteran patients in 12 Veterans 
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Affairs hospitals who had heart failure (n=748), diabetes (n=593), or obstructive lung 
disease (n=1172) to investigate the association between quality of inpatient care and 
unplanned readmission within 14 days [23].  The authors assessed quality of care, using 
following criteria: the admission workup, evaluation and treatment during the stay, and 
criteria for readiness for discharge.  After adjustment for demographic and clinical 
factors, the study found that 1 of 5 readmissions in patients with heart failure, 1 of 7 
readmissions in patients with diabetes, and 1 of 12 in patients with obstructive lung 
disease were attributable to substandard care.  They concluded that suboptimal quality 
of inpatient care increases the risk for unplanned early readmission in patients with heart 
failure, diabetes, or obstructive lung disease.  Because the definition of the readmission 
in the study was restricted to Veterans Affairs hospitals, the attributable risks might be 
underestimated if some patients were readmitted to non-Veterans Affairs hospitals.  The 
finding may not be generalizable to 1) patients who use non-VA hospitals, 2) patients 
with other conditions, and 3) female patients.   
 Ashton et al’s (1997) meta-analysis of 29 studies published from 1973 to through 
1993 examined the association between 31-day readmission and quality of inpatient care 
that are under the control of care providers [24].  The authors classified the datasets 
according to quality of care received as being either normative (defined as care 
conforming to accepted standards of routine hospital practice), substandard (defined as 
care failing to meet standards), and exceptional (defined as exceeding standards).  
Patients who received relatively low quality (‘substandard’ or ‘normative’) were 55 
percent more likely to be readmitted within 31 days after discharge than those who 
received care of higher quality (‘normative’ or ‘exceptional’) (CI: 1.25-1.92).  Patients 
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who received ‘substandard’ care were 24 percent more likely to be readmitted within 31 
days after discharge than those who received ‘normative’ care, yet the confidence interval 
included 1.0 (CI: 0.99-1.57).  Studies counting only ‘unplanned readmissions’ had 
positive results while ‘all readmissions’ tended to have inconclusive results.  Similarly, 
studies defining readmission as return hospitalization to “any hospitals” were found to 
have conclusive results, compared to those defining them as readmission to “same 
hospital”.  The review concluded that early readmission is associated with lower process 
quality of inpatient care.   
 Weissman et al. (1999) investigated the association of “related adverse 
readmission” with quality of care [25].  They sampled 1758 Medicare patients 
hospitalized for congestive heart failure and pneumonia performed in four states, and 
conducted a case-control study.  To determine quality of care, the study used two 
measures: explicit measure, i.e., predetermined criteria, and implicit measure, i.e., post 
hoc subjective assessments by physician.  After adjusting readmission risk scores, there 
were small but statistically significant differences in quality of inpatient care during index 
hospitalization (measured by both explicit and implicit criteria) between patients who 
subsequently experienced “related adverse readmissions” and those who did not 
experience “related adverse readmissions”.  Interestingly, the magnitude of the relation 
between related adverse readmission and quality was greater in pneumonia than in 
congestive heart failure.  An intriguing finding is that while generally smaller and 
statistically insignificant, patients experiencing “other admissions” (i.e., readmissions not 
deemed to be related or adverse) tended to have lower quality of care during their index 
hospitalization compared with non-readmitted patients.   
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 A review article by Benbassat and Taragin (2000) found that up to 48% of all 
readmissions were related to sub-optimal care during the index hospitalization, such as 
poor resolution of the main problem and unstable therapy at discharge [26].  Up to 75% 
of all readmission were believed to be preventable if standard care were used after index 
discharge.  The review concluded that while global readmission rates are not a useful 
indicator of quality of care, high readmission rates of patients with defined conditions 
such as heart failure or diabetes may identify quality of care problems.   
 
Link between hospital-level process quality of inpatient care and preventable 
readmissions 
 Prior studies have examined the association between process quality of inpatient 
care and clinical outcome measures, yet much attention has been paid to the mortality 
[18-22, 72, 73].  While most studies suggest that better performance for process 
measures is associated with lower mortality for heart failure [21, 22], acute myocardial 
infarction [18-22], and pneumonia [21, 22], some studies reported mixed findings for 
heart failure [72] or disassociation [73].   
 Several prior studies examined the association between hospital-level processes 
quality of inpatient care and cardio-vascular readmission [74, 75] and combined mortality 
or all-cause readmission [72].  Table 1 summarized these studies.  All of these studies 
used data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized 
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Patients with Heart Failure (OPTIMIZE-HF) registry and, thus the context of care was 
heart failure.  
 Hernandes et al. (2010) investigated whether hospital performance for process 
quality metrics were associated with patient-level post discharge outcomes including 
1-year or 60-day cardiovascular readmission, i.e., subsequent admission for a 
cardiovascular reason, and 1-year or 60-day mortality [74].  The study employed 
following emerging process quality measures that were not among the heart failure 
performance measures used by CMS: any beta-blocker for patients with left ventricular 
systolic dysfunction (LVSD); evidence-based beta-blocker for patients with LVSD; 
warfarin for patients with atrial fibrillation; aldosterone antagonist for patients with 
LVSD; implantable cardioverter-defibrillator for patients with ejection fraction ≤ 35%; 
and referral to disease management.  Hospitals’ performance for process measures were 
calculated by dividing the number of patients for whom the process of care was 
documented by the number of patients who were eligible.  The study found significant 
associations between hospitals’ performance for process quality measures and 1-year 
cardiovascular mortality, with the exception of the warfarin and referral to disease 
management.  However, none of the hospital-level process quality of inpatient care 
measures were significantly associated with lower risk of 60-day or 1-year cardiovascular 
readmission, with the exception of the beta-blocker, after controlling for patient 
demographic and clinical factors and hospitals’ heart failure volume.  OPTIMIZE-HF 
hospitals (n=141) were self-selected and hence, the external validity of this finding may 
be limited if participating hospitals differed from nonparticipating hospitals.   
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 Patterson et al. (2010) investigated the association between hospital-level 
performance for process quality metrics and 1-year cardiovascular readmission and 
1-year mortality [75].  They used process quality measures endorsed by CMS: 1) 
discharge instructions that address diet, exercise, medications, and relevant follow-up 
care for patients discharged to home; 2) assessment of left ventricular function; 3) 
prescription of an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor 
blocker (ARB) at discharge to eligible patients with left ventricular systolic dysfunction 
without contraindications; and 4) smoking cessation counseling for patients who had 
smoked within 1 year of admission.  Additionally, they included another measure that 
was not endorsed by CMS: beta-blocker for patients with LVSD.  The study found that 
hospital-level performance for process measures including discharge instructions, 
prescription of an ACE inhibitor or ARB, and smoking cessation counseling was not 
associated with lower patient-level cardiovascular readmission at 1 year, after accounting 
for patient clinical and demographic factors and hospital-level volume.  However, none 
of the process metrics were associated with 1-year mortality.  They observed a 
statistically significant positive association between hospitals’ adherence to assessment of 
left ventricular function and cardiovascular readmission at 1 year.  The external validity 
of this finding remains uncertain because participating hospitals (n=150) may differ from 
nonparticipating hospitals.   
 Fonarow et al. (2007) examined the relationship between performance measures 
for patients hospitalized with heart failure and relevant clinical outcomes including 60- to 
90-day mortality and combined mortality or all-cause readmissions [72].  They included 
five heart failure inpatient performance measures: 1) discharge instructions, 2) evaluation 
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of left ventricular systolic function, 3) ACE inhibitor or ARB for left ventricular systolic 
dysfunction, 4) smoking cessation advice and counseling, and 5) anticoagulant at 
discharge for patients with atrial fibrillation.  Of the 5 heart failure performance 
measures, 2 were significantly associated with reduced risk of combined mortality or 
all-cause readmissions: ACE inhibitor/ARB for LVSD and beta-blocker at discharge.  
Interestingly, ACE inhibitor/ARB for LVSD was a marginally significant predictor for 
mortality (Hazard Ratio: 0.61; 95% CI, 0.35-1.06), but it turned out to be significant for 
the combined mortality or readmission (OR: 0.51; 95% CI, 0.34-0.78).  While this study 
did not explicitly investigate the association of ACE inhibitor/ARB for LVSD and 
readmission, this finding suggests that ACE inhibitor/ARB for LVSD may be an 
independent predictor for all-cause readmissions.  Similar to the other works from the 
OPTIMIZE-HF registry, this work did not account for other hospital characteristics.  
Again, the external validity of this finding remains uncertain because participating 
hospitals (n=91) were self-selected.  
 
Organizational-level factors associated with preventable readmissions 
 While no previous studies examined organization factors associated with 
preventable readmissions, several studies examined the hospital characteristics associated 
with 30-day, all-cause readmission rates [11-13, 54].  Table 2 summarizes these studies.  
Using a 1974-1977 Medicare data set, Anderson et al. (1985) examined hospital factors 
associated 60-day all-cause readmission rates. While teaching hospitals and small size 
hospitals tended to have higher readmission rates, this finding needs to be interpreted 
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with caution because the analytic modeling was not specified [54].  Using national 
claims data for Medicare patients with heart failure discharged from US hospitals in 2006 
to 2007, Joynt et al. (2011-a) examined hospital characteristics associated with 30-day, 
all-cause readmission rates [11].  Ownership, cardiac capability, nurse staffing, and 
hospital size are independently associated with the likelihood of 30-day, all-cause 
readmission.  Specifically, likelihood of 30-day, all-cause readmission was higher for 
patients discharged from hospital without cardiac services and hospitals with partial 
cardiac services (compared with full cardiac services), and with low nurse staffing 
(compared with high nurse staffing).  Likelihood of readmission was also higher for 
patients discharged from both for-profit and public hospitals (compared with not-for 
profit) and small size hospitals (compared with large hospitals).  Likelihood of 
readmission was higher for patients discharged from hospitals located in counties with 
low median income (compared with high income), but the association did not persist after 
accounting for other hospital characteristics.    
 Using same claims data and cohort, Joynt et al. (2011-b) examined the association 
between condition-specific hospital volume and patient outcomes including 30-day, 
mortality rates and 30-day, all-cause readmission rates [12].  Hospital volume of patient 
with heart failure was captured with a categorical variable (low: 25-200 discharge over 
23-month study period, medium: 201-400, high: >400).  While they found that among 
patients with heart failure, being admitted to a hospital with a higher volume of patients 
with heart failure was associated with lower 30-day, mortality rates, a similar significant 
association was not observed in 30-day, all-cause readmission rates.  The strongest 
effect of volume on mortality was observed in the group of hospitals with the lowest 
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volume.  The findings may not have internal validity because the study employed a 
standard logistic regression while not accounting for clustering of patients within 
hospitals.  The finding is inconsistent with other studies which found inverse 
associations between hospital volume and 30-day readmission for infection after coronary 
artery bypass surgery [35, 76].  While examining prior literature on mortality is beyond 
the scope of this review, it is worth reviewing another work that examined the relation of 
hospital volume and mortality for medical conditions.   
 Ross et al. (2010) used national claims data for Medicare patients with heart 
failure discharged from US hospitals in 2004 to 2006 to examine the association between 
hospital volume and the 30-day mortality rate for patients who are hospitalized for heart 
failure, acute myocardial infarction, or pneumonia [28].  Hospital volume was inversely 
associated with 30-day mortality rates for all conditions.  Consistent with the findings 
from Joynt et al. (2011-b), the association between volume and outcome was attenuated 
as the hospital’s volume increased.  While this study did not examine readmission rates 
as outcome variable, it suggests that condition-specific hospital volume may matter in 
readmission rates. 
 Using national claims data for Medicare patients with heart failure, acute 
myocardial infarction, or pneumonia discharged from US hospitals in 2006 to 2008, Joynt 
et al. (2011-c) investigated whether being discharged from minority-serving hospitals 
was associated with the likelihood of all-cause, 30-day readmission [13].  To identify 
minority-serving hospitals, the authors calculated the proportion of its Medicare patients 
who are black and categorized hospitals in the highest decile of proportion of black 
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patients as minority serving.  They found that among patients with heart failure, being 
discharged from minority-serving hospitals was associated with 14% higher odds of 
readmission than patients from non-minority-serving hospitals.  Among patients with 
acute myocardial infarction, being discharged from minority-serving institutions was 
associated with 22% higher odds of readmission.  Among patients with pneumonia, 
being discharged from minority-serving institutions was associated with 18% higher odds 
of readmission.  These findings were not accounted for other hospital characteristics.  
After accounting for other hospital characteristics, black patients with acute myocardial 
infarction from minority-serving hospitals had 22% higher odds of readmission than 
non-black patients from non-minority serving hospitals; black patients from non-minority 
serving hospitals had 11% higher odds of readmission than non-black patients from 
non-minority serving hospitals.  Black patients with heart failure from minority-serving 
hospitals had 10% higher odds of readmission than non-black patients from non-minority 
serving institution; black patients from non-minority serving hospitals had 2% higher 
odds of readmission than non-black patients from non-minority serving hospitals.  Black 
patients with pneumonia from minority-serving hospitals had 22% higher odds of 
readmission than non-black patients from non-minority serving institution; black patients 
from non-minority serving hospitals had 12% higher odds of readmission than non-black 
patients from non-minority serving hospitals.  While authors noted that their analytic 
models (multivariate logistic regression) included within hospital clustering, they did not 
provide further details on their statistical modeling.   
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Gaps in the previous literature 
 Although the majority of the prior research on readmission focuses on individuals’ 
clinical and socio-demographic risk factors, a small but increasing body of research has 
investigated whether hospitals’ structural and operational characteristics may influence 
the likelihood of all-cause readmission.  There have been many attempts to investigate 
the association between hospitals’ performance for process quality of inpatient care and 
clinical outcomes, but much focus lied on mortality.  Although findings have been 
mixed, the majority of the studies on mortality suggest that higher performance for 
process quality of inpatient care is associated with lower mortality.   
 To date, no prior literature has examined the link, at hospital level, between 
potentially preventable readmission rates and hospital performance for process quality of 
inpatient care.  Several studies, at patient-level, indicated the inverse association 
between (early, unplanned, or early unplanned) readmission and antecedent quality of 
inpatient care.  A few recent studies, using data from OPTIMIZE-HF registry, have 
investigated the link, at hospital-level, between hospital performance for process quality 
of inpatient care for heart failure and readmission after index hospitalization for heart 
failure.  While these studies generally suggest a disassociation of hospital-level process 
quality of inpatient care for heart failure with cardiovascular or all-cause readmissions, it 
is uncertain whether the finding can be generalizable to other medical conditions such as 
pneumonia or acute myocardial infarction and to non-OPTIMIZE-HF institutions.  
These studies employed longer readmission timeframes, i.e., 60-day to 1-year, which are 
not suitable for evaluating process quality of inpatient care during the index 
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hospitalization.  Furthermore, hospital characteristics that have been suggested to 
influence the clinical outcomes were not accounted for in any of these OPTIMIZE-HF 
studies and thus, results may be biased.   
 This dissertation will overcome shortcomings and fill the gap in the prior 
literature by investigating the association between hospital performance for process 
quality of inpatient care and risk-adjusted, 30-day potentially preventable readmissions 
(PPR) after hospitalization for three common medical conditions- acute myocardial 
infarction, heart failure, and pneumonia-, controlling for organizational characteristics.  
Based on the prior literature, we constructed the conceptual model for the present study 
and it is presented below. 
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Conceptual Model 
 The conceptual model guiding this work is displayed in Figure 1.  Because we 
investigate hospital effects on patient outcomes, we formulate a hierarchical model 
wherein patients are nested in hospitals.  The constructs illustrated in Figure 1 are 
measured at two levels.  Patient characteristics and the outcome, PPR, are measured on 
patients and hospital level factors, including process quality, are measured on hospitals.  
We highlight two key constructs in this study with bold lines around the boxes: process 
quality and the outcome-whether patients are readmitted for potentially preventable 
reason(s) or not.  Our research questions are captured in Arrow A (Research Question 1) 
and B2 (Research Question 2).  The analysis for Question 1 relies on controlling for 
confounders, whereas the analysis for Question 2 examines an interaction.  The rest of 
the arrows -A, B1, C, D, E, F, G, and H- represent variables that are controlled in the 
study.   
 The within hospital regression coefficients express the associations of 
patient-level explanatory variables on the patient outcome (PPR) within a given hospital; 
the between hospital regression coefficients express the associations of the hospital-level 
explanatory variables on the group mean of the patient outcome (PPR rate).  Note that 
process quality is measured on hospitals, not on patients.   
We capture process quality with hospitals’ adherence to recommended clinical 
process of care.  Specifically, the construct of process quality is operationalized in an 
aggregate measure: the proportion of patients who received the recommended care out of 
all the patients who were eligible for the recommended care.   
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We examine the link between hospitals’ performance for process quality and the 
group mean of PPR, i.e., PPR rate, which is captured by Arrow A (Research Question 1).  
We hypothesize that hospitals with better performance for process quality of inpatient 
care would have lower PPR rates.  This hypothesized association is controlled for 
patients’ risk factors and hospital characteristics.  We then explore whether experience 
in caring for patients, measured by condition-specific hospital volume, moderates the 
relationship between process quality of inpatient care and PPR rates, which is captured by 
Arrow B2 (Research Question 2).      
 We capture patient clinical characteristics with following measures: severity 
(measured by prior hospitalization), comorbidity (measured by Elixhasuer comorbid 
conditions), and cardiac procedures for AMI patients (measured by coronary artery 
bypass graft or percutaneous transluminal coronary angioplasty).  The association 
between clinical characteristics and outcome is captured in Arrow D, E, and F.  We 
capture patient socio-demographic characteristics with following measures: age, sex, race, 
income (measured by median household income state quartile for patient ZIP Code), 
which is captured by Arrow G.  We also control patients’ discharge location, which is 
captured in Arrow H.  The structural and demographic characteristics of the hospitals 
(Arrow A and C) are included for purposes of statistical control.  We capture hospital 
structure with following measures: hospital ownership status, teaching intensity, Magnet 
status (a proxy of nurse care environments), condition-specific hospital volume (a proxy 
of experience with managing condition), capacity to perform cardiac catherization (a 
proxy of high-tech cardiac services), Medicare disproportionate-share hospital (DSH) 
index (a proxy of the proportion of poor patients), and system affiliation.  While we do 
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not generate formal hypotheses, we consider hospitals with more experiences, high-tech, 
and better nurse care environment would be associated with the better patient outcome, 
i.e., low PPR rates.  We capture hospital demographic composition with the following 
measures: condition-specific average number of Elixhauser comorbid condition, and 
condition-specific proportion of patients having a history of hospitalization.  We capture 
hospital location with Metropolitan Statistical Area.  
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CHAPTER III: METHODS 
Subjects and Databases 
Three diagnosis-based patient cohorts were defined as follows: patients aged 65 
years or older enrolled in Medicare fee-for-service program for 2007 who had been 
discharged from the acute care hospital in California and Florida with the principal 
diagnosis of heart failure (International Classification of Disease, Ninth Revision, 
Clinical Modification [ICD-9-CM] codes 402.01, 402.11, 402.91, 404.01, 404.03, 404.11. 
404.13, 404.91, 404.93, or 428.0-428.9, acute myocardial infarction (ICD-9-CM codes 
410.0-410.9), and pneumonia (ICD-9-CM codes 480.8, 480.9, 481, or 482.0-487.0).  
The conditions were selected in that they are common, costly causes of hospitalization.  
Since this study used state-level discharge records, rather than national-level records, 
out-of-state patients’ readmissions could not be ascertained.  Therefore, out-of-state 
patients were excluded.  Patients who died are excluded because they are not eligible for 
readmissions.  An admission with a discharge status of “left against medical advice” 
was also excluded because hospitals did not have the opportunity to deliver intended care.   
 Data on inpatient hospital discharges records for the 24-month period from 
January 1, 2006, through December 31, 2007 were drawn from complete hospital 
discharges in the Healthcare Cost and Utilization Project State Inpatient Database (herein 
referred to as the HCUP-SID) of the Agency for Healthcare Research and Quality (herein 
referred to as the AHRQ) and the Supplemental Files for Revisit Analyses (herein 
referred to as the Revisit Files).  The HCUP-SID is the largest collection of all-payer, 
uniform, state-based, inpatient administrative data.  The HCUP database contains 
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discharge-level rather than patient-level data, and there is no unique patient identifier that 
can serve to track readmissions.  To facilitate analyses that focus on multiple hospital 
stays by the same patient, AHRQ created the Revisit Files which can be linked to the 
HCUP state-level databases to identify multiple patient visits in the hospital setting while 
adhering to strict privacy regulations.  Two data periods were used in the analysis.  
From HCUP-SID database for the 12-month period from January 1, 2007, through 
December 31, 2007, we tracked potentially preventable readmissions, severity, 
comorbidities, and post-discharge characteristics.  Next, the HCUP-SID file for the 
12-month period from January 1, 2006, through December 31, 2006 was used to track 
history of hospitalization within 1 year before the index admission. 
 Data on quality of inpatient care were obtained from the Centers for Medicare and 
Medicaid Services (CMS) Hospital Compare database for 2007.  The measures of 
quality of inpatient care cover the corresponding clinical conditions that were tracked for 
readmissions: heart failure, acute myocardial infarction, and pneumonia, between January 
1 and December 31, 2007. 
 We used two data sources for hospital characteristics: American Hospital 
Association Annual Survey of Hospitals files and the HCUP-SID file.  Data on hospital 
structural characteristics (such as size and ownership status) where patients were treated 
during initial hospitalizations were obtained from the American Hospital Association 
Annual Survey of Hospitals files for 2007.  The American Hospital Association Annual 
Survey of Hospitals collects data each year from hospitals nationwide regardless of their 
membership status and typically obtains an overall response rate of 85% or greater (AHA, 
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1999).  Data on hospital operational and demographic characteristics (such as mean 
number of patient comorbid conditions and condition-specific hospital volume) were 
directly derived from inpatient discharge records from HCUP-SID file.   
 To create the analytical file, inpatient discharge records from the HCUP-SID file 
were linked to the AHA-ASH files for information on hospitals where patients were 
treated during index hospitalization.  The HCUP-SID file provides information on the 
hospital identifier used by AHA.  Then, this dataset was merged with CMS Hospital 
Compare database using Medicare provider number. 
 
Variables & Measures 
Dependent Variable: Potentially Preventable Readmissions (PPR) 
Our outcome variable is a dichotomous measure of whether a patient was 
readmitted for potentially preventable reasons (coded 0) or not (coded 1).  We employed 
the potentially preventable readmission (herein referred to as the PPR) methodology 
developed by 3M Health Information Systems.  3M PPR algorithm defines PPRs as 
return hospitalizations within a specified time interval that may have resulted from 
deficiencies in the process of care in the initial admission, inadequate discharge planning, 
or lack of post discharge follow-up [5].   Based on all combinations of diagnoses for an 
index admission and for a readmission, 3M algorithm determines whether a particular 
diagnosis of readmission was clinically related to the index admission and, therefore, was 
potentially preventable.  The PPR software uses primary and secondary diagnostic codes, 
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procedure codes, and all-patient refined diagnosis related group (APR-DRG) codes to 
determine the preventability of readmissions.  In developing PPR logic, clinical panels 
applied criteria for clinical relevance and preventability. 
It should be noted the limitation of the 3M PPR measure.  PPR measure requires 
validation studies assessing reproducibility and reliability of the judgment process.  
While 3M PPR methodology needs validation studies, it is being used in several state 
agencies including New York, Florida, Texas, Maryland, Massachusetts, Colorado, and 
Hawaii.  It was also used by the Medicare Payment Advisory Commission (MedPAC), 
an independent Congressional agency.   
 The 3M PPR logic can be divided into three phases.  In phase I, each admission 
is assigned an APR-DRG to identify globally-excluded admissions and Non-events.  
Globally-excluded admissions include admissions for major or metastatic malignancies, 
multiple trauma, and burns.  A Non-event is an admission to a non-acute care facility 
such as a nursing home or an admission to an acute care hospital for non-acute care (e.g., 
rehabilitation or convalescence).  Non-events during the readmission time window 
between an initial admission and a readmission are ignored in the determination of PPR.  
The following admissions are classified as Non-events: 1) admission to non-acute care 
facilities, 2) admissions to an acute care hospital for patients assigned to the base 
APR-DRG for rehabilitation, aftercare, and convalescence, and 3) same-day transfers to 
an acute care hospital for non-acute care.   
In phase II, the readmission time interval is applied to the remaining admissions 
resulting in each admission being preliminarily classified into one of four admission 
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categories: Initial Admission, Readmission, Only Admission, and Transfer Admission.  
The Initial Admission is an admission that is followed by a clinically-related readmission 
(i.e., PPR).  The Initial Admission initiates a readmission chain which is a sequence of 
PPRs that are all clinically-related to the Initial Admission.  An Only Admission is an 
admission for which there is neither a preceding Initial Admission nor a PPR within the 
readmission time window.  Transfer Admissions are a subset of Only Admissions that 
have a discharge status of “transferred to an acute care hospital”.  Transfer Admissions 
are not eligible to be PPRs.  Note that Initial Admissions and Only Admissions 
represent admissions that are at risk for being followed by a PPR.    
In phase III, PPRs are identified based on the clinical relationship between the 
Initial Admission and readmissions, within the readmission time window.  A 
readmission is considered clinically-related to the Initial Admission if the reason for the 
readmission falls into one of following categories:  
 Medical readmission for a continuation or recurrence of the reason for the 
Initial Admission, or for a condition closely related to the reason for the Initial 
Admission 
 Ambulatory care sensitive conditions as designated by the AHRQ 
 All other readmissions for a chronic problem that may be related to care either 
during or after the initial admission 
 Medical readmission for an acute medical condition or complication that may 
be related to or may have resulted from care during the initial admission or in 
the post-discharge period after the Initial Admission 
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 Readmission for a surgical procedure to address a continuation or a recurrence 
of the problem causing the Initial Admission 
 Readmission for a surgical procedure to address a complication that may be 
related to or may have resulted from care during the initial admission 
Our outcome variable is a dichotomous measure of whether a patient readmitted for 
potentially preventable reasons (Initial Admission: coded 0) or not (Only Admission: 
coded 1).  The PPR software allows researchers to specify additional criteria to be PPRs, 
including readmission setting (i.e., readmission to the same-hospital or to the across 
hospitals) and readmission time interval.  We used across-hospital readmissions rather 
than same-hospital readmissions.  Using same-hospital readmission may generate a 
serious bias in favor of institutions whose patients are readmitted elsewhere [77].  We 
employed 30-days as readmission time interval because the shorter readmission window 
is useful for evaluating quality of care during index hospitalization.   
 
Explanatory variable: Clinical Process Quality   
The explanatory variable for the present study is hospital-level process quality of 
inpatient care.  Process measures are procedures, treatments, or interventions that are 
designed to improve patient outcomes.  Unlike outcome measure, such as mortality and 
readmission rates, process measures reflect actionable for quality improvement activities 
as they are under the control of hospitals and health care providers [78].  In addition, 
process measures may provide positive spillover effects, such as raising health care 
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providers’ awareness about clinical guidelines and enhancing overall commitment to a 
high quality of care [79].  Hospitals that better adhere to the recommended clinical 
process care may devote their resources to improving quality of care and hence, are likely 
to perform well in other process and outcome measures.  Hence, hospitals’ performance 
on process quality metrics may be an indicator for a latent construct of unobserved 
aspects of quality of inpatient care. 
We used CMS Hospital Compare hospital process of quality measure set.  The 
Hospital Quality Alliance (HQA), a national public-private collaboration between the 
CMS and hospital organizations, report hospitals’ performance on process of care 
measures through the Hospital Compare.  These measures evaluate a hospital’s 
adherence to recommended clinical process of care for heart attack, heart failure and 
pneumonia.  Six of the measures assess process quality of care for heart attack, three of 
the measures assess process quality of care for heart failure, and six of measures assess 
clinical process quality of care for pneumonia.  Beneficial effects of these measures on 
the readmission are well documented [80-83]. 
 Measures for heart attack include: (1) aspirin at arrival; (2) aspirin at discharge; (3) 
beta-blocker at arrival; (4) angiotensin converting enzyme (ACE) inhibitor for left 
ventricular systolic (LVS) dysfunction; (5) fibrinolytic medication within 30 Minutes of 
arrival; and (6) PCI within 90 minutes of arrival.  Measures for heart failure include: (1) 
written discharge instructions or education material that address activity level, diet, 
discharge medication, follow-up appointment, weight monitoring, and what to do if 
symptoms worsen; (2) evaluation of left ventricular function; and (3) prescription of an 
angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) at 
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discharge to eligible patients with left ventricular systolic dysfunction without 
contraindications.  Measures for pneumonia include: (1) pneumococcal vaccination, (2) 
initial antibiohjotic timing; (3) influenza vaccination; (4) blood culture performed in the 
emergency department prior to initial antibiotic received in hospital; (5) appropriate 
initial antibiotic selection; and (6) oxygenation assessment.  For each measure, a 
hospital’s performance was calculated as the proportion of all eligible patients who 
received the indicated care.  To ensure the stability of the measures, hospitals with fewer 
than 15 patients for an individual measure were excluded. 
 Composite measures enable us to improve the ability to detect differences by 
capturing the spectrum of care of a condition into a single measure [84, 85].  Hence, we 
also constructed two condition-specific composite measures from the individual measures.  
First, composite measures at admission and at discharge within conditions were 
calculated using a weighted average of performance across all measures, respectively.  
AMI measures assessed at admission included: 1) aspirin at arrival, 2) beta-blocker at 
arrival, and 3) percutaneous coronary interventions (PCI) within 90m of arrival.  AMI 
measures assessed at discharge included: 1) angiotensin converting enzyme inhibitor 
(ACE Inhibitor) or Angiotensin Receptor Blockers (ARB) for Left Ventricular Systolic 
Dysfunction (LVSD), 2) aspirin at discharge, and 3) beta-blocker at discharge.  
Pneumonia measures assessed at admission included: 1) assessed and given influenza 
vaccination and 2) assessed and given pneumococcal vaccination.  Pneumonia measures 
assessed at discharge included: 1) initial antibiotic(s) within 6h after arrival, 2) 
oxygenation assessment, 3) the most appropriate initial antibiotic(s), and 4) initial 
emergency room (ER) blood culture performed prior to first hospital dose of antibiotics.  
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There was no HF composite measure assessed at admission.  HF measures assessed at 
discharge included: 1) ACE inhibitor or ARB for LVSD, 2) evaluation of LVS Function, 
and 3) discharge instructions.   
 Second, a global composite measure was calculated by aggregating all individual 
measures within conditions using a weighted average of performance across all measures.  
A global measure was not calculated for heart failure because there was no admission 
composite measure.  Therefore, for pneumonia and AMI, three composite measures (i.e., 
admission composite measure, discharge composite measure, and global composite 
measure) were constructed, respectively, and for heart failure, only one composite 
measure (i.e., discharge composite measure) was calculated.  Hospitals with fewer than 
15 patients for an individual measure were not included in the calculation of the 
composite score.  However, as long as a hospital reported a denominator of at least 15 
cases for at least one measure, the hospital had composite scores.   
 There is no flawless measure; the CMS Hospital Compare measures also have 
several potential limitations.  The data are based on voluntarily self-reported measures, 
and consequently it is likely that there is a systematic scoring bias in hospitals' 
incomplete reporting across all measures.  That is, hospitals might not report specific 
performance scores if they poorly performed in the particular measure.  Another issue 
related to Medicare’s Hospital Compare is reliability of the submitted data.  While CMS 
audits submitted data, it is not adequate for validation of the data because CMS audit 
process is based on random sample of hospitals.        
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Patient-level control variables 
 We adjusted patients’ clinical, socio-demographical, and post discharge 
characteristics that may influence the likelihood of patient being readmitted for 
potentially preventable reasons.  We captured patients’ socio-demographic background 
by several measures: age (continuous variable measured in years), sex (dichotomous 
variable: female=1, male=0), race/ethnicity (categorical variable: White=0, Black=1, 
Hispanic=2, others=3), and median household income state quartile for patient ZIP Code 
(categorical variable: poorest=1, poor=2, wealthy=3, wealthiest=4).  We captured 
patients’ severity by history of hospitalization within 1 year (categorical variable: no 
history of hospitalization=0, hospitalized for same condition with the index admission 
and no history of hospitalization for other condition=1, no history of hospitalization for 
the same condition with the index admission and hospitalized for other diagnosis=2, 
hospitalized for both the same and other condition with the index admission=3).  We 
identified patients’ comorbid conditions with Elixhauser index by a series of dummy 
variables of whether patients had a comorbid condition (coded 1) or not (coded 0).   
The Elixhauser index captures the presence of 31 diseases using administrative data.  
We captured disposition of the patient at discharge (categorical variable: routine/home=0, 
nursing home=1, home health care=2, other=3).  For patients with acute myocardial 
infarction, we captured the location of acute myocardial infarction by two dummy 
variables of whether patients had an “anterior AMI” (coded 1) or not (coded 0) and 
whether patients had an “other AMI” (coded 1) or not.  In addition, we also captured 
cardiac procedures by dummy variables of whether patients with acute myocardial 
infarction underwent coronary artery bypass graft (coded 1) or not and of whether 
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patients underwent percutaneous transluminal coronary angioplasty (PTCA) (coded 1) or 
not (coded 0). 
 
Hospital-level control variables  
 We controlled for a number of hospital level factors, including structural, 
operational, and demographic characteristics of hospitals.  Structural and operational 
characteristics included hospital ownership status (categorical variable: public, non-profit, 
for-profit), teaching intensity (categorical variable: non-teaching if zero resident-to-bed 
ratio, low-intensity if 0-0.05 resident-to-bed ratio, medium-intensity if 0.05-0.6 
resident-to-bed ratio, and high-intensity if >0.6 resident-to-bed ratio), Medicare 
disproportionate-share hospital (DSH) index as a proxy of the proportion of poor patients, 
whether a hospital had a better nurse care environments  (coded 1) or not (coded 0), 
measured by Magnet status, whether a hospital was affiliated with health care systems 
(coded 1) or not (coded 0), and hospital location based on Metropolitan Statistical Area 
(categorical variable: metro, micro/division, or rural).  A dummy variable was also 
constructed to indicate the State.  We captured condition-specific hospital volume of the 
elderly patients (continuous variables).   
 We captured hospital demographic composition with several measures: hospital 
average number of Elixhauser comorbid condition for each condition, proportion of 
patients having a history of hospitalization for both the same and other condition with the 
index admission for each condition.   
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Analytic approach 
 Because of the hierarchical structure of the data, with patients nested within 
hospitals, we used hierarchical generalized linear modeling, a multilevel logistic 
regression model, to measure the relationship between process quality inpatient care and 
PPR.   
 We first fit a null model with no fixed effects and random intercept effects for 
hospitals to test whether significant variation in PPR exists across hospitals.  
 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߚ଴௝   ...………………………….......... (eq.1) 
ߚ଴௝ ൌ ߛ଴଴ ൅ ݑ଴௝   …………………………............................. (eq.2) 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߛ଴଴ ൅ ݑ଴௝   …....................................... (eq.3) 
 
where ݌௜௝is the probability of the ith patient in the jth hospital PPR, ݑ଴௝ is the random 
effect at the hospital level, and ߛ଴଴is the regression intercept.  We find the single 
equation model eq.3 by substituting eq.2 into eq.1.  Then we modeled patient level 
predictors of probability of PPR. 
 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߚ଴௝ ൅ ߛ௣଴ࢄ௣௜௝   ……………………… (eq.4) 
ߚ଴௝ ൌ ߛ଴଴ ൅ ݑ଴௝   …………………………….…….………… (eq.5) 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߛ଴଴ ൅ ߛ௣଴ࢄ௣௜௝ ൅ ݑ଴௝   ……………….. (eq.6) 
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where  ܺ௣௜௝ are p explanatory variable at the patient level.  Again, the intercept was 
allowed to vary across hospitals (i.e. to be random).  All independent variables at patient 
level were estimated as fixed effects.  In other words, the between-hospital variances of 
their associations to the outcome are fixed to zero.  Our final model included patient 
level predictors and hospital level predictors.   
 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߚ଴௝ ൅ ߛ୮଴ࢄ௣௜௝   ………………………. (eq.7) 
ߚ଴௝ ൌ ߛ଴଴ ൅ ߛ଴௤ࢆ௤௝ ൅ ݑ଴௝   ……………………….………….. (eq.8) 
log ቀ൫݌௜௝ 1 െ ݌௜௝⁄ ൯ቁ ൌ ߛ଴଴ ൅ ߛ୮଴ࢄ௣௜௝ ൅ ߛ଴௤ࢆ௤௝ ൅ ݑ଴௝  ……… (eq.9) 
 
where ܺ௣௜௝ are p explanatory variable at the patient level and ܼ௤௝ are q explanatory 
variable at the hospital level.  While the intercept was allowed to be random, all 
independent variables at both patient and hospital level were estimated as fixed effects.  
This model allows us to examine whether the hospital-level explanatory variables, such 
as process quality of inpatient care, are associated with the hospital-level estimate of the 
proportion of patients who were readmitted for potentially preventable reasons (i.e., the 
PPR rate in each hospital).   
 
 In the fixed-effects part, we calculated odds ratios (OR) and their 95% confidence 
intervals (95% CI).  In the random-effects part, we obtained the variance and their 95% 
confidence intervals (95% CI) at the hospital level.  In order to quantify the importance 
of variance at hospital level, we calculated intraclass correlation coefficient (ICC) and the 
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median odd ratio (MOR).  Intraclass correlation coefficient (on the logit scale) indicates 
the proportion of variance that is accounted for by the hospital level.  ICC is calculated 
by using following formula:  ߩூ ൌ ߪ௨మ/ሺߪ௨మ ൅ ߪ௘మሻ, where ߪ௘మ is the variance of the 
standard logistic distribution, estimated by ߨଶ 3⁄ ൌ 3.29.  In addition to the ICC, the 
MOR was calculated and examined to the degree of heterogeneity.  The MOR converts 
the variances into the OR scale which is comparable with the OR of the patient- or 
hospital-level explanatory variables and thereby enables us to interpret variance more 
intuitively.   The MOR can be interpreted as how much a patient’s odds of being 
readmitted would increase if the patient moved to a hospital with larger random intercept 
(i.e. higher PPR rates).  The MOR is calculated by using the following formula: 
MOR ൌ exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
 
 Our outcome variable is a binary measure of whether a patient readmitted for 
potentially preventable reasons (Initial Admission, coded 0) or not (Only Admission, 
coded 1).  While most patients in the cohorts of acute myocardial infarction and 
pneumonia had 1 candidate discharge record of either Initial Admission or Only 
Admission within a 1-year period, multiple candidate discharges were frequent in the 
patient cohort of heart failure.  We randomly selected 1 discharge if the multiple 
candidate discharges records were observed within a 1-year period.  As mentioned 
earlier, we excluded patients who died during index hospitalization because they are not 
eligible for readmissions.  We lack of data on post-discharge patient mortality. We 
were not able to track process measure-specific 30-day PPR that match specific quality 
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measures because we lack patient-level data on the eligible population and those who 
received the indicated care. 
The associations between process quality measures and condition-specific PPR 
were modeled separately.  This work performed all statistical analyses using STATA 
11.2 (StataCorp, College Station, TX). A P value of less than .05 was considered 
statistically significant. 
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CHAPTER IV: RESULTS 
 Overall, 42051 heart failure, 21635 acute myocardial infarction, and 36384 
pneumonia discharges were analyzed.  Mean age of the heart failure cohort was 80.5, 
54.5% were female, and 72.2% were white.  Mean age of the acute myocardial 
infarction cohort was 78.9, 49.3% were female, and 79.4% were white.  For the 
pneumonia cohort, mean age was 80.3, 55.5% were female, and 76.7% were white.   
 
Hospital Characteristics 
 The characteristics of the hospitals are summarized in Table 3.  Overall, 427 
hospitals were included in the analysis of heart failure, 380 in acute myocardial infarction, 
and 426 in pneumonia.  The numbers of hospitals were different by conditions as the 
number of hospitals which reported performance for process quality measures were 
different by conditions.  As noted, for descriptive purposes, this study divided hospitals 
into three groups according to their condition-specific, crude 30-day PPR rates.  The 
mean crude 30-day PPR rates are 16.63% for heart failure, 17.11% for acute myocardial 
infarction, and 11.50% for pneumonia, respectively.  Among hospitals with low crude 
30-day PPR rates for heart failure, a larger proportion of hospitals were private non-profit, 
had cardiac catherization capabilities, were located in urban areas, and had a low DSH 
index.  Among hospitals with low crude 30-day PPR rates for pneumonia, a larger 
proportion of hospitals had cardiac catherization capabilities, had Magnet status, were 
located in urban, were located in California, had a low DSH index, and cared for less 
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severe patients (measured by proportion of patients with history of prior hospitalization 
for both pneumonia and other conditions).  Among hospitals with low crude 30-day PPR 
rates for acute myocardial infarction, a larger proportion of hospitals were private 
non-profit, had cardiac catherization capabilities, had Magnet status, were located in 
urban, were located in California, had a low DSH index, and cared for less severe patients 
(measured by proportion of patients with prior hospitalization for both acute myocardial 
infarction and other conditions).   
 Hospitals with high condition-specific patient volume, with cardiac catherization 
capabilities, and with urban location had low crude 30-day PPR rates across all three 
conditions. 
 
Hospital performance on process quality measures  
 Hospital performance for individual process quality measures and the composite 
measures are summarized in Table 4.  In general, there was little variation in the 
measures of process quality of inpatient care for all conditions across hospitals.  In the 
case of five out of six individual measures for acute myocardial infarction, hospitals 
performing in the top 25th percentile adhered to the recommended care more than 99% of 
the time.  For the measures of heart failure, hospitals performing in the top 25th 
percentile adhered to the recommended care more than 95% of the time for all three 
individual measures.  For the measures of pneumonia, hospitals performing in the top 
25th percentile adhered to the recommended care more than 94% of the time for all six 
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individual measures. There were relatively more variations among lower-performing 
hospitals compared to the higher-performing counterparts. In general, there were 
relatively more variations in the following measures: evaluation of LVS function for 
heart failure patients, PCI within 90m of arrival for acute myocardial infarction patients, 
and assessed and given influenza vaccination and pneumococcal vaccination for 
pneumonia patients.   
 
Hierarchical Analyses 
Within Hospitals (Level 1) Results 
 While our primary focus lies on hospital characteristics associated with PPR rates, 
we briefly report key findings on the association between patient-level risk factors and 
30-day PPR.  Patient level factors that are associated with 30-day risk-adjusted PPR are 
summarized in Table 4 for heart failure, Table 6 for acute myocardial infarction, and 
Table 7 for pneumonia.  Multivariate results indicate that patients who were discharged 
to home health care or nursing home are more likely to be readmitted for a potentially 
preventable reason compared to those who were discharged to home (i.e., routine 
discharge) across all three conditions.  Specifically, for heart failure patients, discharge 
to home health care had increased the odds of being readmitted for a potentially 
preventable reason by 17-18% (p<.001) and discharge to nursing home increased the 
odds of being readmitted for a potentially preventable reason by 57-58% (p<0.001) 
compared to those discharged to home or self-care, after controlling for patient- and 
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hospital-level characteristics (Table 3).  For acute myocardial infarction and pneumonia 
patients, the magnitudes of the increased odds of 30-day PPR were stronger than heart 
failure; discharge to home health care increased the odds of being readmitted for a 
potentially preventable reason by 30-41% (p<0.001) compared to discharge to home or 
self-care, after controlling for patient- and hospital-level characteristics, and discharge to 
nursing home care increased the odds of being readmitted for a potentially preventable 
reason by 87-99% (p<0.001) compared to discharge to home or self-care (Table 4).  In 
the case of pneumonia patients, the magnitude of the increased odds of 30-day PPR was 
stronger than other conditions.  Discharged to home health care increased the odds of 
being readmitted for a potentially preventable reason by 34-36% compared to those 
discharged to home or self-care (p<0.001) and discharge to nursing home increased the 
odds of being readmitted for a potentially preventable reason by 110-114%, after 
controlling for patient- and hospital-level characteristics (p<0.001) (Table 7).   
 Patients with more severity, measured by history of prior admission, also had 
higher odds of 30-day PPR across all three conditions.  For the heart failure cohort, 
history of prior hospitalization in 12 months for both heart failure and other conditions  
increased the odds of being readmitted for a potentially preventable reason by 83% 
compared to no history of hospitalization in 12 months (p<0.001) (Table 5).  For the 
pneumonia cohort, magnitude of the increased odds of 30-day PPR was slightly stronger 
than heart failure cohort; history of prior hospitalization in 12 months for both pneumonia 
and other conditions increased the odds of being readmitted for a potentially preventable 
reason by 85-86% compared to patients without history of hospitalization in 12 months 
(p<0.001) (Table 6).  For acute myocardial infarction patients, magnitude of the 
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increased odds of 30-day PPR was weaker than other two conditions; prior 
hospitalization in 12 months for both acute myocardial infarction and other conditions 
increased the odds of being readmitted for a potentially preventable reason by 47-50% as 
compared to patients without history of hospitalization in 12 months (p<0.001) (Table 7).  
History of prior hospitalization in 12 months with the same diagnosis as the initial 
admission was also a strong risk factor for 30-day PPR across all conditions although 
magnitude of increased odds of 30-day PPR is weaker than history of prior admissions 
for both same diagnosis and other conditions for the initial admission.  For acute 
myocardial infarction, undergoing coronary artery bypass grafting (CABG) decreased the 
odds of being readmitted for a potentially preventable reason by 22-23% compared to 
patients without the procedure (p<0.01).  For acute myocardial infarction, undergoing 
percutaneous transluminal coronary angioplasty (PTCA) increased the odds of being 
readmitted for a potentially preventable reason by 12-14% (p<0.05). 
 Patients with renal failure and chronic pulmonary disease had increased odds of 
30-day PPR across all three conditions.  Specifically, for heart failure patients, having 
renal failure increased the odds of being readmitted for a potentially preventable reason 
by 24% (p<0.001) and having chronic pulmonary disease increased the odds of being 
readmitted for a potentially preventable reason by 11% (p<0.001) (Table 5).  For acute 
myocardial infarction patients, having renal failure increased the odds of being 
readmitted for a potentially preventable reason by 18-21% (p<0.001) and having chronic 
pulmonary disease increased the odds of being readmitted for a potentially preventable 
reason by 17-19% (p<0.001) (Table 6).  For pneumonia patients, having renal failure 
increased the odds of being readmitted for a potentially preventable reason by 13-14% 
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(p<0.01) and having chronic pulmonary disease increased the odds of being readmitted 
for a potentially preventable reason by 19% (p<0.001) (Table 7).  In addition to these 
two comorbid conditions, heart failure patients with iron deficiency anemias, diabetes 
with chronic complications, fluid & electrolyte disorders, peripheral vascular disorders, 
or psychoses had increased odds of 30-day PPR (p<0.05 for all).  While acute 
myocardial infarction patients with diabetes (both with and without complications) and 
with peptic ulcer disease had increased odds of 30-day PPR; those with metastatic cancer 
had decreased odds of 30-day PPR (p<0.05).  Lastly, pneumonia patients with 
rheumatoid arthritis, congestive heart failure, or weight loss had higher odds of 30-day 
PPR (p<0.05 for all).  
 Several socio-demographic factors were associated with 30-day PPR.  For heart 
failure patients, advanced age and Hispanic race (compared to white), were significantly 
associated with increase odds of 30-day PPR (p<0.05 for all).  For pneumonia patients, 
female sex and other races (compared to white) were associated with decreased odds of 
30-days PPR (p<0.05 for all).  For acute myocardial infarction patients, none of the 
socio-demographic factors were found to be associated with odds of 30-day PPR.   
 
Between Hospitals (Level 2) Results  
 The results of our 22 separate unconditional models consistently indicate that 
statistically significant variance in PPR rates exists at the hospital level, underlining the 
need to look at the hierarchical nature of PPR (p<0.001 for 20 models and p<0.01 for 2 
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out of 22 models).  Degree of variance in PPR rates between hospitals varies by medical 
conditions; variance is smaller in cardiovascular conditions than in pneumonia.  
Variance between hospitals in unconditional models (Model 1) for heart failure ranged 
from 0.029 to 0.030, for acute myocardial infarction ranged from 0.023 to 0.040, and for 
pneumonia ranged from 0.105 to 0.113.  The reason for slightly different variances 
between hospitals in the same condition is due to different number of observation in each 
model.  Variance between hospitals in the full models without interaction (Model 3) for 
heart failure ranged from 0.015 to 0.016, for acute myocardial infarction ranged from 
0.005 to 0.023, and for pneumonia ranged from 0.058 to 0.062.  
 As mentioned earlier, due to limitations of the ICC for non-linear outcomes, we 
also calculated the median odds ratio (MOR).  After controlling for patient-and 
hospital-level characteristics (Model 3), for a randomly selected heart failure patient 
changing hospital, from low to high odds of being readmitted within 30 days for a 
potentially preventable reason, the odds would in median increase by 1.13-fold (Median 
Odds Ratio=1.13 for all of the four heart failure measures).  After controlling for 
patient-and hospital-level characteristics, for a randomly selected acute myocardial 
infarction patient changing hospital, from low to high odds of being readmitted within 30 
days for a potentially preventable reason, the odds would in median increase by from 
1.07-fold to 1.16-fold (range of Median Odds Ratio for 9 AMI measures: 1.07-1.16).  
For an pneumonia patient changing hospital, from low to high odds of being readmitted 
within 30 days for a potentially preventable reason, the odds would increase by from 
1.26-fold to 1.27-fold (range of Median Odds Ratio for 9 PN measures: 1.26-1.27).  In 
other words, a randomly selected pneumonia patient’s median odds ratio of being 
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readmitted within 30 days for a potentially preventable reason(s) would increase 1.26- to 
1.27-fold if he/she was discharged from a hospital with a higher PPR rates. 
 
Association between process quality of inpatient care and condition-specific, 30-day 
risk-adjusted PPR rates 
-Main effect 
 Summary of association of condition-specific PPR with individual and composite 
process quality measures after controlling patient- and hospital-level factors are 
summarized in Table 8 for heart failure, Table 9 for acute myocardial infarction, and 
Table 10 for pneumonia, respectively.  Full results are presented in Appendix Tables 
(Appendix Tables 1 to 4 for heart failure, 5 to 13 for acute myocardial infarction, and 14 
to 22 for pneumonia).   
 We found that the existence of inverse association between process quality of 
inpatient care and 30-day, risk-adjusted PPR rates varies by medical conditions; that is, 
we observed the hypothesized inverse association between process quality of inpatient 
care and 30-day, risk-adjusted PPR rates in pneumonia but not generally in two 
cardiovascular conditions (i.e., heart failure and acute myocardial infarction).  For 
pneumonia, as performance for process quality of inpatient care increases, 30-day, 
risk-adjusted hospital PPR rates tend to decline after adjusting for patient clinical and 
demographical characteristics and hospital characteristics (Table 10).  There was a 
significant inverse association between all 3 composite measures (i.e., admission, 
47 
 
discharge, and global composite) and 30-day, risk-adjusted PPR rates (p<0.05 for each 
measure).  Specifically, for every one point increase in the admission composite score 
out of 100 possible points, the odds of being readmitted for a potentially preventable 
reason decreased by 2% (p<0.01).  For the discharge composite measure, a weaker 
magnitude of association was observed than admission composite measure; for every one 
point increase in the discharge composite score out of 100 possible points, the odds of 
being readmitted within 30 days for a potentially preventable reason decreased by 0.2% 
decrease in the odds of being readmitted within 30 days for a potentially preventable 
reason (p<0.05).  For every one point increase in the global composite score out of 100 
possible points, the odds of being readmitted within 30 days for a potentially preventable 
reason decreased by 0.8% (p<0.01).   
 For the individual pneumonia process quality measure, two out of six individual 
measures had a statistically significant inverse association with 30-day, risk-adjusted PPR 
rates (p<0.05 for each measure) and other three measures exhibited marginally significant 
inverse trends (p<0.10 for each measure).  Specifically, for every one point increase in 
the “assessed and given influenza vaccination” out of 100 possible points, the odds of 
being readmitted within 30 days for a potentially preventable reason decreased by 0.3% 
decrease in the odds of being readmitted within 30 days for a potentially preventable 
reason (p<0.05).  “the most appropriate initial antibiotic(s)” turned out to be inversely 
associated with 30-day, risk-adjusted PPR rates; that is, for every one point increase in 
the most appropriate initial antibiotic(s) out of 100 possible points, the odds of being 
readmitted within 30 days for a potentially preventable reason decreased by 3.4%, 
(p<0.01).   
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 The rest of the individual measures for pneumonia exhibited marginal influence 
on the PPR rates, with the exception of “Initial ER Blood Culture Performed Prior To 
First Hospital Dose of Antibiotic”.  Specifically, for every one-point increase in 
“Assessed and Given Pneumococcal Vaccination” the odds of being readmitted within 30 
days for a potentially preventable reason decreased by 0.2% (p=0.08).  For every 
one-point increase in “Initial Antibiotic(s) within 6h After Arrival” the odds of being 
readmitted within 30 days for a potentially preventable reason decreased by 0.7% 
(p=0.05).  Lastly every one point increase in “Oxygenation Assessment” the odds of 
being readmitted within 30 days for a potentially preventable reason decreased by 3.3% 
(p=0.05). 
 Contrary to the pneumonia, the quality scores for the two cardiovascular 
conditions were generally found to be unrelated to 30-day, risk-adjusted PPR rates after 
adjusting for patient clinical and demographical characteristics and hospital 
characteristics.  For acute myocardial infarction, neither composite nor individual 
measures had a statistically significant relation to 30-day, risk-adjusted PPR rate, with the 
exception of “PCI within 90m of arrival” (Table 9).  There was a relatively larger 
variation in hospital performance for this measure, “PCI within 90m of arrival”, 
compared to other process quality measures for acute myocardial infarction.  For every 
one point increase in “PCI within 90m of arrival, the odds of being readmitted within 30 
days for a potentially preventable reason decreased by 0.4% (p<0.01).  The admission 
composite measure was marginally significant, but had a modest influence on the 30-day, 
risk-adjusted PPR rates; for every one point increase in admission composite measure, 
the odds of being readmitted within 30 days for a potentially preventable reason 
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decreased by 1% (p=0.09).  For other individual and composite measures for acute 
myocardial infarction, although statistically insignificant, the inverse direction of the 
association between process measures and PPR rates was consistently observed.  As for 
heart failure, none of the composite and individual measures were statistically associated 
with 30-day, risk-adjusted PPR rates after adjusting for patient clinical and 
demographical characteristics and hospital characteristics (Table 8).   
- Interaction effect 
 We found no evidence of an interaction effect between condition-specific hospital 
volume and process quality of inpatient care for any of the three conditions.  
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CHAPTER V: DISCUSSION 
The present work examined the association between process quality of inpatient 
care and condition-specific risk-adjusted 30-day PPR rates (Research Question 1), and 
found that better performance on the process quality metrics was associated with the 
better patient outcome (i.e., low PPR rates) in pneumonia, but not generally in two 
cardiovascular conditions (i.e., heart failure and acute myocardial infarction).  Hospitals 
with better performance for process quality measures had lower condition-specific 30-day 
PPR rates for pneumonia, even after taking patient risk factors and hospital 
characteristics into account (p<0.05 for 5 out of 9 process quality measures and p<0.10 
for 3 out of 9 measures).  These findings are consistent with the results of previous 
studies that examined the association between quality of inpatient care and mortality rates 
at hospital level [21, 22].  However, we did not find a similar inverse pattern for heart 
failure and acute myocardial infarction.  While we observed, in the case of acute 
myocardial infarction, a statistically significant inverse association in one individual 
measure (i.e., PCI within 90m of arrival) and a marginally significant inverse trend in one 
composite measure (i.e., admission composite measure), none of the process quality 
measures for heart failure were found to be associated with condition-specific 30-day 
PPR rates.  Our findings of disassociation between heart failure process quality metrics 
and 30-day PPR rates are consistent with findings from previous OPTIMIZE-HF studies 
investigating the association between process quality measures for heart failure and 
cardiovascular readmissions [74, 75].  
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We also investigated whether the influence of process quality of inpatient care on 
potentially preventable readmission rates contingent on hospital condition-specific 
volume (Research Question 2), but found no evidence of an interaction effect for all three 
conditions.   
 There are possible reasons why the findings in cardiovascular conditions are 
dissimilar from those in pneumonia.  One hypothesis is that there was not enough 
variation in the cardiovascular measures of quality of inpatient care across hospitals for 
the present work to detect their significant associations with 30-day PPR rates.  For 
example, “PCI within 90 minutes of arrival” exhibited the lowest performance score with 
the largest variation among process quality measures for acute myocardial infarction, and 
among measures in acute myocardial infarction, it was the only significant measure that 
was inversely related to 30-day PPR rates.  While plausible, this hypothesis alone may 
not perfectly explicate the disassociations between process quality metrics and 30-day 
PPR rates because variations in the process quality measures for pneumonia were not 
substantially large, compared to those in the process measures for cardiovascular 
conditions.  In addition to little variations in the cardiovascular process measures, 
variance is relatively smaller in cardiovascular conditions compared to pneumonia.  
Variance between hospitals in unconditional models for heart failure ranged from 0.029 
to 0.030, for acute myocardial infarction ranged from 0.023 to 0.040, and for pneumonia 
ranged from 0.105 to 0.113.   
 Another hypothesis is that cardiovascular process quality metrics selected for the 
present study may indeed not be related with 30-day PPR rates.  Cardiovascular process  
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quality metrics employed in this study capture only incomplete information on hospitals’ 
adherence.  For example, five out of six AMI individual process quality measures are 
medication-related, such as beta-blocker, aspirin, and ACE Inhibitor.  Information about 
whether a hospital prescribed a drug (e.g., beta blocker) in aggregate only does not 
capture other important information about whether the appropriate dose was used, about 
whether appropriately prescribed a drug considering all of the types of unwanted 
medication reaction [86], or about whether patients adhered to medication instructions 
after discharge.  Those missing information for which current process metrics cannot 
capture might have associations with 30-day PPR rates.   
 Lastly, 30 days might be too short to observe the association of the medications, 
particularly beta-blockers, with PPR rates.  One systemic review of randomized 
controlled trials on beta blocker in the treatment for AMI found that short-term use (less 
than 1 year) of blockade after acute myocardial infarction may not have as large benefits 
as does long-term use (more than 1 year) [87].  This finding suggests that a longer 
readmission time-frame would be more suitable to detect link between beta-blockers and 
PPR rates, but, paradoxically, a longer readmission time-frame (> 90 days) reflects the 
effectiveness of community-based, monitoring and maintenance systems [4].  This study 
adopted a readmission time interval of 30-day because hospitals may have greater control 
over the clinical processes during the hospitalization and the discharge process.   
 Findings from the present study have implications for payers, providers, and 
future research on readmission.  This study identified risk factors for 30-day PPR among 
patients with heart failure, acute myocardial infarction, and pneumonia.  If readmission 
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becomes a part of an incentive program, hospitals may choose to focus their scarce 
resources on this subset of patients at high risks of potentially preventable readmissions.  
More importantly, our findings at hospital-level suggest that 30-day PPR rates in 
pneumonia might be reduced by hospitals’ efforts to better adhere to the recommended 
care.  This study also has an important implication to future health service research on 
readmission.  While a complex set of factors may contribute to occurrence of 
preventable readmissions, most theoretical and empirical attention has been paid to the 
patient-level factors, including demographics, socioeconomic standing, behaviors, and 
disease states.  The future research on potentially preventable readmissions might need 
to account for the quality of inpatient care provided to the patients during index 
hospitalization as well.  
 Better adherence to the process quality metrics for cardiovascular conditions 
currently in use by CMS may not lead to low 30-day PPR rates.  While we found an 
inverse association between process quality metrics currently in use by CMS for 
pneumonia and 30-day PPR rates, that was not the case for cardiovascular conditions.  
Performance for current clinical process quality metrics for pneumonia might be able to 
be considered as a potential indicator of 30-day PPR rates, but not for heart failure and 
acute myocardial infarction.  Performance measures should be confined to those clinical 
process of care for which the evidence is so robust that successful adherence to them 
increases the likelihood of optimal patient outcomes [88, 89].  Policy implications 
emerge from the present study.  First, if a policy objective is to reduce 30-day PPR rates 
for heart failure and acute myocardial infarction through enhancing hospital performance 
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for process quality of care, more evidence-based process quality metrics closely linked to 
30-day PPR rates needs to be developed.  Second, one size does not fit all.  As 
evidenced in this study, both the existence of an association and the magnitude of 
association between process and outcome are different for each condition.  Before 
implementing pay-for-performance broadly across all condition, policy makers need to 
confirm a causative association between process care metrics and patient outcomes for 
each condition. 
 Our findings should be interpreted with caution as this study has several 
limitations.  First, there have been no empirical studies validating the PPR algorithm.  
In developing PPR logic, clinical panels applied criteria for clinical relevance and 
preventability.  The PPR algorithm needs validation studies assessing reproducibility 
and reliability of the judgment process.  However, as mentioned earlier, the 
methodologies are being used in several state agencies, including New York, Florida, 
Texas, Massachusetts, Colorado, and Hawaii.  Second, risk-adjustment method used in 
this study has an inherent limitation in that it is only able to adjust to the extent that 
clinical information about the patient is captured by administrative data.  Administrative 
data sets have been criticized as lacking clinical detail, such as diagnostic and prognostic 
information, required to permit adequate adjustment for each patient's underlying medical 
condition[90-94].  Although we used a well-validated risk-adjustment model designed 
for use with administrative data [95, 96], the findings should be interpreted with cautions.  
Third, this work used a hospital discharge dataset that may contain misclassification of 
the variables due to coding errors in ICD-9-CM codes.  Fourth, the findings from this 
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study are limited in the reliance on the cross-sectional observational data which does not 
allow us to investigate a causal relationship between performance for process quality and 
30-day PPR rates.  It is possible that the observed association between process quality of 
inpatient care and 30-day PPR rates is confounded by patient or hospital factors that are 
not observed in our data.  More information about the patients and hospitals is needed to 
clarify whether the association reflects a causal relationship.  Fifth, because sample 
hospitals are located in California and Florida, our findings may not generalize to other 
geographic areas.  Similarly, as we focused only on three medical conditions, our 
findings may not be generalized to other medical and surgical conditions.  Finally, it is 
unclear how accurate hospitals’ process quality performance is.  Hospitals self-report 
their process quality performance and hence, it is likely that there is a systematic scoring 
bias in hospitals' incomplete reporting across all measures.  That is, hospitals might not 
report specific performance scores if they poorly performed in the particular measure.  If 
it is the case, the association between process quality of inpatient care and 30-day PPR 
rates may be weaker.  
We suggest avenues for future research on the PPR and process quality metrics.  
The first area of research for the future is to examine whether the findings of this study 
are generalizable at the national level.  We excluded patients who died during index 
hospitalization because they are not eligible for readmissions.  Consequently, higher 
in-hospital or post-discharge mortality rates could bias PPR rates because patients who 
died can no longer be readmitted.  A potential consequence of not accounting for the 
inter-dependence of these two risks is that if a hospital has higher mortality rate, a smaller 
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proportion of patients are eligible for PPR.  Hence, adjusting for the risk of mortality 
during index hospitalization and post discharge may alter our results.  Future studies 
need to investigate the association between process quality of inpatient care and 30-day 
PPR controlling for the simultaneous risk of intrahospital mortality and post discharge 
mortality.  The competing risks Cox proportional hazards regression model, controlling 
for the simultaneous risk of mortality, may be used in future studies.  Another area of 
future research is to examine, with a prospective, longitudinal study design, whether 
changes in performance for process quality metrics lead to changes in 30-day PPR rates.  
As discussed, process quality metrics in current use by CMS capture only whether 
hospitals adhere to a particular recommended procedure in a discrete manner (i.e., 
success or failure) even if there should be variation in quality of adherence to a particular 
recommended care.  As noted, information about whether a hospital adhered to a 
recommended process care does not tell much about quality of adherence.  Can we 
assume that the quality of performance for a particular process quality measure among 
hospitals if they performed equivalently for the measure?  Future research needs to 
explore the degree of heterogeneity of adherence to process quality metrics in equally 
performing groups although this will necessitate considerable time and resources to 
investigate.  This would make it possible to further differentiate the performance on 
process care measures that is once seemingly homogeneous.  Will our findings be 
different if a shorter readmission time frame will be chosen?  Future research need to 
investigate whether our findings will be unchanged even with shorter readmission time 
frame such as 7-days or 15-days.  Lastly, future research needs to determine the 
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association between process quality measures and 30-day PPR rates for other medical 
conditions and surgical procedures.   
Hospitals have a significant stake in identifying strategies that can reduce 
occurrences of preventable readmissions.  The recently enacted health reform legislation 
introduces a Hospital Readmissions Reduction Program (Section 3025 of the Patient 
Protection and Affordable Care Act).  For fiscal years beginning on or after October 1, 
2012, inpatient payments to hospitals will be reduced if a hospital experiences excessive 
readmissions within a specified period following discharge for a heart attack, heart failure, 
or pneumonia [97].  The present study revealed the inverse association of process 
quality of inpatient care with 30-day PPR rates in the case of pneumonia but not 
cardiovascular conditions.  Our work also identified patient risk factors associated with 
the risk of PPR at patient-level analysis.  Findings from this study may be served as 
useful sources to entities that are seeking ways to reduce the occurrences of PPRs. 
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Table 1:  
Studies investigating a link between performance for process measures and readmissions (or combined readmission and mortality) 
 
Citation 
Readmission 
Conditions & 
Timeframe 
Population & 
Setting 
Data 
sources 
Design & 
Sample size 
Statistical 
approach 
Process  
measures Results 
 
Hernandez 
[74] 
 
Cardiovascular 
readmission / 
60-day & 1-year 
 
HF patients from 
OPTIMIZE-HF 
registry 
 
OPTIMIZE-HF 
registry linked 
to Medicare 
claims data 
 
Retrospective 
cohort /  
Patients: 
20441; 
Hospitals: 
141 
 
Cox proportional 
hazards model 
 
6 performance measures: 1) 
Any β-blocker; 2) 
Evidence-based β-blocker; 3) 
Warfarin; 4) Aldosterone 
antagonist; 5) Implantable 
cardioverter-defibrillator; and 
6) Disease management 
 
“Evidence-based 
β-blocker” was 
associated with 
reduced risk of 
cardiovascular 
readmission both at 
60-day and 1-year. 
 
Patterson 
[75] 
 
Cardiovascular 
readmission / 
1-year 
 
HF patients from 
OPTIMIZE-HF 
registry 
 
OPTIMIZE-HF 
registry linked 
to Medicare 
claims data 
 
Retrospective 
cohort /  
Patients: 
22750; 
Hospitals: 
150 
 
Cox proportional 
hazards model 
 
5 performance measures: 1) 
discharge instruction; 2) 
Assessment of left 
ventricular function; 3) 
prescription of ACE inhibitor 
or angiotensin receptor 
blocker at discharge; 4) 
prescription of beta-blockers 
at discharge; and 5) smoking 
cessation counseling 
 
None of the 
performance measures 
was associated with 
reduced risk of 
cardiovascular 
readmission both at 
1-year. 
 
Fonarow 
[72] 
 
Combined 
mortality and 
all-cause 
readmission / 
60-90 days 
 
HF patients from 
OPTIMIZE-HF 
registry 
 
OPTIMIZE-HF 
registry linked 
to Medicare 
claims data 
 
Prospective 
cohort /  
Patients: 
5791; 
Hospitals: 91 
 
Cox proportional 
hazards models 
for mortality 
outcome and 
logistic 
regression model 
for the combined 
measure  
 
5 performance measures: 1) 
discharge instruction; 2) 
Assessment of left 
ventricular function; 3) 
prescription of ACE inhibitor 
or angiotensin receptor 
blocker at discharge; 4) 
prescription of beta-blockers 
at discharge; 5) Warfarin for 
atrial fibrillation; and 6) 
smoking cessation counseling 
 
“Prescription of ACE 
inhibitor or 
angiotensin receptor 
blocker at discharge” 
and “beta-blocker at 
discharge” were 
associated with 
reduced risk of 
combined mortality 
and readmission at 60- 
to 90-day. 
 
OPTIMZE-HF: Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure 
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Table 2:  
Studies (n=4) investigating hospital factors associated with all-cause readmissions  
 
Citation 
Readmission 
Conditions & 
Timeframe 
Population & 
Setting 
Data 
sources 
Design & 
Sample size  
Statistical 
approach 
Hospital factors 
associated with 
high readmission 
rates   
 
Anderson 
[54] 
 
All-cause /  
60-day  
 
Medicare patients 
(no restriction for 
the diagnosis of 
initial admission) 
 
1974-1977 
Medicare 
claims date; 
AHA Annual 
Survey of 
Hospitals (year 
N.S.) 
 
Cross-sectional / 
Patients: 
270,266; 
Hospitals: N.S. 
 
N.S. 
 
Non-teaching; 
With fewer beds   
 
Joynt 
(2011-a)   
[11] 
 
All-cause /  
30-day 
 
Medicare patients 
with heart failure 
 
2006-2007 
Medicare 
Provider 
Analysis 
Review 
(MedPAR); 
2007 AHA 
Annual Survey 
of Hospitals 
 
Cross-sectional / 
Discharge: 
905,764; 
Hospitals:  
4567 
 
Ordinary Least 
Square model 
 
For-profit and public; 
without cardiac 
services and hospitals 
with partial cardiac 
services; low nurse 
staffing; with fewer 
beds   
 
Joynt 
(2011-b) 
[12] 
 
All-cause /  
30-day 
 
Medicare patients 
with heart failure 
 
2006-2007 
Medicare 
Provider 
Analysis 
Review 
(MedPAR); 
2007 AHA 
Annual Survey 
of Hospitals 
 
Cross-sectional / 
Discharge:  
1,029,497; 
Hospitals: 
 4,095 
 
Logistic 
Regression 
model 
 
With low-volume for 
mortality rate but not 
for readmission rate  
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Joynt 
(2011-c) 
[13] 
 
All-cause /  
30-day 
 
Medicare patients 
with heart failure, 
acute myocardial 
infarction, or 
pneumonia 
 
2006-2008 
Medicare 
Provider 
Analysis 
Review 
(MedPAR); 
2007 AHA 
Annual Survey 
of Hospitals 
 
Retrospective 
cohort /  
Discharge:  
3,163,011; 
Hospitals:  
4,560 
 
Logistic 
Regression 
model 
 
Minority-serving 
hospitals   
 
N.S.: Not Specified 
AHA: American Hospital Association 
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Table 3: 
Hospital Characteristics 
 
 Heart Failure Acute Myocardial Infarction Pneumonia 
 Low (n=143) 
Medium 
(n=142) 
High 
(n=142) 
P 
Value 
Low 
(n=127) 
Medium 
(n=127) 
High 
(n=126) 
P 
Value 
Low 
(n=142) 
Medium 
(n=142) 
High 
(n=142) 
P 
Value 
             
Crude 30-day PPR Rate 12.31% 16.66% 24.69%  7.79% 15.47% 26.72%  6.84% 11.9% 19.77%  
             
Ownership     0.017    0.043    0.343 
  Public 21 (15) 16 (11) 32 (23)  24 (19) 13 (10) 21 (15)  26 (18) 18 (13) 25 (18)  
  Private not-for-profit 83 (58) 86 (61) 61 (43)  74 (58) 76 (60) 59 (47)  76 (54) 85 (60) 69 (48)  
  Private for-profit 39 (27) 40 (28) 49 (34)  29 (23) 38 (30) 46 (36)  40 (28) 39 (27) 48 (34)  
Cardiac Catherization     0.008    0.000    0.000 
  No  41 (29) 30 (21) 54 (38)  25 (20) 15 (12) 44 (35)  35 (25) 27 (19) 62 (44)  
  Yes 102 (71) 112 (79) 88 (62)  102 (80) 112 (88) 82 (65)  107 (75) 115 (81) 80 (56)  
Teaching intensity  
(Resident-to-bed ratio)     0.422    0.823    0.678 
  0 (non-teaching) 110 (77) 102 (72) 95 (67)  86 (68) 90 (71) 89 (70)  107 (75) 98 (69) 101 (71)  
  0-0.05 (low intensity) 11 (8) 20 (14) 19 (13)  15 (12) 17 (13) 16 (13)  12 (9) 17 (12) 21 (15)  
0.05-0.6 (medium   
intensity) 15 (10) 12 (8) 17 (12)  18 (14) 14 (11) 11 (9)  14 (10) 17 (12) 13 (9)  
  >0.6 (high intensity) 7 (5) 8 (6) 11 (8)  8 (6) 6 (5) 10 (8)  9 (6) 10 (7) 7 (5)  
Magnet hospitals    0.671    0.461    0.017 
  Non-Magnet 135 (94) 134 (94) 137 (96)  119 (94) 119 (94) 122 (97)  130 (92) 135 (95) 140 (99)  
  Magnet 8 (6) 8 (6) 5 (3.52)  8 (6) 8 (6) 4 (3)  12 (8) 7 (5) 2 (1)  
Volume     0.066    0.000    0.071 
  1st quartile (smallest) 41 (29) 26 (18) 42 (30)  30 (24) 20 (16) 48 (38)  35 (25) 24 (17) 48 (34)  
  2nd quartile 32 (22) 37 (26) 36 (25)  32 (25) 21 (17) 41 (32)  35 (25) 37 (26) 34 (24)  
  3rd quartile 36 (25) 33 (23) 39 (27)  37 (29) 32 (25) 25 (20)  37 (26) 39 (27) 31 (22)  
  4th quartile (largest) 34 (24) 46 (33) 25 (18)  28 (22) 54 (42) 12 (10)  35 (25) 42 (30) 29 (20)  
System affiliation    0.111    0.859    0.462 
  System hospital 46 (32) 30 (21) 38 (27)  33 (26) 31 (24) 29 (23)  36  (25) 34 (24) 43 (30)  
  Non-system hospital 97 (68) 112 (79) 104 (73)  94 (74) 96 (76) 97 (77)  106 (75) 108 (76) 99 (70)  
Metropolitan Statistical 
Area    0.001    0.022    0.001 
  Rural 9 (6) 6 ( 4) 14 (10)  2 (2) 5 (4) 13 (10)  8 (6) 11 (8) 11 (8)  
  Micro/Division 39 (27) 53 (37) 68 (48)  51 (40) 46 (36) 52 (41)  43 (30) 44 (31) 73 (51)  
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  Metro 95 (67) 83 (59) 60 (42)  74 (58) 76 (60) 61 (48)  91 (64) 87 (61) 58 (41)  
State    0.853    0.008    0.000 
  California 89 (62) 91 (64) 93 (65)  91 (72) 67 (53) 79 (63)  80 (56) 81 (57) 112 (79)  
  Florida 54 (38) 51 (36) 49 (35)  36 (28) 60 (47) 47 (37)  62 (44) 61 (43) 30 (21)  
DSH Index    0.048    0.301    0.049 
  1st thirtiles (low) 50 (35) 45 (32) 48 (34)  50 (39) 41 (32) 36 (29)  53 (37) 41 (29) 48 (34)  
  2nd thirtiles 53 (37) 54 (38) 35 (25)  43 (34) 42 (33) 42 (33)  46 (33) 59 (41) 37 (26)  
  3rd thirtiles (high) 40 (28) 43 (30) 59 (41)  34 (27) 44 (35) 48 (38)  43 (30) 42 (30) 57 (40)  
Number of comorbidity    0.249    0.262    0.096 
  1st thirtiles (low) 55 (38) 43 (30) 45 (32)  50 (39) 38 (30) 39 (31)  50 (35) 38 (27) 54 (38)  
  2nd thirtiles 43 (30) 56 (40) 43 (30)  41 (32) 48 (38) 38 (30)  51 (36) 54 (38) 37 (26)  
  3rd thirtiles (high) 45 (32) 43 (30) 54 (38)  36 (28) 41 (32) 49 (39)  41 (29) 50 (35) 51 (36)  
Proportion of patients 
with prior hospitalization 
for both HF and other 
conditions 
   0.538    0.000    0.000 
  1st thirtiles (low) 51 (36) 49 (34) 43 (30)  46 (36) 28 (22) 53 (42)  62 (44) 51 (36) 29 (20)  
  2nd thirtiles 46 (32) 52 (37) 45 (32)  42 (33) 61 (48) 24 (19)  47 (33) 54 (38) 41 (29)  
  3rd thirtiles (high) 46 (32) 41 (29) 54 (38)  39 (31) 38 (30) 49 (39)  33 (23) 37 (26) 72 (51)  
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Table 4:  
Summary of Hospital Performance for Condition-Specific Process Quality Measures 
 
 Hospital, 
No 
Overall 
[Mean (SD)] 
Hospitals in the top 
25% (4th quartile) 
[Mean (SD)] 
Hospitals in the middle  
50% (2nd & 3rd quartile) 
[Mean (SD)] 
Hospitals in the 
low 25% (1st quartile) 
[Mean (SD)] 
Heart Failure       
ACE Inhibitor or ARB for LVSD  d 396 87.27 (9.80) 97.94 (1.51) 89.47 (3.70) 74.58 (8.15) 
Evaluation of LVS Function  d 425 70.31 (23.90) 95.62 (3.25) 74.71 (8.33) 36.88 (17.95) 
Discharge Instructions  d 426 91.10 (14.16) 99.40 (0.49) 95.28 (2.20) 75.79 (21.05) 
   - HF Discharge Composite score   d 427 82.17 (15.46) 95.99 (2.17) 85.57 (4.36) 61.66 (16.67) 
      
Acute Myocardial Infarction       
ACE Inhibitor or ARB for LVSD  d 222 89.36 (8.75) 99.59 (0.76) 91.50 (3.63) 78.11 (6.29) 
Aspirin at Arrival  a  379 96.39 (4.11) 99.21 (0.87) † 96.56 (0.49) ‡ 91.31 (4.32) 
Aspirin at Discharge  d 339 93.91 (8.02) 100 (0) 96.62 (1.85) 83.31 (9.61) 
Beta Blocker at Arrival  a 369 92.78 (7.15) 99.64 (0.48) 94.91 (2.24) 83.20 (7.20) 
Beta Blocker at Discharge  d 343 94.39 (7.36) 100 (0) 96.95 (1.56) 86.19 (9.21) 
PCI Within 90m of Arrival  a 168 66.05 (19.53) 87.89 (4.59) 70.01 (8.23) 38.43 (12.00) 
   - AMI Admission Composite score   a 380 93.27 (5.36) 98.57 (1.04) 94.16 (1.91) 86.22 (5.20) 
   - AMI Discharge Composite score   d 345 93.63 (7.37) 99.42 (0.57) 95.48 (1.76) 84.25 (9.04) 
   - AMI Composite score 370 93.83 (5.28) 98.74 (0.81) 94.81 (1.65) 87.04 (5.77) 
      
Pneumonia       
Assessed and Given Influenza Vaccination d 411 70.13 (23.31) 94.05 (3.49) 75.36 (8.56) 37.98 (18.43) 
Assessed and Given Pneumococcal 
Vaccination  d 424 75.22 (20.59) 94.74 (2.62) 80.53 (6.74) 46.77 (18.79) 
Initial Antibiotic(s) within 6h After Arrival a 394 92.49 (7.20) 99.22 (0.88) 94.45 (1.98) 84.01 (7.65) 
Oxygenation Assessment  a 426 99.72 (1.60) - - - 
The Most Appropriate Initial Antibiotic(s) a 422 88.00 (8.12) 95.69 (1.69) 89.60 (2.39) 78.35 (8.90) 
Initial ER Blood Culture Performed prior to 
First Hospital Dose of Antibiotics  a 415 88.89 (6.95) 96.20 (1.35) 90.78 (2.23) 80.04 (6.03) 
   - PN Admission Composite score  a 426 93.37 (3.75) 97.15 (1.02) 93.94 (1.16) 88.48 (3.69) 
   - PN Discharge Composite score  d 424 73.72 (20.78) 93.55 (3.25) 78.37 (6.93) 44.61 (18.35) 
   - PN Composite score 425 87.71 (7.97) 95.41 (1.65) 89.23 (2.44) 77.08 (7.86) 
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To ensure the stability of the measures, hospitals with fewer than 15 patients in the denominator of a measure are excluded.  A composite score for a condition is calculated only 
if that hospital treated at least 15 patients for one of the process measures for that condition.  If a hospital did not treat at least 15 patients in any one indicator, then no composite 
score was calculated.  For that reason, the number of hospitals’ composite measures do not equal to the number of individual measure.     
†: hospitals in the 3rd and 4th quartiles;   
‡: hospitals in the 2nd quartile 
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Table 5:  
Summary of Within-Hospital (Level 1) Model of Heart Failure PPR† 
 
 
M_HF1: 
ACE Inhibitor or 
ARB for LVSD 
M_HF2: 
Evaluation of 
LVS Function  
M_HF3:  
Discharge  
Instructions  
M_HFCD: 
Discharge  
Composite score  
 aOR aOR aOR aOR 
 Socio-Demographic & Post-discharge      
  Age 1.005* 1.006** 1.006** 1.006** 
  Female NSS NSS NSS NSS 
  Race (Ref: White)     
   Black NSS NSS NSS NSS 
   Hispanic NSS 1.098* 1.096* 1.096* 
   Others NSS NSS NSS NSS 
  Disposition (Ref=Routine)     
   Home Health Care 1.175*** 1.174*** 1.174*** 1.174*** 
   Nursing Home  1.575*** 1.572*** 1.575*** 1.575*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)      
   2nd quartile NSS NSS NSS NSS 
   3rd quartile NSS NSS NSS NSS 
   4th quartile NSS NSS NSS NSS 
     
Severity     
  Prior admission (1y) (Ref=No)     
  Prior admission (1y) other than heart failure 1.263* 1.237* 1.236* 1.236* 
  Prior admission (1y) for heart failure 1.355*** 1.356*** 1.356*** 1.356*** 
Prior admission (1y) for both heart failure  
and other conditions 1.830
*** 1.831*** 1.831*** 1.831*** 
     
Comorbidities     
  AIDS 4.828* 4.873* 4.842* 4.869* 
  Alcohol abuse NSS NSS NSS NSS 
  Deficiency anemias 1.084** 1.079* 1.079* 1.080* 
  Rheumatoid arthritis NSS NSS NSS NSS 
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  Chronic blood loss anemia NSS NSS NSS NSS 
  Chronic pulmonary disease 1.105*** 1.106*** 1.107*** 1.107*** 
  Coagulopathy NSS NSS NSS NSS 
  Depression NSS NSS NSS NSS 
  Diabetes, uncomplicated NSS NSS NSS NSS 
  Diabetes w/ chronic complications 1.170** 1.166** 1.166** 1.166** 
  Drug abuse NSS NSS NSS NSS 
  Hypertension NSS NSS NSS NSS 
  Hypothyroidism NSS NSS NSS NSS 
  Liver disease NSS NSS NSS NSS 
  Lymphoma NSS NSS NSS NSS 
  Fluid and electrolyte disorders 1.097** 1.098** 1.098** 1.098** 
  Metastatic cancer NSS NSS NSS NSS 
  Other neurological disorders NSS NSS NSS NSS 
  Obesity NSS NSS NSS NSS 
  Paralysis NSS NSS NSS NSS 
  Peripheral vascular disorders 1.172*** 1.165*** 1.164*** 1.165*** 
  Psychoses 1.223* 1.217* 1.216* 1.216* 
  Pulmonary circulation disorders NSS NSS NSS NSS 
  Renal failure 1.239*** 1.241*** 1.241*** 1.241*** 
  Solid tumor without metastasis NSS NSS NSS NSS 
  Peptic ulcer disease  NSS NSS NSS NSS 
  Valvular disease NSS NSS NSS NSS 
  Weight loss NSS NSS NSS NSS 
 
NSS: Not statistically significant 
aOR: Adjusted Odds Ratio 
†: Full results are presented in Appendix Tables 1 to 4 
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Table 6:  
Summary of Within-Hospital (Level 1) Model of Acute Myocardial Infarction PPR† 
 
 
M_HA1: 
ACE Inhibitor or 
ARB for LVSD 
M_HA2: 
Aspirin at 
Arrival 
M_HA3: 
Aspirin at 
Discharge 
M_HA4: 
Beta Blocker 
at Arrival 
M_HA5: 
Beta Blocker 
at Discharge 
M_HA7: 
PCI Within 
90m of Arrival 
 aOR aOR aOR aOR aOR aOR 
       
 Socio-Demographic & Post-discharge        
  Age NSS NSS NSS NSS NSS NSS 
  Female NSS NSS NSS NSS NSS NSS 
  Race (Ref: White)       
   Black NSS NSS NSS NSS NSS NSS 
   Hispanic NSS NSS NSS NSS NSS NSS 
   Others NSS NSS NSS NSS NSS NSS 
  Disposition (Ref=Routine)       
   Home Health Care 1.342*** 1.304*** 1.312*** 1.301*** 1.310*** 1.407***
   Nursing Home  1.868*** 1.879*** 1.879*** 1.868*** 1.873*** 1.985***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)        
   2nd quartile NSS NSS NSS NSS NSS NSS 
   3rd quartile NSS NSS NSS NSS NSS NSS 
   4th quartile NSS NSS NSS NSS NSS NSS 
       
 Severity       
  Prior admission (1y) (Ref=No)       
  Prior admission (1y) other than AMI NSS NSS NSS NSS NSS - 
  Prior admission (1y) for AMI 1.377*** 1.352*** 1.357*** 1.354*** 1.360*** 1.407***
 Prior admission (1y) for both AMI and 
 other conditions 1.473
*** 1.476*** 1.499*** 1.471*** 1.500*** 1.985*** 
  AMI location: Anterior NSS NSS NSS NSS NSS NSS 
  AMI location: Other NSS NSS NSS NSS NSS NSS 
       
 Procedure       
  CABG 0.782** 0.773*** 0.776** 0.771*** 0.777** 0.778**
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  PTCA 1.136* 1.124* 1.124* 1.121* 1.123* 1.138*
       
Comorbidities       
  AIDS NSS NSS NSS NSS NSS - 
  Alcohol abuse NSS NSS NSS NSS NSS NSS 
  Deficiency anemias NSS NSS NSS NSS NSS NSS 
  Rheumatoid arthritis NSS NSS NSS NSS NSS NSS 
  Chronic blood loss anemia NSS NSS NSS NSS NSS NSS 
  Congest Heart Failure NSS NSS NSS NSS NSS NSS 
  Chronic pulmonary disease 1.174*** 1.185*** 1.184*** 1.191*** 1.182*** 1.165**
  Coagulopathy NSS NSS NSS NSS NSS NSS 
  Depression NSS NSS NSS NSS NSS NSS 
  Diabetes, uncomplicated 1.159** 1.155** 1.152** 1.153** 1.152** 1.168**
  Diabetes w/ chronic complications 1.229* 1.264** 1.272** 1.262** 1.264** 1.283**
  Drug abuse NSS NSS NSS NSS NSS NSS 
  Hypertension NSS NSS NSS NSS NSS NSS 
  Hypothyroidism NSS NSS NSS NSS NSS NSS 
  Liver disease NSS NSS NSS NSS NSS NSS 
  Lymphoma NSS NSS NSS NSS NSS NSS 
  Fluid and electrolyte disorders NSS NSS NSS NSS NSS NSS 
  Metastatic cancer 0.231* 0.277* 0.303* 0.286* 0.293* NSS 
  Other neurological disorders NSS NSS NSS NSS NSS NSS 
  Obesity NSS NSS NSS NSS NSS NSS 
  Paralysis NSS NSS NSS NSS NSS NSS 
  Peripheral vascular disorders NSS NSS NSS NSS NSS NSS 
  Psychoses NSS NSS NSS NSS NSS NSS 
  Pulmonary circulation disorders NSS NSS NSS NSS NSS NSS 
  Renal failure 1.196*** 1.208*** 1.202*** 1.212*** 1.207*** 1.181**
  Solid tumor without metastasis NSS NSS NSS NSS NSS NSS 
  Peptic ulcer disease  NSS NSS 4.744* 4.735* 4.737* NSS 
  Valvular disease NSS NSS NSS NSS NSS NSS 
  Weight loss NSS NSS NSS NSS NSS NSS 
 
NSS: Not statistically significant 
aOR: Adjusted Odds Ratio 
†: Full results are presented in Appendix Tables 5 to 13 
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Table 6:  
Summary of Within-Hospital (Level 1) Model of Acute Myocardial Infarction PPR (Cont’d) 
 
 
M_HACA: 
Admission 
Composite 
M_HACD: 
Discharge 
Composite 
M_HACOMP: 
Global 
Composite 
 aOR aOR aOR 
 Socio-Demographic & Post-discharge     
  Age NSS NSS NSS 
  Female NSS NSS NSS 
  Race (Ref: White)    
   Black NSS NSS NSS 
   Hispanic NSS NSS NSS 
   Others NSS NSS NSS 
  Disposition (Ref=Routine)    
   Home Health Care 1.304*** 1.313*** 1.303***
   Nursing Home  1.882*** 1.871*** 1.870***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)     
   2nd quartile NSS NSS NSS 
   3rd quartile NSS NSS NSS 
   4th quartile NSS NSS NSS 
    
 Severity    
  Prior admission (1y) (Ref=No)    
  Prior admission (1y) other than AMI NSS NSS NSS 
  Prior admission (1y) for AMI 1.352*** 1.357*** 1.355***
 Prior admission (1y) for both AMI and 
 other conditions 1.475
*** 1.499*** 1.481*** 
  AMI location: Anterior NSS NSS NSS 
  AMI location: Other NSS NSS NSS 
    
 Procedure    
  CABG 0.770*** 0.776** 0.777**
  PTCA 1.120* 1.123* 1.119*
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Comorbidities    
  AIDS NSS NSS NSS 
  Alcohol abuse NSS NSS NSS 
  Deficiency anemias NSS NSS NSS 
  Rheumatoid arthritis NSS NSS NSS 
  Chronic blood loss anemia NSS NSS NSS 
  Congest Heart Failure NSS NSS NSS 
  Chronic pulmonary disease 1.186*** 1.185*** 1.188***
  Coagulopathy NSS NSS NSS 
  Depression NSS NSS NSS 
  Diabetes, uncomplicated 1.154** 1.153** 1.152**
  Diabetes w/ chronic complications 1.265** 1.268** 1.259**
  Drug abuse NSS NSS NSS 
  Hypertension NSS NSS NSS 
  Hypothyroidism NSS NSS NSS 
  Liver disease NSS NSS NSS 
  Lymphoma NSS NSS NSS 
  Fluid and electrolyte disorders NSS NSS NSS 
  Metastatic cancer 0.278* 0.293* 0.282*
  Other neurological disorders NSS NSS NSS 
  Obesity NSS NSS NSS 
  Paralysis NSS NSS NSS 
  Peripheral vascular disorders NSS NSS NSS 
  Psychoses NSS NSS NSS 
  Pulmonary circulation disorders NSS NSS NSS 
  Renal failure 1.209*** 1.199*** 1.211***
  Solid tumor without metastasis NSS NSS NSS 
  Peptic ulcer disease  NSS 4.736* 4.701*
  Valvular disease NSS NSS NSS 
  Weight loss NSS NSS NSS 
 
NSS: Not statistically significant 
aOR: Adjusted Odds Ratio 
†: Full results are presented in Appendix Tables 5 to 13 
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Table 7:  
Summary of Within-Hospital (Level 1) Model of Pneumonia PPR 
 
 
M_PN1: 
Assessed & 
Given 
Influenza 
Vaccination 
M_PN2: 
Assessed & 
Given 
Pneumococcal 
Vaccination 
M_PN2: 
Initial 
Antibiotic(s) 
within 6h After 
Arrival 
M_PN4: 
Oxygenation 
Assessment 
M_PN5: 
the Most 
Appropriate  
Initial  
Antibiotic(s) 
M_PN7: 
Initial ER Blood 
Culture Performed 
Prior To First 
Hospital Dose Of 
Antibiotics 
Socio-Demographic & Post-discharge       
  Age NSS NSS NSS NSS NSS NSS 
  Female 0.876*** 0.877*** 0.882*** 0.877*** 0.875*** 0.878*** 
  Race (Ref: White)       
   Black NSS NSS NSS NSS NSS NSS 
   Hispanic NSS NSS NSS NSS NSS NSS 
   Others 0.856* 0.861* NSS 0.863* 0.863* 0.862* 
  Disposition (Ref=Routine)       
   Home Health Care 1.355*** 1.346*** 1.359*** 1.345*** 1.350*** 1.338*** 
   Nursing Home  2.139*** 2.128*** 2.134*** 2.124*** 2.129*** 2.110*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)        
   2nd quartile NSS NSS NSS NSS NSS NSS 
   3rd quartile NSS NSS NSS NSS NSS NSS 
   4th quartile NSS NSS NSS NSS NSS NSS 
Severity       
  Prior admission (1y) (Ref=No)       
  Prior admission (1y) other than PN NSS NSS NSS NSS NSS NSS 
  Prior admission (1y) for PN 1.435*** 1.440*** 1.421*** 1.441*** 1.438*** 1.439*** 
 Prior admission (1y) for both PN   
 and other conditions 1.859
*** 1.857*** 1.854*** 1.852*** 1.857*** 1.853*** 
Comorbidities       
  Alcohol abuse NSS NSS NSS NSS NSS NSS 
  Deficiency anemias NSS NSS NSS NSS NSS NSS 
  Rheumatoid arthritis 1.267** 1.266** 1.262** 1.266** 1.269** 1.268** 
  Chronic blood loss anemia NSS NSS NSS NSS NSS NSS 
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  Congest Heart Failure 1.206*** 1.211*** 1.212*** 1.210*** 1.208*** 1.215*** 
  Chronic pulmonary disease 1.191*** 1.188*** 1.195*** 1.187*** 1.192*** 1.193*** 
  Coagulopathy NSS NSS NSS NSS NSS NSS 
  Depression NSS NSS NSS NSS NSS NSS 
  Diabetes, uncomplicated NSS NSS NSS NSS NSS NSS 
  Diabetes w/ chronic complications NSS NSS NSS NSS NSS NSS 
  Drug abuse NSS NSS NSS NSS NSS NSS 
  Hypertension NSS NSS NSS NSS NSS NSS 
  Hypothyroidism NSS NSS NSS NSS NSS NSS 
  Liver disease NSS NSS NSS NSS NSS NSS 
  Lymphoma NSS NSS NSS NSS NSS NSS 
  Fluid and electrolyte disorders NSS NSS NSS NSS NSS NSS 
  Metastatic cancer NSS NSS NSS NSS NSS NSS 
  Other neurological disorders NSS NSS NSS NSS NSS NSS 
  Obesity NSS NSS NSS NSS NSS NSS 
  Paralysis NSS NSS NSS NSS NSS NSS 
  Peripheral vascular disorders NSS NSS NSS NSS NSS NSS 
  Psychoses NSS NSS NSS NSS NSS NSS 
  Pulmonary circulation disorders NSS NSS NSS NSS NSS NSS 
  Renal failure 1.138** 1.133** 1.132** 1.131** 1.139** 1.132** 
  Solid tumor without metastasis NSS NSS NSS NSS NSS NSS 
  Peptic ulcer disease  NSS NSS NSS NSS NSS NSS 
  Valvular disease NSS NSS NSS NSS NSS NSS 
  Weight loss 1.178* 1.184* 1.161* 1.190* 1.180* 1.184* 
 
NSS: Not statistically significant 
aOR: Adjusted Odds Ratio 
†: Full results are presented in Tables 14 to 22 
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Table 7:  
Summary of Within-Hospital (Level 1) Model of Pneumonia PPR (Cont’d) 
 
 
M_PNCA: 
Admission 
Composite 
M_PNCD: 
Discharge 
Composite 
M_PNCOMP: 
Global 
Composite 
 aOR aOR aOR 
Socio-Demographic & Post-discharge     
  Age NSS NSS NSS 
  Female 0.876*** 0.877*** 0.877*** 
  Race (Ref: White)    
   Black NSS NSS NSS 
   Hispanic NSS NSS NSS 
   Others 0.864* 0.856* 0.861* 
  Disposition (Ref=Routine)    
   Home Health Care 1.347*** 1.346*** 1.348*** 
   Nursing Home  2.125*** 2.128*** 2.126*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)     
   2nd quartile NSS NSS NSS 
   3rd quartile NSS NSS NSS 
   4th quartile NSS NSS NSS 
Severity    
  Prior admission (1y) (Ref=No)    
  Prior admission (1y) other than PN NSS NSS NSS 
  Prior admission (1y) for PN 1.441*** 1.440*** 1.441*** 
 Prior admission (1y) for both PN and 
 other conditions 1.853
*** 1.857*** 1.856*** 
Comorbidities    
  Alcohol abuse NSS NSS NSS 
  Deficiency anemias NSS NSS NSS 
  Rheumatoid arthritis 1.268** 1.266** 1.267** 
  Chronic blood loss anemia NSS NSS NSS 
  Congest Heart Failure 1.209*** 1.211*** 1.212*** 
  Chronic pulmonary disease 1.187*** 1.188*** 1.187*** 
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  Coagulopathy NSS NSS NSS 
  Depression NSS NSS NSS 
  Diabetes, uncomplicated NSS NSS NSS 
  Diabetes w/ chronic complications NSS NSS NSS 
  Drug abuse NSS NSS NSS 
  Hypertension NSS NSS NSS 
  Hypothyroidism NSS NSS NSS 
  Liver disease NSS NSS NSS 
  Lymphoma NSS NSS NSS 
  Fluid and electrolyte disorders NSS NSS NSS 
  Metastatic cancer NSS NSS NSS 
  Other neurological disorders NSS NSS NSS 
  Obesity NSS NSS NSS 
  Paralysis NSS NSS NSS 
  Peripheral vascular disorders NSS NSS NSS 
  Psychoses NSS NSS NSS 
  Pulmonary circulation disorders NSS NSS NSS 
  Renal failure 1.133** 1.133** 1.133** 
  Solid tumor without metastasis NSS NSS NSS 
  Peptic ulcer disease  NSS NSS NSS 
  Valvular disease NSS NSS NSS 
  Weight loss 1.187* 1.184* 1.182* 
 
NSS: Not statistically significant 
aOR: Adjusted Odds Ratio 
†: Full results are presented in Table 14 to 22 
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Table 8:  
Summary of Association between Process Quality Measures and Heart Failure PPR using  
Hierarchical Logistic Regression† 
 
 Heart Failure 30-day PPR rates 
 Coefficient Standard Error Odds Ratio 
Discharge Composite Score -0.000 0.002 1.000 
  n: level-1 (patients) = 42051    
  n: level-2 (hospitals) = 427    
ACE Inhibitor or ARB for LVSD 0.001 0.002 1.001 
  n: level-1 (patients) = 41323    
  n: level-2 (hospitals) = 396    
Evaluation of LVS Function -0.000 0.001 1.000 
  n: level-1 (patients) = 42038    
  n: level-2 (hospitals) = 425    
Discharge Instructions 0.001 0.002 1.001 
  n: level-1 (patients) = 42044    
  n: level-2 (hospitals) = 426    
 
†: Multivariable analysis adjusted for 1) patient level variables (level 1), including age, sex, race/ethnicity, 
discharge destination, severity measured by prior hospitalization, and Elixhauser comorbid conditions, and 
2) hospital level variables (level 2), including hospital ownership status, whether a hospital perform cardiac 
catherization, Magnet status, system affiliation, teaching intensity, and mean number of comorbid 
conditions, proportion of patients with prior history of hospitalization for both HF and other conditions, 
condition-specific hospital volume, DSH index, and State. 
Full results are presented in Appendix Tables 1 to 4 
* p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 9:  
Summary of Association between Process Quality Measures and Acute Myocardial 
Infarction PPR using Hierarchical Logistic Regression† 
 
 Coef. Std. Err. P-value OR 
     
Admission Composite Score -0.010~ 0.006 0.085 0.990~ 
  n: level-1 (patients) = 21635     
  n: level-2 (hospitals) = 380     
Discharge Composite Score -0.004 0.005 0.464 0.996 
  n: level-1 (patients) = 21367     
  n: level-2 (hospitals) = 346     
Global Composite Score -0.008 0.006 0.204 0.992 
  n: level-1 (patients) = 21580     
  n: level-2 (hospitals) = 371     
ACE Inhibitor or ARB for LVSD -0.001 0.003 0.726 0.999 
  n: level-1 (patients) = 19086     
  n: level-2 (hospitals) = 222     
Aspirin at Arrival -0.010 0.008 0.202 0.990 
  n: level-1 (patients) = 21628     
  n: level-2 (hospitals) = 379     
Aspirin at Discharge -0.003 0.005 0.533 0.997 
  n: level-1 (patients) = 21301     
  n: level-2 (hospitals) = 340     
Beta Blocker at Arrival -0.001 0.004 0.725 0.999 
  n: level-1 (patients) = 21548     
  n: level-2 (hospitals) = 369     
Beta Blocker at Discharge -0.003 0.005 0.533 0.997 
  n: level-1 (patients) = 21328     
  n: level-2 (hospitals) = 344     
PCI Within 90m of Arrival -0.004** 0.001 0.012 0.996** 
  n: level-1 (patients) = 16654     
  n: level-2 (hospitals) = 168     
 
†: Multivariable analysis adjusted for 1) patient level variables (level 1), including age, sex, race/ethnicity, 
discharge destination, severity measured by prior hospitalization, and Elixhauser comorbid conditions, and 
2) hospital level variables (level 2), including hospital ownership status, whether a hospital perform cardiac 
catherization, Magnet status, system affiliation, teaching intensity, and mean number of comorbid 
conditions, proportion of patients with prior history of hospitalization for both AMI and other conditions, 
AMI location condition-specific hospital volume, DSH index, and State. 
Full results are presented in Appendix Tables 5 to 13. 
~ p < 0.10,  * p < 0.05,  ** p < 0.01,  *** p < 0.001 
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Table 10:  
Summary of Association between Pneumonia PPR and Process Quality Measures using 
Hierarchical Logistic Regression† 
 
 Coef. Std. Err. P-value OR 
     
Admission Composite Score -0.020** 0.007 0.004 0.980** 
  n: level-1 (patients) = 36384     
  n: level-2 (hospitals) = 426     
Discharge Composite Score -0.002* 0.001 0.048 0.998* 
  n: level-1 (patients) = 36374     
  n: level-2 (hospitals) = 424     
Global Composite Score -0.008* 0.003 0.010 0.992* 
  n: level-1 (patients) = 36378     
  n: level-2 (hospitals) = 425     
Assessed and Given Influenza Vaccination -0.003* 0.001 0.017 0.997* 
  n: level-1 (patients) = 35964     
  n: level-2 (hospitals) = 411     
Assessed and Given Pneumococcal Vaccination -0.002~ 0.001 0.078 0.998 
  n: level-1 (patients) = 36374     
  n: level-2 (hospitals) = 424     
Initial Antibiotic(s) within 6h After Arrival -0.007~ 0.004 0.050 0.993 
  n: level-1 (patients) = 35202     
  n: level-2 (hospitals) = 394     
Oxygenation Assessment -0.033~ 0.017 0.052 0.967 
  n: level-1 (patients) = 36384     
  n: level-2 (hospitals) = 426     
the Most Appropriate Initial Antibiotic(s) -0.008** 0.003 0.005 0.992** 
  n: level-1 (patients) = 36172     
  n: level-2 (hospitals) = 422     
Initial ER Blood Culture Performed Prior To First 
Hospital Dose Of Antibiotics -0.005 0.004 0.134 0.995 
  n: level-1 (patients) = 36118     
  n: level-2 (hospitals) = 415     
 
†: Multivariable analysis adjusted for 1) patient level variables (level 1), including age, sex, race/ethnicity, 
discharge destination, severity measured by prior hospitalization, and Elixhauser comorbid conditions, and 
2) hospital level variables (level 2), including hospital ownership status, whether a hospital perform cardiac 
catherization, Magnet status, system affiliation, teaching intensity, and mean number of comorbid 
conditions, proportion of patients with prior history of hospitalization for both PN and other conditions, 
condition-specific hospital volume, DSH index, and State. 
Full results are presented in Tables 14 to 22 
~ p < 0.10,  * p < 0.05,  ** p < 0.01,  *** p < 0.001 
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APPENDICES 
 
Appendix Table 1: 
Association of HF-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Discharge Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.005* 0.002 1.006** 0.006** 0.002 1.006** 0.006** 0.002 1.006** 
  Female   -0.021 0.029 0.981 -0.025 0.028 0.975 -0.025 0.028 0.975 
  Race (Ref: White)            
   Black   0.082 0.052 1.085 0.064 0.052 1.066 0.065 0.052 1.067 
   Hispanic   0.131** 0.045 1.140** 0.092* 0.046 1.096* 0.092* 0.046 1.096* 
   Others   -0.039 0.060 0.962 -0.088 0.062 0.916 -0.087 0.062 0.916 
  Disposition (Ref=Routine)            
   Home Health Care   0.149*** 0.036 1.161*** 0.160*** 0.036 1.174*** 0.160*** 0.036 1.174*** 
   Nursing Home    0.450*** 0.034 1.568*** 0.454*** 0.034 1.575*** 0.454*** 0.034 1.574*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.066 0.038 0.936 -0.049 0.038 0.952 -0.049 0.038 0.952 
   3rd quartile   0.007 0.039 1.007 0.031 0.039 1.031 0.031 0.039 1.032 
   4th quartile   -0.015 0.042 0.985 0.006 0.044 1.006 0.009 0.044 1.009 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than heart failure   0.210
* 0.095 1.234* 0.212* 0.095 1.236* 0.212* 0.095 1.237* 
Prior admission (1y) for  
heart failure   0.304
*** 0.031 1.355*** 0.304*** 0.031 1.356*** 0.304*** 0.031 1.356*** 
Prior admission (1y) for  
both heart failure and other    0.605
*** 0.037 1.832*** 0.605*** 0.037 1.831*** 0.605*** 0.037 1.831*** 
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conditions 
Comorbidities            
  AIDS   1.562* 0.772 4.768* 1.583* 0.770 4.869* 1.586* 0.770 4.883* 
  Alcohol abuse   -0.006 0.119 0.994 -0.016 0.119 0.984 -0.016 0.119 0.984 
  Deficiency anemias   0.076* 0.030 1.079* 0.077* 0.030 1.080* 0.077* 0.030 1.080* 
  Rheumatoid arthritis   0.089 0.084 1.093 0.098 0.084 1.103 0.098 0.084 1.103 
  Chronic blood loss anemia   0.056 0.113 1.057 0.060 0.113 1.062 0.061 0.113 1.062 
  Chronic pulmonary disease   0.101*** 0.028 1.107*** 0.102*** 0.028 1.107*** 0.102*** 0.028 1.108*** 
  Coagulopathy   -0.015 0.070 0.985 -0.005 0.070 0.995 -0.005 0.070 0.995 
  Depression   0.013 0.047 1.013 0.014 0.047 1.014 0.014 0.047 1.014 
  Diabetes, uncomplicated   0.047 0.031 1.049 0.047 0.031 1.048 0.047 0.031 1.048 
Diabetes w/ chronic   
complications   0.156
** 0.048 1.168** 0.153** 0.048 1.166** 0.153** 0.048 1.166** 
  Drug abuse   0.245 0.238 1.278 0.203 0.238 1.225 0.202 0.238 1.224 
  Hypertension   -0.022 0.029 0.979 -0.012 0.029 0.988 -0.012 0.029 0.988 
  Hypothyroidism   0.018 0.035 1.019 0.023 0.035 1.023 0.022 0.035 1.022 
  Liver disease   0.177 0.102 1.194 0.181 0.102 1.199 0.182 0.102 1.200 
  Lymphoma   -0.045 0.237 0.956 -0.026 0.237 0.975 -0.026 0.237 0.975 
Fluid and electrolyte  
disorders   0.089
** 0.031 1.093** 0.094** 0.031 1.098** 0.094** 0.031 1.098** 
  Metastatic cancer   -0.394 0.339 0.674 -0.386 0.339 0.680 -0.386 0.339 0.680 
Other neurological  
disorders   0.007 0.049 1.007 0.010 0.049 1.010 0.010 0.049 1.011 
  Obesity   -0.049 0.047 0.952 -0.038 0.047 0.963 -0.038 0.047 0.963 
  Paralysis   -0.109 0.097 0.897 -0.116 0.097 0.890 -0.116 0.097 0.890 
Peripheral vascular  
disorders   0.137
*** 0.038 1.147*** 0.152*** 0.038 1.165*** 0.152*** 0.038 1.164*** 
  Psychoses   0.205* 0.086 1.228* 0.196* 0.086 1.216* 0.195* 0.086 1.215* 
Pulmonary circulation  
disorders   0.081 0.323 1.085 0.081 0.323 1.085 0.080 0.323 1.083 
  Renal failure   0.209*** 0.030 1.233*** 0.216*** 0.030 1.241*** 0.216*** 0.030 1.241*** 
Solid tumor without  
metastasis   -0.032 0.100 0.968 -0.031 0.100 0.970 -0.032 0.100 0.969 
  Peptic ulcer disease    0.140 0.641 1.150 0.142 0.641 1.153 0.142 0.641 1.153 
  Valvular disease   -0.303 0.246 0.738 -0.292 0.246 0.747 -0.290 0.246 0.748 
  Weight loss   0.057 0.085 1.059 0.061 0.085 1.063 0.062 0.085 1.064 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.029 0.039 0.972 -0.028 0.039 0.972 
Ownership (Ref: Public)            
  Private, not-for-profit      -0.078 0.049 0.925 -0.080 0.048 0.923 
  Private, for-profit      -0.064 0.056 0.938 -0.067 0.056 0.935 
System affiliation      0.023 0.039 1.023 0.021 0.039 1.022 
Cardiac catherization facility      -0.169*** 0.050 0.845*** -0.163** 0.050 0.850** 
Magnet hospital      -0.138* 0.067 0.871* -0.147* 0.067 0.863* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.034 0.049 1.035 0.037 0.049 1.037 
  Medium      0.035 0.054 1.036 0.031 0.054 1.031 
  High      0.078 0.078 1.082 0.084 0.078 1.088 
Hospital location (Ref: Rural)             
  Micro/Division      -0.085 0.082 0.918 -0.083 0.082 0.920 
  Metro      -0.163* 0.077 0.850* -0.159* 0.077 0.853* 
Disproportionate Share 
Hospital (DSH) Index       0.162 0.127 1.176 0.151 0.127 1.163 
Mean number of Elixhauser 
comorbid conditions      -0.071 0.041 0.931 -0.068 0.041 0.934 
Proportion of patients with 
prior hospitalization for both 
HF and other conditions 
     -0.080 0.343 0.923 -0.083 0.342 0.920 
Volume (Ref=1st quartile: 
smallest)      -0.000 0.000 1.000 -0.000 0.000 1.000 
PQM (%): Discharge 
Composite Score      -0.000 0.002 1.000 -0.003 0.002 0.997 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.030*** 0.007 0.028*** 0.007  0.016*** 0.006  0.015*** 0.006  
  ICC 0.009  0.008   0.005   0.005   
88 
 
  MOR 1.179  1.173   1.129   1.125   
            
n: level-1 (patients) 42051  42051   42051   42051   
n: level-2 (hospitals) 427  427   427   427   
AIC 37119  36381   36356   36356   
 
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 2:  
Association of HF-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (ACE Inhibitor or ARB for LVSD) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.005* 0.002 1.005* 0.005* 0.002 1.005* 0.005* 0.002 1.005* 
  Female   -0.021 0.029 0.979 -0.026 0.029 0.975 -0.026 0.029 0.975 
  Race (Ref: White)            
   Black   0.068 0.052 1.071 0.051 0.053 1.052 0.050 0.053 1.052 
   Hispanic   0.123** 0.045 1.131** 0.082 0.047 1.086 0.083 0.047 1.087 
   Others   -0.041 0.061 0.960 -0.090 0.062 0.914 -0.090 0.062 0.914 
  Disposition (Ref=Routine)            
   Home Health Care   0.153*** 0.036 1.165*** 0.162*** 0.036 1.175*** 0.161*** 0.036 1.175*** 
   Nursing Home    0.451*** 0.034 1.571*** 0.454*** 0.034 1.575*** 0.454*** 0.034 1.574*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.072 0.038 0.931 -0.053 0.038 0.948 -0.052 0.038 0.950 
   3rd quartile   0.004 0.039 1.004 0.029 0.040 1.029 0.031 0.040 1.031 
   4th quartile   -0.025 0.043 0.976 -0.001 0.044 0.999 0.003 0.044 1.003 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than heart failure   0.233
* 0.095 1.262* 0.233* 0.095 1.263* 0.234* 0.095 1.263* 
Prior admission (1y) for  
heart failure   0.303
*** 0.032 1.354*** 0.304*** 0.032 1.355*** 0.304*** 0.032 1.355*** 
Prior admission (1y) for  
both heart failure and other  
conditions 
  0.605*** 0.037 1.831*** 0.605*** 0.038 1.830*** 0.604*** 0.038 1.830*** 
Comorbidities            
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  AIDS   1.568* 0.771 4.795* 1.574* 0.770 4.828* 1.578* 0.769 4.844* 
  Alcohol abuse   -0.007 0.119 0.993 -0.019 0.119 0.981 -0.019 0.119 0.981 
  Deficiency anemias   0.081** 0.030 1.084** 0.081** 0.030 1.084** 0.080** 0.030 1.084** 
  Rheumatoid arthritis   0.092 0.085 1.096 0.101 0.085 1.106 0.101 0.085 1.106 
  Chronic blood loss anemia   0.057 0.113 1.058 0.060 0.113 1.062 0.060 0.113 1.062 
  Chronic pulmonary disease   0.101*** 0.028 1.106*** 0.100*** 0.028 1.105*** 0.100*** 0.028 1.106*** 
  Coagulopathy   -0.011 0.070 0.989 -0.001 0.070 0.999 -0.001 0.070 0.999 
  Depression   0.016 0.048 1.016 0.017 0.048 1.017 0.017 0.048 1.017 
  Diabetes, uncomplicated   0.053 0.031 1.054 0.052 0.031 1.053 0.052 0.031 1.053 
Diabetes w/ chronic   
complications   0.160
*** 0.048 1.174*** 0.157** 0.048 1.170** 0.158** 0.048 1.171** 
  Drug abuse   0.273 0.238 1.314 0.235 0.238 1.265 0.235 0.238 1.265 
  Hypertension   -0.023 0.029 0.978 -0.013 0.029 0.987 -0.013 0.029 0.987 
  Hypothyroidism   0.016 0.035 1.016 0.020 0.035 1.021 0.020 0.035 1.020 
  Liver disease   0.165 0.104 1.179 0.169 0.104 1.184 0.169 0.104 1.184 
  Lymphoma   -0.031 0.237 0.970 -0.013 0.237 0.987 -0.015 0.237 0.985 
Fluid and electrolyte  
disorders   0.088
** 0.031 1.092** 0.093** 0.031 1.097** 0.093** 0.031 1.098** 
  Metastatic cancer   -0.393 0.339 0.675 -0.386 0.339 0.680 -0.387 0.339 0.679 
Other neurological  
disorders   0.011 0.049 1.011 0.013 0.049 1.013 0.013 0.049 1.013 
  Obesity   -0.059 0.048 0.943 -0.049 0.048 0.952 -0.050 0.048 0.951 
  Paralysis   -0.115 0.098 0.891 -0.122 0.098 0.885 -0.121 0.098 0.886 
Peripheral vascular  
disorders   0.144
*** 0.038 1.155*** 0.159*** 0.038 1.172*** 0.158*** 0.038 1.172*** 
  Psychoses   0.213* 0.086 1.237* 0.201* 0.086 1.223* 0.201* 0.086 1.223* 
Pulmonary circulation  
disorders   0.074 0.323 1.076 0.074 0.323 1.077 0.074 0.324 1.076 
  Renal failure   0.208*** 0.031 1.231*** 0.214*** 0.031 1.239*** 0.214*** 0.031 1.239*** 
Solid tumor without  
metastasis   -0.056 0.101 0.945 -0.055 0.101 0.946 -0.055 0.101 0.947 
  Peptic ulcer disease    0.140 0.641 1.150 0.145 0.641 1.156 0.142 0.641 1.153 
  Valvular disease   -0.282 0.247 0.755 -0.272 0.247 0.762 -0.271 0.247 0.763 
  Weight loss   0.059 0.085 1.061 0.064 0.085 1.066 0.064 0.085 1.066 
           
Level 2: Hospital Characteristics           
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California (Ref: Florida)      -0.026 0.039 0.974 -0.021 0.039 0.979 
Ownership (Ref: Public)            
  Private, not-for-profit      -0.072 0.049 0.931 -0.077 0.049 0.926 
  Private, for-profit      -0.043 0.057 0.958 -0.049 0.057 0.952 
System affiliation      0.015 0.040 1.015 0.014 0.040 1.015 
Cardiac catherization facility      -0.164** 0.051 0.849** -0.160** 0.051 0.852** 
Magnet hospital      -0.126 0.067 0.881 -0.143* 0.070 0.867* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.032 0.049 1.033 0.036 0.049 1.036 
  Medium      0.036 0.053 1.037 0.037 0.053 1.037 
  High      0.049 0.082 1.050 0.049 0.082 1.050 
Hospital location (Ref: Rural)             
  Micro/Division      -0.108 0.083 0.898 -0.106 0.083 0.899 
  Metro      -0.189* 0.078 0.828* -0.188* 0.078 0.829* 
Disproportionate Share 
Hospital (DSH) Index       0.185 0.128 1.203 0.182 0.128 1.200 
Mean number of Elixhauser 
comorbid conditions      -0.076 0.042 0.927 -0.079 0.042 0.924 
Proportion of patients with 
prior hospitalization for both 
HF and other conditions 
     -0.088 0.350 0.916 -0.096 0.350 0.908 
Volume (Ref=1st quartile: 
smallest)      -0.000 0.000 1.000 -0.000 0.000 1.000 
PQM (%): ACE Inhibitor or 
ARB for LVSD      0.001 0.002 1.001 -0.001 0.003 0.999 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.029**  0.027**   0.015**   0.015**   
  ICC 0.009  0.008   0.005   0.005   
  MOR 1.177  1.170   1.125   1.123   
            
92 
 
n: level-1 (patients) 41323  41323   41323   41323   
n: level-2 (hospitals) 396  396   396   396   
AIC 36406  35680   35657   35658   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 3:  
Association of HF-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Evaluation of LVS Function) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.005** 0.002 1.006** 0.006** 0.002 1.006** 0.006** 0.002 1.006** 
  Female   -0.020 0.028 0.981 -0.025 0.028 0.975 -0.025 0.028 0.975 
  Race (Ref: White)            
   Black   0.082 0.052 1.086 0.064 0.052 1.066 0.066 0.052 1.068 
   Hispanic   0.132** 0.045 1.142** 0.094* 0.046 1.098* 0.094* 0.046 1.099* 
   Others   -0.038 0.060 0.963 -0.088 0.062 0.916 -0.088 0.062 0.916 
  Disposition (Ref=Routine)            
   Home Health Care   0.149*** 0.036 1.161*** 0.160*** 0.036 1.174*** 0.160*** 0.036 1.174*** 
   Nursing Home    0.448*** 0.034 1.566*** 0.452*** 0.034 1.572*** 0.452*** 0.034 1.571*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.068 0.038 0.934 -0.049 0.038 0.952 -0.049 0.038 0.952 
   3rd quartile   0.007 0.039 1.007 0.032 0.039 1.032 0.032 0.039 1.032 
   4th quartile   -0.014 0.042 0.986 0.007 0.044 1.007 0.011 0.044 1.011 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than heart failure   0.211
* 0.095 1.235* 0.213* 0.095 1.237* 0.213* 0.095 1.237* 
Prior admission (1y) for  
heart failure   0.304
*** 0.031 1.355*** 0.304*** 0.031 1.356*** 0.304*** 0.031 1.356*** 
Prior admission (1y) for  
both heart failure and other  
conditions 
  0.605*** 0.037 1.832*** 0.605*** 0.037 1.831*** 0.605*** 0.037 1.831*** 
Comorbidities            
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  AIDS   1.562* 0.772 4.770* 1.584* 0.770 4.873* 1.588* 0.770 4.892* 
  Alcohol abuse   -0.005 0.119 0.995 -0.016 0.119 0.984 -0.015 0.119 0.985 
  Deficiency anemias   0.076* 0.030 1.079* 0.076* 0.030 1.079* 0.076* 0.030 1.079* 
  Rheumatoid arthritis   0.090 0.084 1.094 0.099 0.084 1.104 0.099 0.084 1.104 
  Chronic blood loss anemia   0.058 0.113 1.060 0.063 0.113 1.065 0.064 0.113 1.066 
  Chronic pulmonary disease   0.101*** 0.028 1.106*** 0.101*** 0.028 1.106*** 0.102*** 0.028 1.107*** 
  Coagulopathy   -0.015 0.070 0.986 -0.005 0.070 0.995 -0.004 0.070 0.996 
  Depression   0.014 0.047 1.014 0.015 0.047 1.015 0.015 0.047 1.015 
  Diabetes, uncomplicated   0.048 0.031 1.049 0.047 0.031 1.048 0.047 0.031 1.048 
Diabetes w/ chronic   
complications   0.156
** 0.048 1.169** 0.154** 0.048 1.166** 0.154** 0.048 1.167** 
  Drug abuse   0.246 0.238 1.278 0.203 0.238 1.225 0.201 0.238 1.223 
  Hypertension   -0.022 0.029 0.978 -0.013 0.029 0.987 -0.013 0.029 0.987 
  Hypothyroidism   0.018 0.035 1.018 0.022 0.035 1.022 0.021 0.035 1.022 
  Liver disease   0.178 0.102 1.194 0.181 0.102 1.199 0.182 0.102 1.200 
  Lymphoma   -0.044 0.237 0.957 -0.025 0.237 0.975 -0.025 0.237 0.976 
Fluid and electrolyte  
disorders   0.089
** 0.031 1.093** 0.094** 0.031 1.098** 0.094** 0.031 1.098** 
  Metastatic cancer   -0.394 0.339 0.675 -0.385 0.339 0.680 -0.385 0.339 0.680 
Other neurological  
disorders   0.008 0.049 1.008 0.011 0.049 1.011 0.011 0.049 1.011 
  Obesity   -0.048 0.047 0.953 -0.038 0.047 0.963 -0.038 0.047 0.963 
  Paralysis   -0.108 0.097 0.897 -0.116 0.097 0.891 -0.116 0.097 0.890 
Peripheral vascular  
disorders   0.138
*** 0.038 1.147*** 0.152*** 0.038 1.165*** 0.152*** 0.038 1.164*** 
  Psychoses   0.206* 0.086 1.229* 0.196* 0.086 1.217* 0.195* 0.086 1.215* 
Pulmonary circulation  
disorders   0.082 0.323 1.085 0.082 0.323 1.085 0.080 0.323 1.083 
  Renal failure   0.210*** 0.030 1.234*** 0.216*** 0.030 1.241*** 0.216*** 0.030 1.241*** 
Solid tumor without  
metastasis   -0.032 0.100 0.969 -0.030 0.100 0.970 -0.031 0.100 0.970 
  Peptic ulcer disease    0.140 0.641 1.150 0.143 0.641 1.153 0.145 0.641 1.156 
  Valvular disease   -0.303 0.246 0.738 -0.292 0.246 0.747 -0.290 0.246 0.748 
  Weight loss   0.058 0.085 1.060 0.061 0.085 1.063 0.063 0.085 1.065 
           
Level 2: Hospital Characteristics           
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California (Ref: Florida)      -0.029 0.039 0.972 -0.030 0.039 0.970 
Ownership (Ref: Public)            
  Private, not-for-profit      -0.075 0.049 0.928 -0.073 0.048 0.930 
  Private, for-profit      -0.060 0.056 0.942 -0.061 0.056 0.941 
System affiliation      0.025 0.039 1.026 0.021 0.039 1.022 
Cardiac catherization facility      -0.166*** 0.050 0.847*** -0.162** 0.050 0.851** 
Magnet hospital      -0.138* 0.067 0.871* -0.142* 0.067 0.868* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.035 0.049 1.035 0.037 0.049 1.038 
  Medium      0.035 0.054 1.036 0.030 0.054 1.031 
  High      0.077 0.078 1.080 0.078 0.078 1.082 
Hospital location (Ref: Rural)             
  Micro/Division      -0.086 0.082 0.917 -0.087 0.082 0.917 
  Metro      -0.165* 0.077 0.848* -0.165* 0.077 0.848* 
Disproportionate Share 
Hospital (DSH) Index       0.166 0.127 1.181 0.151 0.127 1.163 
Mean number of Elixhauser 
comorbid conditions      -0.068 0.041 0.934 -0.068 0.041 0.934 
Proportion of patients with 
prior hospitalization for both 
HF and other conditions 
     -0.096 0.343 0.908 -0.086 0.343 0.918 
Volume (Ref=1st quartile: 
smallest)      -0.000 0.000 1.000 -0.000 0.000 1.000 
PQM (%): Evaluation of LVS 
Function      -0.000 0.001 1.000 -0.002 0.001 0.998 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.030***  0.028***   0.016**   0.015***   
  ICC 0.009  0.008   0.005   0.005   
  MOR 1.179  1.173   1.129   1.124   
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n: level-1 (patients) 42038  42038   42038   42038   
n: level-2 (hospitals) 425  425   425   425   
AIC 37098  36361   36337   36337   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 4:  
Association of HF-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Discharge Instructions) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.006** 0.002 1.006** 0.006** 0.002 1.006** 0.006** 0.002 1.006** 
  Female   -0.019 0.028 0.981 -0.025 0.028 0.975 -0.025 0.028 0.975 
  Race (Ref: White)            
   Black   0.082 0.052 1.085 0.064 0.052 1.066 0.064 0.052 1.066 
   Hispanic   0.131** 0.045 1.140** 0.091* 0.046 1.096* 0.091* 0.046 1.096* 
   Others   -0.038 0.060 0.962 -0.087 0.062 0.916 -0.087 0.062 0.917 
  Disposition (Ref=Routine)            
   Home Health Care   0.149*** 0.036 1.161*** 0.160*** 0.036 1.174*** 0.160*** 0.036 1.174*** 
   Nursing Home    0.450*** 0.034 1.569*** 0.454*** 0.034 1.575*** 0.454*** 0.034 1.575*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.066 0.038 0.936 -0.049 0.038 0.952 -0.049 0.038 0.952 
   3rd quartile   0.006 0.039 1.006 0.030 0.039 1.031 0.030 0.039 1.031 
   4th quartile   -0.015 0.042 0.985 0.006 0.044 1.006 0.006 0.044 1.006 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than heart failure   0.211
* 0.095 1.235* 0.212* 0.095 1.236* 0.212* 0.095 1.236* 
Prior admission (1y) for  
heart failure   0.304
*** 0.031 1.355*** 0.305*** 0.031 1.356*** 0.305*** 0.031 1.356*** 
Prior admission (1y) for  
both heart failure and other  
conditions 
  0.605*** 0.037 1.832*** 0.605*** 0.037 1.831*** 0.605*** 0.037 1.831*** 
Comorbidities            
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  AIDS   1.562* 0.772 4.767* 1.577* 0.770 4.842* 1.577* 0.770 4.841* 
  Alcohol abuse   -0.006 0.119 0.994 -0.016 0.119 0.984 -0.016 0.119 0.984 
  Deficiency anemias   0.075* 0.030 1.078* 0.076* 0.030 1.079* 0.076* 0.030 1.079* 
  Rheumatoid arthritis   0.090 0.084 1.094 0.099 0.084 1.104 0.099 0.084 1.104 
  Chronic blood loss anemia   0.056 0.113 1.057 0.059 0.113 1.061 0.059 0.113 1.061 
  Chronic pulmonary disease   0.101*** 0.028 1.107*** 0.102*** 0.028 1.107*** 0.102*** 0.028 1.107*** 
  Coagulopathy   -0.015 0.070 0.985 -0.005 0.070 0.995 -0.005 0.070 0.995 
  Depression   0.013 0.047 1.013 0.014 0.047 1.014 0.014 0.047 1.014 
  Diabetes, uncomplicated   0.047 0.031 1.049 0.047 0.031 1.048 0.046 0.031 1.048 
Diabetes w/ chronic   
complications   0.156
** 0.048 1.168** 0.153** 0.048 1.166** 0.153** 0.048 1.165** 
  Drug abuse   0.246 0.238 1.278 0.203 0.238 1.224 0.202 0.238 1.224 
  Hypertension   -0.021 0.029 0.979 -0.012 0.029 0.988 -0.011 0.029 0.989 
  Hypothyroidism   0.019 0.035 1.019 0.023 0.035 1.023 0.022 0.035 1.023 
  Liver disease   0.178 0.102 1.194 0.182 0.102 1.199 0.182 0.102 1.199 
  Lymphoma   -0.045 0.237 0.956 -0.026 0.237 0.975 -0.026 0.237 0.974 
Fluid and electrolyte  
disorders   0.088
** 0.031 1.092** 0.093** 0.031 1.098** 0.093** 0.031 1.098** 
  Metastatic cancer   -0.394 0.339 0.674 -0.386 0.339 0.680 -0.387 0.339 0.679 
Other neurological  
disorders   0.007 0.049 1.007 0.010 0.049 1.010 0.010 0.049 1.010 
  Obesity   -0.049 0.047 0.952 -0.038 0.047 0.963 -0.038 0.047 0.963 
  Paralysis   -0.108 0.097 0.898 -0.114 0.097 0.892 -0.114 0.097 0.892 
Peripheral vascular  
disorders   0.137
*** 0.038 1.147*** 0.152*** 0.038 1.164*** 0.152*** 0.038 1.164*** 
  Psychoses   0.205* 0.086 1.228* 0.195* 0.086 1.216* 0.195* 0.086 1.216* 
Pulmonary circulation  
disorders   0.082 0.323 1.085 0.081 0.323 1.085 0.081 0.323 1.084 
  Renal failure   0.210*** 0.030 1.233*** 0.216*** 0.030 1.241*** 0.216*** 0.030 1.241*** 
Solid tumor without  
metastasis   -0.032 0.100 0.968 -0.031 0.100 0.969 -0.032 0.100 0.969 
  Peptic ulcer disease    0.140 0.641 1.151 0.142 0.641 1.152 0.141 0.641 1.151 
  Valvular disease   -0.303 0.246 0.739 -0.292 0.246 0.747 -0.291 0.246 0.747 
  Weight loss   0.057 0.085 1.059 0.061 0.085 1.063 0.061 0.085 1.063 
           
Level 2: Hospital Characteristics           
99 
 
California (Ref: Florida)      -0.029 0.039 0.972 -0.029 0.039 0.972 
Ownership (Ref: Public)            
  Private, not-for-profit      -0.077 0.049 0.926 -0.080 0.049 0.923 
  Private, for-profit      -0.062 0.056 0.940 -0.064 0.057 0.938 
System affiliation      0.019 0.039 1.020 0.020 0.039 1.020 
Cardiac catherization facility      -0.173*** 0.051 0.841*** -0.171*** 0.051 0.842*** 
Magnet hospital      -0.139* 0.067 0.870* -0.142* 0.068 0.868* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.033 0.049 1.034 0.033 0.049 1.033 
  Medium      0.033 0.054 1.033 0.032 0.054 1.032 
  High      0.079 0.078 1.082 0.081 0.078 1.084 
Hospital location (Ref: Rural)             
  Micro/Division      -0.093 0.083 0.911 -0.093 0.083 0.912 
  Metro      -0.167* 0.078 0.846* -0.166* 0.078 0.847* 
Disproportionate Share 
Hospital (DSH) Index       0.173 0.127 1.189 0.173 0.127 1.189 
Mean number of Elixhauser 
comorbid conditions      -0.073 0.041 0.930 -0.071 0.041 0.931 
Proportion of patients with 
prior hospitalization for both 
HF and other conditions 
     -0.067 0.343 0.935 -0.074 0.344 0.929 
Volume (Ref=1st quartile: 
smallest)      -0.000 0.000 1.000 -0.000 0.000 1.000 
PQM (%): Discharge 
Instructions      0.001 0.002 1.001 0.000 0.003 1.000 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.030***  0.028**   0.016***   0.015***   
  ICC 0.009  0.008   0.005   0.005   
  MOR 1.179  1.173   1.128   1.123   
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n: level-1 (patients) 42044  42044   42044   42044   
n: level-2 (hospitals) 426  426   426   426   
AIC 37113  36375   36350   36352   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 5:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Admission Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.004 0.003 1.004 0.004 0.003 1.004
  Female   -0.000 0.041 1.000 0.001 0.041 1.001 0.001 0.041 1.001
  Race (Ref: White)            
   Black   0.085 0.087 1.088 0.069 0.088 1.071 0.069 0.088 1.071
   Hispanic   0.027 0.068 1.027 0.012 0.071 1.012 0.012 0.071 1.012
   Others   -0.041 0.084 0.960 -0.063 0.086 0.939 -0.063 0.086 0.939
  Disposition (Ref=Routine)            
   Home Health Care   0.262*** 0.055 1.300*** 0.265*** 0.055 1.304*** 0.265*** 0.055 1.304***
   Nursing Home    0.632*** 0.051 1.882*** 0.632*** 0.052 1.882*** 0.632*** 0.052 1.881***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.064 0.053 0.938 -0.043 0.053 0.957 -0.043 0.053 0.958
   3rd quartile   -0.045 0.055 0.956 -0.018 0.056 0.982 -0.020 0.056 0.981
   4th quartile   -0.083 0.058 0.921 -0.052 0.060 0.949 -0.053 0.060 0.949
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.076 0.261 1.079 0.072 0.261 1.075 0.072 0.261 1.075 
Prior admission (1y) for  
AMI   0.301
*** 0.041 1.351*** 0.302*** 0.041 1.352*** 0.302*** 0.041 1.352*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.397*** 0.096 1.487*** 0.389*** 0.097 1.475*** 0.389*** 0.097 1.475*** 
  AMI location: Anterior   0.048 0.068 1.049 0.048 0.068 1.049 0.047 0.068 1.049
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  AMI location: Other   0.051 0.062 1.052 0.055 0.062 1.056 0.055 0.062 1.056
Procedure            
  CABG   -0.272*** 0.077 0.762*** -0.261*** 0.078 0.770*** -0.261*** 0.078 0.770***
  PTCA   0.101* 0.048 1.107* 0.113* 0.049 1.120* 0.114* 0.049 1.121*
Comorbidities            
  AIDS   1.352 0.746 3.864 1.355 0.744 3.877 1.359 0.744 3.892
  Alcohol abuse   0.088 0.154 1.092 0.088 0.154 1.092 0.087 0.154 1.091
  Deficiency anemias   0.034 0.045 1.034 0.035 0.045 1.036 0.035 0.045 1.036
  Rheumatoid arthritis   -0.044 0.116 0.957 -0.038 0.116 0.963 -0.037 0.116 0.963
  Chronic blood loss anemia   -0.218 0.136 0.804 -0.213 0.136 0.808 -0.212 0.136 0.809
  Congest Heart Failure   -0.202 0.253 0.817 -0.207 0.253 0.813 -0.208 0.253 0.812
  Chronic pulmonary disease   0.168*** 0.043 1.183*** 0.171*** 0.043 1.186*** 0.171*** 0.043 1.186***
  Coagulopathy   -0.155 0.093 0.856 -0.150 0.094 0.861 -0.150 0.094 0.861
  Depression   -0.010 0.073 0.990 -0.006 0.073 0.994 -0.006 0.073 0.994
  Diabetes, uncomplicated   0.144** 0.044 1.155** 0.143** 0.044 1.154** 0.143** 0.044 1.154**
Diabetes w/ chronic  
complications   0.232
** 0.077 1.261** 0.235** 0.077 1.265** 0.235** 0.077 1.264** 
  Drug abuse   -0.255 0.368 0.775 -0.248 0.369 0.780 -0.249 0.369 0.779
  Hypertension   0.047 0.044 1.048 0.046 0.044 1.047 0.046 0.044 1.047
  Hypothyroidism   0.044 0.055 1.046 0.045 0.055 1.046 0.045 0.055 1.046
  Liver disease   0.020 0.191 1.020 0.018 0.191 1.018 0.019 0.191 1.019
  Lymphoma   0.210 0.409 1.233 0.222 0.410 1.248 0.222 0.409 1.248
Fluid and electrolyte  
disorders   0.053 0.046 1.054 0.056 0.046 1.057 0.055 0.046 1.057 
  Metastatic cancer   -1.268* 0.598 0.281* -1.281* 0.598 0.278* -1.281* 0.598 0.278*
Other neurological  
disorders   -0.125 0.067 0.882 -0.124 0.067 0.883 -0.124 0.067 0.883 
  Obesity   -0.052 0.072 0.950 -0.046 0.072 0.955 -0.046 0.072 0.955
  Paralysis   0.008 0.107 1.008 0.013 0.107 1.013 0.013 0.107 1.013
Peripheral vascular  
disorders   0.071 0.051 1.074 0.074 0.052 1.076 0.074 0.052 1.077 
  Psychoses   0.074 0.119 1.077 0.079 0.119 1.083 0.079 0.119 1.082
Pulmonary circulation  
disorders   0.320 0.839 1.377 0.310 0.839 1.364 0.313 0.839 1.367 
  Renal failure   0.189*** 0.048 1.208*** 0.189*** 0.048 1.209*** 0.189*** 0.048 1.209***
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Solid tumor without  
metastasis   -0.169 0.141 0.845 -0.165 0.141 0.848 -0.165 0.141 0.848 
  Peptic ulcer disease    1.274 0.691 3.575 1.281 0.691 3.599 1.281 0.691 3.600
  Valvular disease   -0.298 0.410 0.742 -0.292 0.409 0.747 -0.293 0.409 0.746
  Weight loss   -0.099 0.127 0.906 -0.094 0.127 0.910 -0.094 0.127 0.910
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.065 0.057 1.067 0.067 0.057 1.069
Ownership (Ref: Public)           1.000
  Private, not-for-profit      -0.019 0.068 0.981 -0.015 0.068 0.985
  Private, for-profit      -0.090 0.082 0.914 -0.089 0.082 0.915
System affiliation      0.084 0.055 1.088 0.079 0.056 1.082
Cardiac catherization facility      -0.095 0.095 0.909 -0.095 0.095 0.909
Magnet hospital      -0.124 0.088 0.883 -0.130 0.088 0.878
Teaching intensity  
(Ref: non-teaching)            
  Low      0.117 0.067 1.124 0.116 0.066 1.123
  Medium      -0.060 0.075 0.942 -0.059 0.074 0.943
  High      0.188 0.109 1.207 0.187 0.109 1.206
Hospital location (Ref: Rural)             
  Micro/Division      -0.285* 0.130 0.752* -0.286* 0.130 0.751*
  Metro      -0.335** 0.123 0.716** -0.333** 0.123 0.716**
Disproportionate Share 
Hospital (DSH) Index       0.223 0.192 1.250 0.214 0.193 1.239 
Mean number of Elixhauser 
comorbid conditions      -0.062 0.056 0.940 -0.062 0.056 0.940 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     0.049 0.662 1.050 0.064 0.662 1.066 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Admission 
Composite Measure      -0.010 0.006 0.990 -0.013 0.008 0.987 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
            
104 
 
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.020*   0.019*   
  ICC 0.012  0.009   0.006   0.006   
  MOR 1.209  1.175   1.144   1.142   
            
n: level-1 (patients) 21635  21635   21635   21635   
n: level-2 (hospitals) 380  380   380   380   
AIC 18623  18261   18268   18269   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
105 
 
Appendix Table 6:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Discharge Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.003 0.003 1.003 0.003 0.003 1.003
  Female   0.002 0.041 1.002 0.003 0.041 1.003 0.003 0.041 1.003
  Race (Ref: White)            
   Black   0.080 0.088 1.083 0.061 0.088 1.063 0.061 0.088 1.063
   Hispanic   0.016 0.069 1.016 0.002 0.071 1.002 0.005 0.071 1.005
   Others   -0.031 0.084 0.970 -0.051 0.087 0.950 -0.051 0.087 0.950
  Disposition (Ref=Routine)            
   Home Health Care   0.271*** 0.055 1.311*** 0.272*** 0.056 1.313*** 0.272*** 0.056 1.312***
   Nursing Home    0.629*** 0.052 1.876*** 0.626*** 0.052 1.871*** 0.626*** 0.052 1.870***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.065 0.053 0.937 -0.047 0.054 0.954 -0.049 0.054 0.952
   3rd quartile   -0.048 0.056 0.953 -0.028 0.057 0.973 -0.029 0.057 0.972
   4th quartile   -0.088 0.059 0.915 -0.060 0.061 0.942 -0.059 0.061 0.942
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.083 0.261 1.087 0.074 0.261 1.077 0.076 0.261 1.079 
Prior admission (1y) for  
AMI   0.304
*** 0.041 1.356*** 0.305*** 0.041 1.357*** 0.306*** 0.041 1.357*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.409*** 0.097 1.506*** 0.405*** 0.098 1.499*** 0.405*** 0.098 1.499*** 
  AMI location: Anterior   0.052 0.069 1.053 0.054 0.069 1.056 0.054 0.069 1.056
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  AMI location: Other   0.046 0.062 1.047 0.051 0.062 1.052 0.051 0.062 1.052
Procedure            
  CABG   -0.266*** 0.077 0.766*** -0.253** 0.078 0.776** -0.253** 0.078 0.776**
  PTCA   0.103* 0.048 1.108* 0.116* 0.049 1.123* 0.117* 0.049 1.124*
Comorbidities            
  AIDS   1.355 0.746 3.878 1.341 0.745 3.822 1.345 0.744 3.837
  Alcohol abuse   0.059 0.156 1.061 0.059 0.156 1.061 0.059 0.156 1.061
  Deficiency anemias   0.037 0.046 1.038 0.039 0.046 1.040 0.039 0.046 1.040
  Rheumatoid arthritis   -0.032 0.116 0.968 -0.025 0.116 0.975 -0.024 0.116 0.977
  Chronic blood loss anemia   -0.208 0.136 0.812 -0.206 0.136 0.814 -0.207 0.136 0.813
  Congest Heart Failure   -0.284 0.263 0.753 -0.290 0.263 0.748 -0.292 0.263 0.747
  Chronic pulmonary disease   0.168*** 0.043 1.183*** 0.170*** 0.043 1.185*** 0.170*** 0.043 1.185***
  Coagulopathy   -0.135 0.093 0.874 -0.131 0.094 0.877 -0.131 0.094 0.877
  Depression   -0.013 0.074 0.987 -0.011 0.074 0.989 -0.011 0.074 0.989
  Diabetes, uncomplicated   0.143** 0.044 1.154** 0.142** 0.044 1.153** 0.142** 0.044 1.153**
Diabetes w/ chronic  
complications   0.234
** 0.077 1.264** 0.238** 0.077 1.268** 0.238** 0.077 1.268** 
  Drug abuse   -0.247 0.368 0.781 -0.247 0.368 0.781 -0.248 0.368 0.780
  Hypertension   0.052 0.044 1.054 0.051 0.044 1.052 0.052 0.044 1.053
  Hypothyroidism   0.044 0.055 1.045 0.045 0.055 1.046 0.044 0.055 1.045
  Liver disease   0.015 0.194 1.015 0.014 0.193 1.014 0.014 0.193 1.014
  Lymphoma   0.218 0.409 1.244 0.228 0.409 1.256 0.226 0.409 1.253
Fluid and electrolyte  
disorders   0.047 0.046 1.049 0.051 0.047 1.053 0.051 0.047 1.053 
  Metastatic cancer   -1.207* 0.599 0.299* -1.229* 0.600 0.293* -1.232* 0.600 0.292*
Other neurological  
disorders   -0.114 0.067 0.892 -0.114 0.067 0.893 -0.114 0.067 0.892 
  Obesity   -0.052 0.072 0.949 -0.048 0.072 0.953 -0.047 0.072 0.954
  Paralysis   0.018 0.108 1.018 0.022 0.108 1.022 0.021 0.108 1.021
Peripheral vascular  
disorders   0.072 0.052 1.075 0.074 0.052 1.077 0.075 0.052 1.077 
  Psychoses   0.063 0.120 1.065 0.065 0.120 1.067 0.065 0.120 1.067
Pulmonary circulation  
disorders   0.306 0.841 1.359 0.299 0.841 1.349 0.299 0.840 1.349 
  Renal failure   0.181*** 0.048 1.198*** 0.181*** 0.048 1.199*** 0.181*** 0.048 1.199***
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Solid tumor without  
metastasis   -0.200 0.144 0.819 -0.196 0.144 0.822 -0.196 0.144 0.822 
  Peptic ulcer disease    1.526* 0.730 4.600* 1.555* 0.731 4.736* 1.562* 0.732 4.769*
  Valvular disease   -0.215 0.412 0.807 -0.211 0.411 0.809 -0.208 0.411 0.812
  Weight loss   -0.090 0.128 0.914 -0.083 0.128 0.920 -0.083 0.128 0.920
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.088 0.058 1.092 0.093 0.058 1.098
Ownership (Ref: Public)            
  Private, not-for-profit      -0.015 0.069 0.985 -0.014 0.068 0.986
  Private, for-profit      -0.077 0.082 0.925 -0.074 0.082 0.929
System affiliation      0.069 0.056 1.071 0.062 0.056 1.064
Cardiac catherization facility      -0.073 0.106 0.930 -0.058 0.108 0.944
Magnet hospital      -0.123 0.088 0.884 -0.135 0.089 0.874
Teaching intensity  
(Ref: non-teaching)            
  Low      0.116 0.067 1.122 0.120 0.067 1.128
  Medium      -0.062 0.075 0.940 -0.054 0.076 0.947
  High      0.197 0.110 1.218 0.201 0.109 1.223
Hospital location (Ref: Rural)             
  Micro/Division      -0.262 0.138 0.770 -0.261 0.137 0.770
  Metro      -0.291* 0.131 0.747* -0.286* 0.131 0.751*
Disproportionate Share 
Hospital (DSH) Index       0.226 0.196 1.254 0.215 0.196 1.240 
Mean number of Elixhauser 
comorbid conditions      -0.045 0.058 0.956 -0.045 0.057 0.956 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     -0.071 0.703 0.932 -0.007 0.704 0.993 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Discharge 
Composite Measure      -0.004 0.005 0.996 -0.007 0.006 0.993 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.021**   0.020*   
  ICC 0.012  9   0.006   0.006   
  MOR 1.209  1.177   1.148   1.145   
            
n: level-1 (patients) 21367  21367   21367   21367   
n: level-2 (hospitals) 346  346   346   346   
AIC 18360  18009   18020   18022   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 7:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Global Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.004 0.003 1.004 0.004 0.003 1.004
  Female   0.005 0.041 1.005 0.006 0.041 1.006 0.006 0.041 1.006
  Race (Ref: White)            
   Black   0.081 0.087 1.084 0.064 0.088 1.066 0.064 0.088 1.066
   Hispanic   0.027 0.068 1.028 0.012 0.071 1.012 0.014 0.071 1.014
   Others   -0.041 0.084 0.960 -0.064 0.086 0.938 -0.063 0.086 0.939
  Disposition (Ref=Routine)            
   Home Health Care   0.262*** 0.055 1.300*** 0.265*** 0.055 1.303*** 0.265*** 0.055 1.303***
   Nursing Home    0.628*** 0.051 1.873*** 0.626*** 0.052 1.870*** 0.625*** 0.052 1.869***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.066 0.053 0.936 -0.044 0.053 0.957 -0.045 0.053 0.956
   3rd quartile   -0.050 0.055 0.951 -0.024 0.056 0.976 -0.026 0.056 0.974
   4th quartile   -0.086 0.058 0.918 -0.054 0.060 0.947 -0.053 0.060 0.948
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.075 0.261 1.078 0.067 0.261 1.070 0.067 0.261 1.070 
Prior admission (1y) for  
AMI   0.302
*** 0.041 1.353*** 0.304*** 0.041 1.355*** 0.304*** 0.041 1.355*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.399*** 0.096 1.490*** 0.393*** 0.097 1.481*** 0.393*** 0.097 1.481*** 
  AMI location: Anterior   0.052 0.068 1.053 0.051 0.068 1.053 0.052 0.068 1.053
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  AMI location: Other   0.056 0.062 1.057 0.059 0.062 1.061 0.059 0.062 1.061
Procedure            
  CABG   -0.268*** 0.077 0.765*** -0.252** 0.078 0.777** -0.252** 0.078 0.777**
  PTCA   0.096* 0.048 1.101* 0.113* 0.049 1.119* 0.115* 0.049 1.121*
Comorbidities            
  AIDS   1.353 0.746 3.868 1.345 0.744 3.838 1.351 0.744 3.861
  Alcohol abuse   0.090 0.154 1.094 0.090 0.154 1.094 0.089 0.154 1.093
  Deficiency anemias   0.032 0.045 1.033 0.035 0.045 1.036 0.035 0.045 1.036
  Rheumatoid arthritis   -0.054 0.116 0.948 -0.047 0.116 0.954 -0.045 0.116 0.956
  Chronic blood loss anemia   -0.222 0.136 0.801 -0.217 0.136 0.805 -0.217 0.136 0.805
  Congest Heart Failure   -0.193 0.254 0.824 -0.197 0.253 0.821 -0.199 0.253 0.819
  Chronic pulmonary disease   0.170*** 0.043 1.185*** 0.172*** 0.043 1.188*** 0.172*** 0.043 1.188***
  Coagulopathy   -0.148 0.093 0.862 -0.142 0.093 0.868 -0.141 0.093 0.869
  Depression   -0.019 0.073 0.982 -0.014 0.073 0.986 -0.014 0.073 0.986
  Diabetes, uncomplicated   0.142** 0.044 1.153** 0.141** 0.044 1.152** 0.141** 0.044 1.152**
Diabetes w/ chronic  
complications   0.228
** 0.077 1.257** 0.230** 0.077 1.259** 0.229** 0.077 1.258** 
  Drug abuse   -0.258 0.368 0.773 -0.255 0.368 0.775 -0.257 0.368 0.773
  Hypertension   0.047 0.044 1.049 0.048 0.044 1.049 0.048 0.044 1.049
  Hypothyroidism   0.041 0.055 1.041 0.042 0.055 1.042 0.041 0.055 1.042
  Liver disease   0.025 0.191 1.026 0.025 0.191 1.026 0.025 0.191 1.026
  Lymphoma   0.209 0.409 1.232 0.221 0.409 1.247 0.220 0.409 1.246
Fluid and electrolyte  
disorders   0.052 0.046 1.054 0.056 0.046 1.058 0.056 0.046 1.057 
  Metastatic cancer   -1.254* 0.598 0.285* -1.268* 0.599 0.282* -1.270* 0.599 0.281*
Other neurological  
disorders   -0.121 0.067 0.886 -0.119 0.067 0.888 -0.119 0.067 0.888 
  Obesity   -0.045 0.072 0.956 -0.039 0.072 0.961 -0.038 0.072 0.962
  Paralysis   0.016 0.107 1.016 0.019 0.107 1.020 0.019 0.107 1.019
Peripheral vascular  
disorders   0.073 0.051 1.076 0.076 0.052 1.079 0.077 0.052 1.080 
  Psychoses   0.080 0.119 1.083 0.084 0.119 1.087 0.083 0.119 1.086
Pulmonary circulation  
disorders   0.317 0.839 1.373 0.313 0.838 1.367 0.315 0.838 1.370 
  Renal failure   0.190*** 0.048 1.209*** 0.191*** 0.048 1.211*** 0.191*** 0.048 1.210***
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Solid tumor without  
metastasis   -0.170 0.141 0.844 -0.165 0.141 0.847 -0.165 0.141 0.848 
  Peptic ulcer disease    1.525* 0.730 4.595* 1.548* 0.731 4.701* 1.550* 0.732 4.712*
  Valvular disease   -0.308 0.410 0.735 -0.305 0.410 0.737 -0.305 0.410 0.737
  Weight loss   -0.099 0.127 0.906 -0.094 0.127 0.910 -0.094 0.127 0.910
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.073 0.057 1.076 0.080 0.057 1.083
Ownership (Ref: Public)            
  Private, not-for-profit      -0.012 0.068 0.988 -0.007 0.068 0.994
  Private, for-profit      -0.079 0.082 0.924 -0.075 0.082 0.928
System affiliation      0.075 0.056 1.078 0.064 0.057 1.066
Cardiac catherization facility      -0.106 0.096 0.899 -0.095 0.096 0.909
Magnet hospital      -0.128 0.088 0.880 -0.142 0.089 0.868
Teaching intensity  
(Ref: non-teaching)            
  Low      0.117 0.067 1.124 0.117 0.066 1.125
  Medium      -0.062 0.075 0.940 -0.055 0.075 0.947
  High      0.203 0.109 1.226 0.206 0.108 1.229
Hospital location (Ref: Rural)             
  Micro/Division      -0.293* 0.131 0.746* -0.296* 0.130 0.744*
  Metro      -0.331** 0.125 0.718** -0.329** 0.124 0.720**
Disproportionate Share 
Hospital (DSH) Index       0.221 0.193 1.247 0.200 0.194 1.222 
Mean number of Elixhauser 
comorbid conditions      -0.065 0.057 0.937 -0.065 0.056 0.938 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     -0.010 0.667 0.990 0.048 0.667 1.049 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Global Composite 
Measure      -0.008 0.006 0.992 -0.014 0.008 0.987 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.020**   0.019*   
  ICC 0.012  0.009   0.006   0.006   
  MOR 1.210  1.176   1.146   1.142   
            
n: level-1 (patients) 21580  21580   21580   21580   
n: level-2 (hospitals) 371  371   371   371   
AIC 18594  18234   18241   18242   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 8:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (ACE Inhibitor or ARB for LVSD) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.005 0.003 1.005 0.005 0.003 1.005 0.005 0.003 1.005
  Female   -0.005 0.044 0.995 -0.004 0.044 0.996 -0.003 0.044 0.997
  Race (Ref: White)            
   Black   0.039 0.094 1.040 0.028 0.094 1.029 0.028 0.094 1.028
   Hispanic   0.015 0.074 1.015 0.020 0.076 1.021 0.021 0.076 1.021
   Others   -0.068 0.093 0.934 -0.079 0.095 0.925 -0.078 0.095 0.925
  Disposition (Ref=Routine)            
   Home Health Care   0.294*** 0.059 1.342*** 0.294*** 0.059 1.342*** 0.294*** 0.059 1.341***
   Nursing Home    0.626*** 0.056 1.870*** 0.625*** 0.056 1.868*** 0.624*** 0.056 1.867***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.065 0.057 0.937 -0.051 0.057 0.951 -0.051 0.057 0.950
   3rd quartile   -0.030 0.059 0.970 -0.018 0.060 0.982 -0.018 0.060 0.983
   4th quartile   -0.068 0.064 0.934 -0.045 0.065 0.956 -0.044 0.065 0.957
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.178 0.271 1.195 0.169 0.271 1.185 0.169 0.271 1.184 
Prior admission (1y) for  
AMI   0.317
*** 0.044 1.373*** 0.320*** 0.044 1.377*** 0.320*** 0.044 1.377*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.385*** 0.105 1.469*** 0.387*** 0.106 1.473*** 0.388*** 0.106 1.473*** 
  AMI location: Anterior   0.051 0.072 1.052 0.051 0.072 1.052 0.051 0.072 1.053
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  AMI location: Other   0.034 0.065 1.035 0.037 0.065 1.038 0.037 0.065 1.038
Procedure            
  CABG   -0.248** 0.079 0.781** -0.246** 0.079 0.782** -0.245** 0.079 0.782**
  PTCA   0.125* 0.050 1.133* 0.127* 0.050 1.136* 0.128* 0.050 1.137*
Comorbidities            
  AIDS   1.177 0.882 3.244 1.198 0.883 3.313 1.201 0.883 3.325
  Alcohol abuse   -0.002 0.169 0.998 -0.008 0.169 0.992 -0.008 0.169 0.992
  Deficiency anemias   0.051 0.049 1.053 0.054 0.049 1.055 0.054 0.049 1.056
  Rheumatoid arthritis   -0.081 0.126 0.922 -0.078 0.126 0.925 -0.077 0.126 0.926
  Chronic blood loss anemia   -0.038 0.140 0.963 -0.036 0.140 0.965 -0.036 0.140 0.965
  Congest Heart Failure   -0.357 0.292 0.700 -0.360 0.292 0.698 -0.361 0.292 0.697
  Chronic pulmonary disease   0.157*** 0.046 1.170*** 0.160*** 0.046 1.174*** 0.160*** 0.046 1.174***
  Coagulopathy   -0.158 0.100 0.854 -0.152 0.100 0.859 -0.151 0.100 0.859
  Depression   -0.072 0.081 0.931 -0.069 0.081 0.933 -0.069 0.081 0.933
  Diabetes, uncomplicated   0.148** 0.047 1.160** 0.148** 0.047 1.159** 0.148** 0.047 1.160**
Diabetes w/ chronic  
complications   0.202
* 0.084 1.224* 0.206* 0.084 1.229* 0.206* 0.084 1.228* 
  Drug abuse   -0.109 0.373 0.897 -0.112 0.373 0.894 -0.113 0.373 0.894
  Hypertension   0.075 0.047 1.078 0.072 0.047 1.075 0.072 0.047 1.075
  Hypothyroidism   0.024 0.059 1.024 0.023 0.059 1.023 0.023 0.059 1.023
  Liver disease   -0.088 0.223 0.916 -0.087 0.222 0.917 -0.087 0.222 0.917
  Lymphoma   0.093 0.433 1.097 0.115 0.433 1.122 0.115 0.433 1.122
Fluid and electrolyte  
disorders   0.060 0.050 1.062 0.067 0.050 1.069 0.067 0.050 1.069 
  Metastatic cancer   -1.451* 0.729 0.234* -1.465* 0.728 0.231* -1.467* 0.728 0.231*
Other neurological  
disorders   -0.099 0.073 0.905 -0.096 0.073 0.909 -0.096 0.073 0.909 
  Obesity   -0.064 0.076 0.938 -0.059 0.076 0.942 -0.059 0.076 0.943
  Paralysis   0.089 0.117 1.093 0.094 0.117 1.099 0.095 0.117 1.099
Peripheral vascular  
disorders   0.063 0.055 1.065 0.064 0.055 1.066 0.064 0.055 1.066 
  Psychoses   0.223 0.124 1.250 0.232 0.124 1.261 0.233 0.124 1.262
Pulmonary circulation  
disorders   0.477 0.856 1.612 0.497 0.855 1.644 0.498 0.855 1.645 
  Renal failure   0.181*** 0.052 1.198*** 0.179*** 0.052 1.196*** 0.179*** 0.052 1.196***
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Solid tumor without  
metastasis   -0.211 0.152 0.810 -0.209 0.151 0.811 -0.209 0.151 0.812 
  Peptic ulcer disease    1.263 0.786 3.537 1.308 0.787 3.699 1.311 0.787 3.712
  Valvular disease   -0.185 0.439 0.831 -0.182 0.437 0.834 -0.181 0.438 0.834
  Weight loss   -0.124 0.142 0.883 -0.117 0.142 0.890 -0.117 0.142 0.890
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.099 0.065 1.104 0.099 0.065 1.105
Ownership (Ref: Public)            
  Private, not-for-profit      -0.020 0.074 0.980 -0.018 0.074 0.982
  Private, for-profit      -0.092 0.090 0.912 -0.089 0.091 0.915
System affiliation      0.091 0.062 1.095 0.091 0.062 1.095
Cardiac catherization facility      0.088 0.268 1.092 0.078 0.269 1.081
Magnet hospital      -0.186* 0.095 0.830* -0.191* 0.096 0.826*
Teaching intensity  
(Ref: non-teaching)            
  Low      0.102 0.071 1.107 0.104 0.072 1.110
  Medium      -0.042 0.080 0.959 -0.038 0.080 0.963
  High      0.232* 0.118 1.262* 0.235* 0.118 1.265*
Hospital location (Ref: Rural)             
  Micro/Division      -0.388* 0.171 0.679* -0.391* 0.171 0.677*
  Metro      -0.422* 0.166 0.656* -0.425* 0.166 0.654*
Disproportionate Share 
Hospital (DSH) Index       0.137 0.234 1.147 0.124 0.236 1.132 
Mean number of Elixhauser 
comorbid conditions      -0.085 0.070 0.919 -0.089 0.071 0.915 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     -0.516 0.912 0.597 -0.506 0.911 0.603 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): ACE Inhibitor or 
ARB for LVSD      -0.001 0.003 0.999 -0.003 0.006 0.997 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.033***   0.023**   0.023**   
  ICC 0.012  0.010   0.007   0.007   
  MOR 1.211  1.190   1.156   1.156   
            
n: level-1 (patients) 19086  19086   19086   19086   
n: level-2 (hospitals) 222  222   222   222   
AIC 16251  15945   15956   15958   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 9:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Aspirin at Arrival) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.004 0.003 1.004 0.004 0.003 1.004
  Female   -0.000 0.041 1.000 0.000 0.041 1.000 0.000 0.041 1.000
  Race (Ref: White)            
   Black   0.084 0.087 1.088 0.070 0.088 1.072 0.070 0.088 1.072
   Hispanic   0.027 0.068 1.027 0.014 0.071 1.014 0.017 0.071 1.017
   Others   -0.041 0.084 0.960 -0.062 0.086 0.940 -0.060 0.086 0.942
  Disposition (Ref=Routine)            
   Home Health Care   0.263*** 0.055 1.301*** 0.266*** 0.055 1.304*** 0.266*** 0.055 1.305***
   Nursing Home    0.632*** 0.051 1.882*** 0.631*** 0.052 1.879*** 0.631*** 0.052 1.880***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.063 0.053 0.939 -0.041 0.053 0.960 -0.041 0.053 0.960
   3rd quartile   -0.045 0.055 0.956 -0.019 0.056 0.981 -0.020 0.056 0.980
   4th quartile   -0.083 0.058 0.921 -0.050 0.060 0.951 -0.049 0.060 0.952
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.075 0.261 1.078 0.067 0.261 1.069 0.067 0.261 1.070 
Prior admission (1y) for  
AMI   0.301
*** 0.041 1.351*** 0.302*** 0.041 1.352*** 0.302*** 0.041 1.352*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.396*** 0.096 1.486*** 0.389*** 0.097 1.476*** 0.389*** 0.097 1.476*** 
  AMI location: Anterior   0.048 0.068 1.049 0.047 0.068 1.048 0.047 0.068 1.049
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  AMI location: Other   0.052 0.062 1.053 0.056 0.062 1.057 0.056 0.062 1.057
Procedure            
  CABG   -0.273*** 0.077 0.761*** -0.258*** 0.078 0.773*** -0.258*** 0.078 0.773***
  PTCA   0.101* 0.048 1.106* 0.117* 0.049 1.124* 0.119* 0.049 1.126*
Comorbidities            
  AIDS   1.352 0.746 3.864 1.334 0.744 3.797 1.340 0.744 3.818
  Alcohol abuse   0.088 0.154 1.092 0.087 0.154 1.091 0.087 0.154 1.091
  Deficiency anemias   0.034 0.045 1.035 0.037 0.045 1.038 0.037 0.045 1.038
  Rheumatoid arthritis   -0.044 0.116 0.957 -0.038 0.116 0.963 -0.037 0.116 0.964
  Chronic blood loss anemia   -0.218 0.136 0.804 -0.213 0.136 0.808 -0.213 0.136 0.808
  Congest Heart Failure   -0.190 0.254 0.827 -0.192 0.253 0.825 -0.193 0.253 0.824
  Chronic pulmonary disease   0.168*** 0.043 1.183*** 0.170*** 0.043 1.185*** 0.171*** 0.043 1.186***
  Coagulopathy   -0.156 0.093 0.856 -0.151 0.094 0.860 -0.150 0.094 0.861
  Depression   -0.010 0.073 0.990 -0.007 0.073 0.993 -0.008 0.073 0.992
  Diabetes, uncomplicated   0.144** 0.044 1.155** 0.144** 0.044 1.155** 0.144** 0.044 1.155**
Diabetes w/ chronic  
complications   0.232
** 0.077 1.261** 0.234** 0.077 1.264** 0.234** 0.077 1.264** 
  Drug abuse   -0.255 0.368 0.775 -0.254 0.368 0.776 -0.257 0.368 0.773
  Hypertension   0.046 0.044 1.047 0.047 0.044 1.048 0.047 0.044 1.048
  Hypothyroidism   0.044 0.055 1.045 0.046 0.055 1.047 0.046 0.055 1.047
  Liver disease   0.019 0.191 1.019 0.020 0.191 1.020 0.019 0.191 1.020
  Lymphoma   0.209 0.409 1.233 0.221 0.409 1.247 0.222 0.409 1.249
Fluid and electrolyte  
disorders   0.053 0.046 1.055 0.057 0.046 1.058 0.056 0.046 1.058 
  Metastatic cancer   -1.269* 0.598 0.281* -1.283* 0.598 0.277* -1.284* 0.598 0.277*
Other neurological  
disorders   -0.125 0.067 0.882 -0.123 0.067 0.884 -0.123 0.067 0.884 
  Obesity   -0.052 0.072 0.949 -0.047 0.072 0.954 -0.045 0.072 0.956
  Paralysis   0.007 0.107 1.007 0.012 0.107 1.012 0.011 0.107 1.011
Peripheral vascular  
disorders   0.071 0.051 1.073 0.073 0.052 1.076 0.074 0.052 1.077 
  Psychoses   0.073 0.119 1.076 0.078 0.119 1.081 0.078 0.119 1.081
Pulmonary circulation  
disorders   0.318 0.839 1.374 0.308 0.839 1.361 0.309 0.838 1.362 
  Renal failure   0.188*** 0.048 1.207*** 0.189*** 0.048 1.208*** 0.189*** 0.048 1.209***
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Solid tumor without  
metastasis   -0.170 0.141 0.844 -0.165 0.141 0.848 -0.166 0.141 0.847 
  Peptic ulcer disease    1.273 0.691 3.572 1.296 0.691 3.656 1.295 0.691 3.650
  Valvular disease   -0.307 0.410 0.736 -0.302 0.409 0.739 -0.302 0.409 0.740
  Weight loss   -0.100 0.127 0.905 -0.094 0.127 0.910 -0.095 0.127 0.909
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.066 0.057 1.069 0.070 0.057 1.073
Ownership (Ref: Public)            
  Private, not-for-profit      -0.007 0.068 0.993 -0.010 0.068 0.990
  Private, for-profit      -0.067 0.081 0.936 -0.072 0.081 0.930
System affiliation      0.076 0.055 1.079 0.075 0.055 1.078
Cardiac catherization facility      -0.087 0.095 0.916 -0.080 0.095 0.923
Magnet hospital      -0.123 0.088 0.884 -0.133 0.088 0.876
Teaching intensity  
(Ref: non-teaching)            
  Low      0.114 0.067 1.120 0.113 0.066 1.120
  Medium      -0.057 0.075 0.945 -0.054 0.075 0.948
  High      0.198 0.109 1.219 0.199 0.109 1.220
Hospital location (Ref: Rural)             
  Micro/Division      -0.276* 0.132 0.759* -0.275* 0.131 0.760*
  Metro      -0.316* 0.124 0.729* -0.313* 0.124 0.731*
Disproportionate Share 
Hospital (DSH) Index       0.234 0.192 1.264 0.214 0.193 1.239 
Mean number of Elixhauser 
comorbid conditions      -0.067 0.057 0.936 -0.069 0.057 0.933 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     0.002 0.663 1.002 0.061 0.664 1.062 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Aspirin at Arrival      -0.010 0.008 0.990 -0.016 0.010 0.984
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
            
Random effects            
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  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.020*   0.020*   
  ICC 0.012  0.009   0.006   0.006   
  MOR 1.209  1.175   1.145   1.143   
            
n: level-1 (patients) 21628  21628   21628   21628   
n: level-2 (hospitals) 379  379   379   379   
AIC 18621  18259   18267   18268   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 10:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Aspirin at Discharge) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.003 0.003 1.003 0.003 0.003 1.003
  Female   0.002 0.041 1.002 0.003 0.041 1.003 0.003 0.041 1.003
  Race (Ref: White)            
   Black   0.069 0.088 1.071 0.050 0.089 1.051 0.049 0.089 1.050
   Hispanic   0.016 0.069 1.017 0.001 0.071 1.001 0.003 0.071 1.003
   Others   -0.032 0.084 0.969 -0.054 0.087 0.947 -0.056 0.087 0.946
  Disposition (Ref=Routine)            
   Home Health Care   0.271*** 0.056 1.311*** 0.272*** 0.056 1.312*** 0.271*** 0.056 1.312***
   Nursing Home    0.634*** 0.052 1.885*** 0.631*** 0.052 1.879*** 0.630*** 0.052 1.878***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.064 0.054 0.938 -0.046 0.054 0.955 -0.048 0.054 0.953
   3rd quartile   -0.049 0.056 0.952 -0.029 0.057 0.971 -0.030 0.057 0.970
   4th quartile   -0.085 0.059 0.919 -0.057 0.061 0.945 -0.056 0.061 0.946
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.082 0.261 1.085 0.073 0.261 1.076 0.075 0.261 1.078 
Prior admission (1y) for  
AMI   0.304
*** 0.041 1.355*** 0.305*** 0.041 1.357*** 0.305*** 0.041 1.357*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.408*** 0.097 1.503*** 0.405*** 0.098 1.499*** 0.405*** 0.098 1.499*** 
  AMI location: Anterior   0.055 0.069 1.057 0.057 0.069 1.059 0.058 0.069 1.059
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  AMI location: Other   0.047 0.062 1.049 0.052 0.062 1.053 0.052 0.062 1.054
Procedure            
  CABG   -0.268*** 0.077 0.765*** -0.253** 0.078 0.776** -0.253** 0.078 0.776**
  PTCA   0.101* 0.048 1.106* 0.117* 0.049 1.124* 0.117* 0.049 1.124*
Comorbidities            
  AIDS   1.360 0.746 3.898 1.340 0.744 3.819 1.342 0.744 3.828
  Alcohol abuse   0.057 0.156 1.059 0.057 0.156 1.059 0.057 0.156 1.058
  Deficiency anemias   0.035 0.046 1.036 0.036 0.046 1.037 0.036 0.046 1.037
  Rheumatoid arthritis   -0.033 0.116 0.968 -0.026 0.116 0.974 -0.025 0.116 0.975
  Chronic blood loss anemia   -0.210 0.136 0.811 -0.208 0.136 0.812 -0.209 0.136 0.811
  Congest Heart Failure   -0.286 0.263 0.751 -0.292 0.263 0.747 -0.294 0.263 0.745
  Chronic pulmonary disease   0.168*** 0.043 1.183*** 0.169*** 0.044 1.184*** 0.170*** 0.044 1.185***
  Coagulopathy   -0.139 0.094 0.870 -0.136 0.094 0.873 -0.136 0.094 0.873
  Depression   -0.011 0.074 0.989 -0.009 0.074 0.991 -0.009 0.074 0.991
  Diabetes, uncomplicated   0.142** 0.044 1.153** 0.141** 0.044 1.152** 0.141** 0.044 1.152**
Diabetes w/ chronic  
complications   0.238
** 0.077 1.269** 0.241** 0.077 1.272** 0.241** 0.077 1.273** 
  Drug abuse   -0.249 0.368 0.780 -0.250 0.368 0.779 -0.250 0.368 0.779
  Hypertension   0.053 0.044 1.054 0.051 0.044 1.053 0.052 0.044 1.053
  Hypothyroidism   0.038 0.055 1.039 0.039 0.055 1.040 0.038 0.055 1.039
  Liver disease   0.013 0.194 1.013 0.012 0.193 1.012 0.012 0.193 1.012
  Lymphoma   0.216 0.409 1.241 0.228 0.409 1.256 0.223 0.409 1.250
Fluid and electrolyte  
disorders   0.050 0.047 1.051 0.053 0.047 1.055 0.053 0.047 1.055 
  Metastatic cancer   -1.171 0.600 0.310 -1.195* 0.601 0.303* -1.197* 0.601 0.302*
Other neurological  
disorders   -0.114 0.067 0.892 -0.113 0.067 0.893 -0.114 0.067 0.893 
  Obesity   -0.057 0.073 0.945 -0.052 0.073 0.949 -0.051 0.073 0.950
  Paralysis   0.019 0.108 1.019 0.021 0.108 1.021 0.021 0.108 1.021
Peripheral vascular  
disorders   0.071 0.052 1.073 0.072 0.052 1.075 0.073 0.052 1.076 
  Psychoses   0.065 0.120 1.067 0.066 0.120 1.068 0.066 0.120 1.068
Pulmonary circulation  
disorders   0.309 0.841 1.362 0.303 0.841 1.354 0.301 0.841 1.351 
  Renal failure   0.183*** 0.048 1.201*** 0.184*** 0.048 1.202*** 0.183*** 0.048 1.201***
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Solid tumor without  
metastasis   -0.199 0.144 0.819 -0.195 0.144 0.823 -0.196 0.144 0.822 
  Peptic ulcer disease    1.524* 0.730 4.591* 1.557* 0.731 4.744* 1.558* 0.732 4.751*
  Valvular disease   -0.216 0.412 0.805 -0.213 0.411 0.808 -0.208 0.411 0.812
  Weight loss   -0.099 0.128 0.906 -0.094 0.128 0.911 -0.094 0.128 0.911
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.082 0.058 1.086 0.088 0.058 1.092
Ownership (Ref: Public)            
  Private, not-for-profit      -0.008 0.069 0.992 -0.014 0.069 0.987
  Private, for-profit      -0.075 0.082 0.928 -0.078 0.082 0.925
System affiliation      0.061 0.055 1.063 0.058 0.055 1.060
Cardiac catherization facility      -0.091 0.108 0.913 -0.077 0.109 0.925
Magnet hospital      -0.127 0.089 0.881 -0.140 0.090 0.869
Teaching intensity  
(Ref: non-teaching)            
  Low      0.117 0.067 1.124 0.122 0.067 1.130
  Medium      -0.065 0.076 0.937 -0.057 0.076 0.944
  High      0.199 0.110 1.220 0.201 0.110 1.222
Hospital location (Ref: Rural)             
  Micro/Division      -0.258 0.138 0.772 -0.251 0.138 0.778
  Metro      -0.287* 0.131 0.751* -0.277* 0.131 0.758*
Disproportionate Share 
Hospital (DSH) Index       0.236 0.196 1.266 0.227 0.196 1.255 
Mean number of Elixhauser 
comorbid conditions      -0.033 0.058 0.967 -0.030 0.058 0.970 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     -0.134 0.707 0.874 -0.075 0.707 0.927 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Aspirin at 
Discharge      -0.003 0.005 0.997 -0.006 0.006 0.994 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.021**   0.021*   
  ICC 0.012  0.009   0.006   0.006   
  MOR 1.210  1.178   1.150   1.146   
            
n: level-1 (patients) 21301  21301   21301   21301   
n: level-2 (hospitals) 340  340   340   340   
AIC 18310  17959   17970   17971   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 11:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Beta Blocker at Arrival) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.004 0.003 1.004 0.004 0.003 1.004
  Female   0.004 0.041 1.004 0.005 0.041 1.005 0.005 0.041 1.006
  Race (Ref: White)            
   Black   0.076 0.088 1.079 0.060 0.088 1.062 0.059 0.088 1.061
   Hispanic   0.023 0.069 1.023 0.008 0.071 1.008 0.010 0.071 1.010
   Others   -0.043 0.084 0.958 -0.063 0.086 0.939 -0.062 0.086 0.940
  Disposition (Ref=Routine)            
   Home Health Care   0.262*** 0.055 1.299*** 0.263*** 0.055 1.301*** 0.262*** 0.055 1.300***
   Nursing Home    0.627*** 0.051 1.873*** 0.625*** 0.052 1.868*** 0.624*** 0.052 1.866***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.067 0.053 0.936 -0.047 0.053 0.954 -0.047 0.053 0.954
   3rd quartile   -0.049 0.055 0.953 -0.025 0.056 0.975 -0.026 0.056 0.974
   4th quartile   -0.085 0.059 0.918 -0.054 0.060 0.947 -0.054 0.060 0.948
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.074 0.261 1.077 0.066 0.261 1.068 0.066 0.261 1.069 
Prior admission (1y) for  
AMI   0.302
*** 0.041 1.352*** 0.303*** 0.041 1.354*** 0.304*** 0.041 1.355*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.393*** 0.096 1.481*** 0.386*** 0.098 1.471*** 0.386*** 0.098 1.471*** 
  AMI location: Anterior   0.047 0.068 1.048 0.047 0.068 1.048 0.046 0.068 1.048
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  AMI location: Other   0.051 0.062 1.053 0.055 0.062 1.057 0.054 0.062 1.056
Procedure            
  CABG   -0.275*** 0.077 0.759*** -0.259*** 0.078 0.771*** -0.258*** 0.078 0.772***
  PTCA   0.097* 0.048 1.102* 0.114* 0.049 1.121* 0.118* 0.049 1.125*
Comorbidities            
  AIDS   1.354 0.746 3.873 1.340 0.744 3.817 1.347 0.744 3.848
  Alcohol abuse   0.092 0.154 1.097 0.092 0.154 1.096 0.091 0.154 1.096
  Deficiency anemias   0.029 0.045 1.030 0.031 0.045 1.032 0.031 0.045 1.032
  Rheumatoid arthritis   -0.054 0.116 0.947 -0.048 0.116 0.953 -0.046 0.116 0.955
  Chronic blood loss anemia   -0.217 0.136 0.805 -0.214 0.136 0.808 -0.213 0.136 0.808
  Congest Heart Failure   -0.182 0.254 0.833 -0.187 0.254 0.830 -0.191 0.254 0.826
  Chronic pulmonary disease   0.173*** 0.043 1.188*** 0.175*** 0.043 1.191*** 0.175*** 0.043 1.191***
  Coagulopathy   -0.150 0.094 0.861 -0.145 0.094 0.865 -0.144 0.094 0.866
  Depression   -0.022 0.073 0.978 -0.019 0.073 0.981 -0.019 0.073 0.981
  Diabetes, uncomplicated   0.143** 0.044 1.153** 0.142** 0.044 1.153** 0.142** 0.044 1.153**
Diabetes w/ chronic  
complications   0.231
** 0.077 1.260** 0.233** 0.077 1.262** 0.232** 0.077 1.261** 
  Drug abuse   -0.260 0.369 0.771 -0.256 0.368 0.774 -0.259 0.368 0.772
  Hypertension   0.049 0.044 1.051 0.049 0.044 1.051 0.050 0.044 1.051
  Hypothyroidism   0.038 0.055 1.039 0.040 0.055 1.040 0.039 0.055 1.040
  Liver disease   0.031 0.191 1.032 0.030 0.191 1.031 0.029 0.191 1.030
  Lymphoma   0.207 0.409 1.230 0.218 0.409 1.243 0.218 0.409 1.244
Fluid and electrolyte  
disorders   0.055 0.046 1.056 0.058 0.046 1.060 0.058 0.046 1.060 
  Metastatic cancer   -1.234* 0.599 0.291* -1.251* 0.599 0.286* -1.252* 0.599 0.286*
Other neurological  
disorders   -0.121 0.067 0.886 -0.119 0.067 0.888 -0.119 0.067 0.888 
  Obesity   -0.054 0.072 0.947 -0.049 0.072 0.953 -0.048 0.072 0.954
  Paralysis   0.018 0.107 1.018 0.021 0.107 1.021 0.021 0.107 1.022
Peripheral vascular  
disorders   0.074 0.052 1.076 0.075 0.052 1.078 0.076 0.052 1.079 
  Psychoses   0.087 0.119 1.091 0.091 0.119 1.095 0.090 0.119 1.094
Pulmonary circulation  
disorders   0.318 0.839 1.375 0.312 0.838 1.366 0.316 0.838 1.372 
  Renal failure   0.191*** 0.048 1.210*** 0.192*** 0.048 1.212*** 0.192*** 0.048 1.212***
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Solid tumor without  
metastasis   -0.168 0.141 0.845 -0.165 0.141 0.848 -0.164 0.141 0.849 
  Peptic ulcer disease    1.521* 0.730 4.577* 1.555* 0.731 4.735* 1.544* 0.732 4.681*
  Valvular disease   -0.314 0.410 0.731 -0.309 0.410 0.735 -0.309 0.410 0.734
  Weight loss   -0.112 0.127 0.894 -0.107 0.127 0.898 -0.107 0.127 0.899
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.078 0.057 1.081 0.082 0.057 1.085
Ownership (Ref: Public)            
  Private, not-for-profit      -0.011 0.068 0.989 -0.002 0.069 0.998
  Private, for-profit      -0.069 0.083 0.934 -0.067 0.083 0.935
System affiliation      0.062 0.056 1.064 0.052 0.056 1.053
Cardiac catherization facility      -0.114 0.096 0.893 -0.103 0.097 0.902
Magnet hospital      -0.131 0.088 0.878 -0.146 0.089 0.864
Teaching intensity  
(Ref: non-teaching)            
  Low      0.119 0.067 1.126 0.117 0.067 1.124
  Medium      -0.065 0.075 0.938 -0.067 0.075 0.935
  High      0.187 0.109 1.206 0.192 0.109 1.212
Hospital location (Ref: Rural)             
  Micro/Division      -0.300* 0.131 0.741* -0.309* 0.131 0.734*
  Metro      -0.325** 0.125 0.723** -0.329** 0.124 0.720**
Disproportionate Share 
Hospital (DSH) Index       0.245 0.194 1.277 0.223 0.194 1.250 
Mean number of Elixhauser 
comorbid conditions      -0.045 0.058 0.956 -0.046 0.057 0.955 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     0.009 0.667 1.009 0.050 0.666 1.051 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Beta Blocker at 
Arrival      -0.001 0.004 0.999 -0.006 0.006 0.994 
           1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.021**   0.020*   
  ICC 0.012  0.009   0.006   0.006   
  MOR 1.210  1.176   1.147   1.144   
            
n: level-1 (patients) 21548  21548   21548   21548   
n: level-2 (hospitals) 369  369   369   369   
AIC 18566  18206   18215   18215   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 12:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Beta Blocker at Discharge) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.003 0.003 1.003 0.003 0.003 1.003
  Female   0.006 0.041 1.006 0.006 0.041 1.006 0.006 0.041 1.006
  Race (Ref: White)            
   Black   0.080 0.088 1.083 0.060 0.089 1.062 0.061 0.088 1.062
   Hispanic   0.011 0.069 1.011 -0.002 0.072 0.998 0.001 0.072 1.001
   Others   -0.035 0.085 0.965 -0.054 0.087 0.948 -0.052 0.087 0.949
  Disposition (Ref=Routine)            
   Home Health Care   0.269*** 0.056 1.309*** 0.270*** 0.056 1.310*** 0.270*** 0.056 1.310***
   Nursing Home    0.630*** 0.052 1.878*** 0.628*** 0.052 1.873*** 0.627*** 0.052 1.872***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.067 0.054 0.935 -0.049 0.054 0.952 -0.051 0.054 0.950
   3rd quartile   -0.045 0.056 0.956 -0.025 0.057 0.975 -0.026 0.057 0.974
   4th quartile   -0.090 0.059 0.914 -0.061 0.061 0.941 -0.060 0.061 0.941
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI   0.085 0.261 1.089 0.075 0.261 1.078 0.077 0.261 1.080 
Prior admission (1y) for  
AMI   0.306
*** 0.041 1.358*** 0.307*** 0.041 1.360*** 0.308*** 0.041 1.360*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.409*** 0.097 1.505*** 0.405*** 0.098 1.500*** 0.405*** 0.098 1.500*** 
  AMI location: Anterior   0.054 0.069 1.055 0.055 0.069 1.057 0.056 0.069 1.057
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  AMI location: Other   0.048 0.062 1.049 0.052 0.062 1.053 0.052 0.062 1.053
Procedure            
  CABG   -0.262*** 0.077 0.770*** -0.252** 0.078 0.777** -0.252** 0.078 0.778**
  PTCA   0.105* 0.048 1.111* 0.116* 0.049 1.123* 0.117* 0.049 1.124*
Comorbidities            
  AIDS   1.356 0.746 3.879 1.341 0.745 3.824 1.348 0.744 3.851
  Alcohol abuse   0.061 0.156 1.062 0.060 0.156 1.062 0.060 0.156 1.062
  Deficiency anemias   0.034 0.046 1.035 0.036 0.046 1.037 0.036 0.046 1.037
  Rheumatoid arthritis   -0.031 0.116 0.970 -0.023 0.117 0.977 -0.022 0.117 0.978
  Chronic blood loss anemia   -0.201 0.136 0.818 -0.199 0.136 0.819 -0.200 0.136 0.819
  Congest Heart Failure   -0.274 0.264 0.760 -0.279 0.263 0.756 -0.281 0.263 0.755
  Chronic pulmonary disease   0.165*** 0.043 1.180*** 0.167*** 0.044 1.182*** 0.168*** 0.044 1.183***
  Coagulopathy   -0.136 0.094 0.872 -0.133 0.094 0.876 -0.132 0.094 0.877
  Depression   -0.011 0.074 0.989 -0.009 0.074 0.991 -0.009 0.074 0.991
  Diabetes, uncomplicated   0.142** 0.044 1.153** 0.141** 0.044 1.152** 0.141** 0.044 1.152**
Diabetes w/ chronic  
complications   0.230
** 0.077 1.258** 0.234** 0.077 1.264** 0.234** 0.077 1.264** 
  Drug abuse   -0.225 0.369 0.798 -0.225 0.369 0.799 -0.226 0.369 0.797
  Hypertension   0.050 0.044 1.051 0.049 0.044 1.050 0.049 0.044 1.051
  Hypothyroidism   0.044 0.055 1.045 0.045 0.055 1.046 0.044 0.055 1.045
  Liver disease   0.016 0.194 1.016 0.016 0.193 1.016 0.015 0.193 1.015
  Lymphoma   0.220 0.409 1.246 0.229 0.409 1.257 0.227 0.409 1.255
Fluid and electrolyte  
disorders   0.045 0.047 1.046 0.050 0.047 1.051 0.050 0.047 1.051 
  Metastatic cancer   -1.206* 0.599 0.299* -1.228* 0.600 0.293* -1.231* 0.600 0.292*
Other neurological  
disorders   -0.108 0.067 0.898 -0.106 0.067 0.899 -0.107 0.067 0.899 
  Obesity   -0.053 0.073 0.948 -0.049 0.073 0.953 -0.048 0.073 0.953
  Paralysis   0.015 0.108 1.016 0.020 0.108 1.020 0.019 0.108 1.019
Peripheral vascular  
disorders   0.071 0.052 1.074 0.073 0.052 1.076 0.073 0.052 1.076 
  Psychoses   0.075 0.120 1.078 0.077 0.120 1.081 0.078 0.120 1.081
Pulmonary circulation  
disorders   0.305 0.841 1.356 0.296 0.840 1.345 0.298 0.840 1.347 
  Renal failure   0.187*** 0.048 1.205*** 0.188*** 0.048 1.207*** 0.188*** 0.048 1.206***
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Solid tumor without  
metastasis   -0.198 0.144 0.820 -0.194 0.144 0.823 -0.194 0.144 0.823 
  Peptic ulcer disease    1.527* 0.730 4.603* 1.555* 0.731 4.737* 1.566* 0.732 4.789*
  Valvular disease   -0.221 0.412 0.801 -0.219 0.411 0.803 -0.215 0.411 0.806
  Weight loss   -0.080 0.128 0.923 -0.073 0.128 0.929 -0.072 0.128 0.931
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.098 0.058 1.103 0.101 0.058 1.106
Ownership (Ref: Public)            
  Private, not-for-profit      -0.018 0.069 0.983 -0.013 0.068 0.987
  Private, for-profit      -0.081 0.083 0.923 -0.075 0.083 0.927
System affiliation      0.069 0.056 1.071 0.058 0.057 1.060
Cardiac catherization facility      -0.062 0.109 0.940 -0.043 0.111 0.958
Magnet hospital      -0.124 0.088 0.884 -0.132 0.088 0.876
Teaching intensity  
(Ref: non-teaching)            
  Low      0.117 0.067 1.124 0.121 0.067 1.128
  Medium      -0.062 0.075 0.940 -0.054 0.075 0.947
  High      0.197 0.110 1.217 0.199 0.109 1.221
Hospital location (Ref: Rural)             
  Micro/Division      -0.266 0.137 0.766 -0.270* 0.137 0.763*
  Metro      -0.293* 0.131 0.746* -0.292* 0.131 0.747*
Disproportionate Share 
Hospital (DSH) Index       0.238 0.196 1.268 0.227 0.196 1.255 
Mean number of Elixhauser 
comorbid conditions      -0.055 0.058 0.947 -0.054 0.058 0.948 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     -0.106 0.707 0.899 -0.048 0.707 0.954 
Hospital AMI Volume      -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%): Beta Blocker at 
Discharge      -0.003 0.005 0.997 -0.007 0.007 0.993 
         0.000 0.000 1.000
Interaction  
(Volume ൈ PQM)            
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Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.040***  0.029***   0.021**   0.020*   
  ICC 0.011  0.009   0.006   0.006   
  MOR 1.208  1.177   1.148   1.144   
            
n: level-1 (patients) 21328  21328   21328   21328   
n: level-2 (hospitals) 344  344   344   344   
AIC 18316  17965   17976   17977   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 13:  
Association of AMI-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (PCI Within 90m of Arrival) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.003 1.003 0.003 0.003 1.004 0.003 0.003 1.004
  Female   0.001 0.047 1.001 0.004 0.047 1.004 0.004 0.047 1.004
  Race (Ref: White)            
   Black   0.015 0.103 1.015 -0.030 0.103 0.971 -0.029 0.103 0.971
   Hispanic   -0.020 0.080 0.980 -0.029 0.082 0.971 -0.027 0.082 0.973
   Others   0.028 0.098 1.029 0.016 0.100 1.017 0.014 0.100 1.014
  Disposition (Ref=Routine)            
   Home Health Care   0.341*** 0.063 1.406*** 0.342*** 0.063 1.407*** 0.341*** 0.063 1.407***
   Nursing Home    0.683*** 0.061 1.980*** 0.686*** 0.061 1.985*** 0.685*** 0.061 1.984***
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.063 0.061 0.939 -0.044 0.061 0.957 -0.046 0.061 0.955
   3rd quartile   -0.048 0.064 0.953 -0.021 0.064 0.980 -0.023 0.064 0.977
   4th quartile   -0.100 0.067 0.905 -0.072 0.068 0.931 -0.076 0.068 0.927
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than AMI            
Prior admission (1y) for  
AMI   0.321
*** 0.047 1.379*** 0.315*** 0.047 1.371*** 0.316*** 0.047 1.371*** 
Prior admission (1y) for  
both AMI and other  
conditions 
  0.416** 0.133 1.517** 0.389** 0.134 1.476** 0.390** 0.134 1.477** 
  AMI location: Anterior   0.035 0.076 1.036 0.045 0.076 1.046 0.046 0.076 1.047
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  AMI location: Other   0.081 0.067 1.084 0.090 0.067 1.095 0.091 0.067 1.095
Procedure            
  CABG   -0.245** 0.082 0.783** -0.250** 0.082 0.778** -0.250** 0.082 0.779**
  PTCA   0.129* 0.053 1.137* 0.130* 0.053 1.138* 0.129* 0.053 1.138*
Comorbidities            
  AIDS            
  Alcohol abuse   -0.055 0.183 0.946 -0.058 0.183 0.943 -0.057 0.183 0.944
  Deficiency anemias   0.061 0.053 1.063 0.063 0.053 1.065 0.062 0.053 1.064
  Rheumatoid arthritis   -0.099 0.133 0.906 -0.086 0.133 0.917 -0.086 0.133 0.918
  Chronic blood loss anemia   -0.066 0.151 0.936 -0.065 0.151 0.937 -0.066 0.151 0.936
  Congest Heart Failure   -0.388 0.341 0.678 -0.414 0.341 0.661 -0.416 0.341 0.660
  Chronic pulmonary disease   0.144** 0.050 1.155** 0.153** 0.050 1.165** 0.153** 0.050 1.166**
  Coagulopathy   -0.133 0.105 0.876 -0.132 0.105 0.877 -0.132 0.105 0.876
  Depression   -0.102 0.088 0.903 -0.103 0.089 0.902 -0.104 0.089 0.901
  Diabetes, uncomplicated   0.158** 0.051 1.171** 0.155** 0.051 1.168** 0.156** 0.051 1.169**
Diabetes w/ chronic  
complications   0.237
** 0.091 1.267** 0.249** 0.091 1.283** 0.249** 0.091 1.282** 
  Drug abuse   0.147 0.378 1.158 0.160 0.378 1.174 0.159 0.377 1.172
  Hypertension   0.029 0.050 1.030 0.024 0.051 1.024 0.023 0.051 1.024
  Hypothyroidism   -0.006 0.064 0.994 -0.004 0.064 0.996 -0.004 0.064 0.996
  Liver disease   -0.081 0.237 0.922 -0.083 0.237 0.920 -0.084 0.237 0.920
  Lymphoma   0.321 0.445 1.379 0.361 0.446 1.435 0.359 0.445 1.431
Fluid and electrolyte  
disorders   0.057 0.054 1.059 0.063 0.054 1.065 0.063 0.054 1.065 
  Metastatic cancer   -0.746 0.610 0.474 -0.806 0.610 0.446 -0.803 0.610 0.448
Other neurological  
disorders   -0.083 0.079 0.920 -0.083 0.079 0.920 -0.083 0.079 0.921 
  Obesity   -0.046 0.081 0.955 -0.041 0.081 0.960 -0.041 0.081 0.960
  Paralysis   0.056 0.128 1.058 0.060 0.128 1.062 0.059 0.128 1.061
Peripheral vascular  
disorders   0.089 0.059 1.093 0.091 0.059 1.095 0.091 0.059 1.095 
  Psychoses   0.147 0.137 1.158 0.147 0.137 1.158 0.147 0.137 1.158
Pulmonary circulation  
disorders   0.997 0.931 2.711 1.004 0.929 2.729 1.002 0.929 2.725 
  Renal failure   0.165** 0.056 1.179** 0.167** 0.056 1.181** 0.167** 0.056 1.182**
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Solid tumor without  
metastasis   -0.228 0.166 0.796 -0.227 0.165 0.797 -0.226 0.165 0.798 
  Peptic ulcer disease    1.241 0.789 3.460 1.216 0.788 3.374 1.219 0.788 3.383
  Valvular disease   -0.292 0.512 0.747 -0.292 0.510 0.747 -0.288 0.510 0.750
  Weight loss   -0.025 0.150 0.975 -0.005 0.150 0.995 -0.006 0.150 0.994
           
Level 2: Hospital Characteristics           
California (Ref: Florida)      0.138* 0.064 1.148* 0.144* 0.065 1.154*
Ownership (Ref: Public)            
  Private, not-for-profit      0.019 0.074 1.019 0.029 0.076 1.029
  Private, for-profit      -0.066 0.091 0.936 -0.057 0.092 0.945
System affiliation      0.137* 0.062 1.147* 0.144* 0.062 1.155*
Cardiac catherization facility            
Magnet hospital      -0.161 0.085 0.851 -0.178* 0.089 0.837*
Teaching intensity  
(Ref: non-teaching)            
  Low      0.121 0.068 1.129 0.125 0.067 1.133
  Medium      -0.055 0.078 0.947 -0.060 0.078 0.942
  High      0.251* 0.116 1.286* 0.275* 0.122 1.316*
Hospital location (Ref: Rural)             
  Micro/Division      -0.168 0.228 0.846 -0.177 0.226 0.838
  Metro      -0.238 0.225 0.788 -0.248 0.223 0.781
Disproportionate Share 
Hospital (DSH) Index       0.304 0.257 1.355 0.302 0.255 1.352 
Mean number of Elixhauser 
comorbid conditions      -0.122 0.070 0.885 -0.120 0.070 0.887 
Proportion of patients with 
prior hospitalization for both 
AMI and other conditions 
     0.851 1.102 2.343 0.857 1.098 2.356 
Hospital AMI Volume       -0.000 0.000 1.000 -0.000 0.000 1.000
PQM (%):PCI Within 90m of 
Arrival      -0.004
** 0.001 0.996** -0.002 0.003 0.998 
Interaction  
(Volume ൈ PQM)         -0.000 0.000 1.000 
            
Random effects            
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  Hospital (intercept)            
  Variance between hospitals 0.023**  0.018*   0.005   0.003   
  ICC 0.007  0.006   0.001   0.001   
  MOR 1.157  1.138   1.066   1.058   
            
n: level-1 (patients) 16654  16654   16654   16654   
n: level-2 (hospitals) 168  168   168   168   
AIC 14087  13811   13807   13809   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 14:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Admission Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.128*** 0.034 0.880*** -0.132*** 0.034 0.876*** -0.132*** 0.034 0.876*** 
  Race (Ref: White)            
   Black   0.076 0.076 1.079 0.049 0.077 1.051 0.049 0.077 1.050 
   Hispanic   0.041 0.056 1.041 -0.006 0.057 0.995 -0.005 0.057 0.995 
   Others   -0.070 0.071 0.933 -0.146* 0.072 0.864* -0.146* 0.072 0.865* 
  Disposition (Ref=Routine)            
   Home Health Care   0.287*** 0.049 1.332*** 0.298*** 0.049 1.347*** 0.298*** 0.049 1.347*** 
   Nursing Home    0.758*** 0.040 2.134*** 0.754*** 0.040 2.125*** 0.754*** 0.040 2.125*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.063 0.047 0.939 -0.061 0.047 0.941 -0.061 0.047 0.941 
   3rd quartile   -0.006 0.049 0.994 0.004 0.049 1.004 0.004 0.049 1.004 
   4th quartile   -0.018 0.054 0.982 -0.005 0.055 0.995 -0.005 0.055 0.995 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.095 0.170 1.100 0.080 0.170 1.083 0.080 0.170 1.083 
Prior admission (1y) for  
PN   0.366
*** 0.036 1.442*** 0.365*** 0.036 1.441*** 0.365*** 0.036 1.441*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.642*** 0.057 1.901*** 0.617*** 0.058 1.853*** 0.617*** 0.058 1.853*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.207 0.125 1.231 0.200 0.125 1.222 0.200 0.125 1.221 
  Deficiency anemias   0.027 0.037 1.028 0.028 0.037 1.029 0.028 0.037 1.029 
  Rheumatoid arthritis   0.226** 0.082 1.253** 0.238** 0.082 1.268** 0.238** 0.082 1.268** 
  Chronic blood loss anemia   -0.011 0.158 0.989 0.004 0.158 1.004 0.004 0.158 1.004 
  Congest Heart Failure   0.198*** 0.037 1.219*** 0.190*** 0.036 1.209*** 0.190*** 0.036 1.209*** 
  Chronic pulmonary disease   0.160*** 0.034 1.173*** 0.171*** 0.034 1.187*** 0.171*** 0.034 1.187*** 
  Coagulopathy   -0.174 0.098 0.840 -0.164 0.097 0.849 -0.164 0.097 0.849 
  Depression   -0.095 0.054 0.909 -0.086 0.054 0.917 -0.086 0.054 0.917 
  Diabetes, uncomplicated   0.066 0.039 1.068 0.069 0.039 1.072 0.069 0.039 1.072 
Diabetes w/ chronic  
complications   0.121 0.076 1.129 0.119 0.076 1.127 0.119 0.076 1.127 
  Drug abuse   0.136 0.234 1.146 0.130 0.233 1.139 0.130 0.233 1.139 
  Hypertension   -0.033 0.036 0.968 -0.019 0.036 0.981 -0.019 0.036 0.981 
  Hypothyroidism   -0.008 0.044 0.992 -0.004 0.044 0.996 -0.004 0.044 0.996 
  Liver disease   0.172 0.135 1.188 0.174 0.135 1.190 0.174 0.135 1.190 
  Lymphoma   -0.279 0.239 0.756 -0.257 0.239 0.774 -0.257 0.239 0.774 
Fluid and electrolyte  
disorders   0.050 0.034 1.051 0.055 0.034 1.057 0.055 0.034 1.057 
  Metastatic cancer   0.094 0.269 1.098 0.103 0.269 1.109 0.104 0.269 1.109 
Other neurological  
disorders   0.067 0.045 1.069 0.067 0.045 1.069 0.067 0.045 1.069 
  Obesity   -0.090 0.075 0.914 -0.074 0.075 0.929 -0.074 0.075 0.929 
  Paralysis   0.016 0.088 1.016 0.010 0.088 1.010 0.010 0.088 1.010 
Peripheral vascular  
disorders   0.066 0.058 1.069 0.082 0.058 1.086 0.082 0.058 1.086 
  Psychoses   0.122 0.077 1.130 0.103 0.077 1.108 0.103 0.077 1.108 
Pulmonary circulation  
disorders   0.077 0.075 1.080 0.094 0.075 1.099 0.094 0.075 1.099 
  Renal failure   0.121** 0.045 1.129** 0.125** 0.045 1.133** 0.125** 0.045 1.133** 
Solid tumor without  
metastasis   -0.044 0.091 0.957 -0.038 0.091 0.962 -0.038 0.091 0.962 
  Peptic ulcer disease    0.628 0.527 1.874 0.612 0.526 1.844 0.612 0.526 1.844 
  Valvular disease   -0.024 0.055 0.976 -0.005 0.055 0.995 -0.005 0.055 0.995 
  Weight loss   0.173* 0.072 1.189* 0.171* 0.072 1.187* 0.171* 0.072 1.187* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.143** 0.052 0.867** -0.142** 0.053 0.867** 
Ownership (Ref: Public)            
  Private, not-for-profit      0.043 0.067 1.044 0.043 0.067 1.044 
  Private, for-profit      -0.047 0.078 0.954 -0.048 0.078 0.954 
System affiliation      0.072 0.054 1.075 0.072 0.054 1.074 
Cardiac catherization facility      -0.086 0.061 0.917 -0.086 0.062 0.918 
Magnet hospital      -0.184 0.099 0.832 -0.186 0.101 0.830 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.063 0.069 1.065 0.063 0.069 1.065 
  Medium      -0.066 0.075 0.936 -0.066 0.075 0.936 
  High      0.042 0.111 1.043 0.040 0.112 1.041 
Hospital location (Ref: Rural)             
  Micro/Division      0.025 0.105 1.025 0.025 0.105 1.025 
  Metro      -0.091 0.098 0.913 -0.091 0.098 0.913 
Disproportionate Share 
Hospital (DSH) Index       -0.035 0.162 0.966 -0.036 0.162 0.965 
Mean number of Elixhauser 
comorbid conditions      -0.104
* 0.049 0.901* -0.104* 0.049 0.901* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.238*** 0.680 9.376*** 2.237** 0.680 9.368** 
Hospital PN Volume      -0.000 0.000 1.000 -0.000 0.000 1.000 
PQM (%): Admission 
Composite Measure      -0.020
** 0.007 0.980** -0.021 0.011 0.979 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.111***  0.096***   0.058***   0.058***   
  ICC 0.033  0.028   0.017   0.017   
  MOR 1.375  1.345   1.259   1.259   
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n: level-1 (patients) 36384  36384   36384   36384   
n: level-2 (hospitals) 426  426   426   426   
AIC 27104  26227   26188   26190   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 15:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Discharge Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.128*** 0.034 0.880*** -0.132*** 0.034 0.877*** -0.132*** 0.034 0.877*** 
  Race (Ref: White)            
   Black   0.076 0.076 1.079 0.054 0.077 1.056 0.054 0.077 1.056 
   Hispanic   0.037 0.057 1.038 -0.012 0.058 0.988 -0.011 0.058 0.989 
   Others   -0.070 0.071 0.933 -0.150* 0.072 0.861* -0.146* 0.072 0.865* 
  Disposition (Ref=Routine)            
   Home Health Care   0.287*** 0.049 1.332*** 0.297*** 0.049 1.346*** 0.298*** 0.049 1.347*** 
   Nursing Home    0.760*** 0.040 2.138*** 0.755*** 0.040 2.128*** 0.756*** 0.040 2.129*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.065 0.047 0.937 -0.066 0.047 0.936 -0.066 0.047 0.936 
   3rd quartile   -0.007 0.049 0.993 -0.005 0.049 0.995 -0.003 0.049 0.997 
   4th quartile   -0.018 0.054 0.982 -0.013 0.055 0.987 -0.011 0.055 0.989 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.096 0.170 1.101 0.084 0.170 1.087 0.083 0.170 1.087 
Prior admission (1y) for  
PN   0.367
*** 0.036 1.443*** 0.365*** 0.036 1.440*** 0.364*** 0.036 1.440*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.644*** 0.057 1.904*** 0.619*** 0.058 1.857*** 0.619*** 0.058 1.857*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.207 0.125 1.230 0.200 0.125 1.221 0.198 0.125 1.219 
  Deficiency anemias   0.027 0.037 1.027 0.028 0.037 1.028 0.028 0.037 1.028 
  Rheumatoid arthritis   0.227** 0.082 1.254** 0.236** 0.082 1.266** 0.235** 0.082 1.265** 
  Chronic blood loss anemia   -0.011 0.158 0.989 0.004 0.158 1.004 0.005 0.158 1.005 
  Congest Heart Failure   0.198*** 0.037 1.219*** 0.192*** 0.037 1.211*** 0.192*** 0.037 1.211*** 
  Chronic pulmonary disease   0.162*** 0.034 1.175*** 0.172*** 0.034 1.188*** 0.172*** 0.034 1.188*** 
  Coagulopathy   -0.174 0.098 0.841 -0.167 0.097 0.846 -0.168 0.097 0.846 
  Depression   -0.095 0.054 0.910 -0.086 0.054 0.918 -0.086 0.054 0.918 
  Diabetes, uncomplicated   0.065 0.039 1.068 0.067 0.039 1.070 0.068 0.039 1.070 
Diabetes w/ chronic  
complications   0.121 0.076 1.129 0.121 0.076 1.128 0.121 0.076 1.129 
  Drug abuse   0.136 0.234 1.146 0.131 0.234 1.140 0.133 0.234 1.142 
  Hypertension   -0.032 0.036 0.969 -0.018 0.036 0.982 -0.018 0.036 0.982 
  Hypothyroidism   -0.011 0.044 0.989 -0.007 0.044 0.993 -0.007 0.044 0.993 
  Liver disease   0.173 0.135 1.189 0.175 0.135 1.192 0.177 0.135 1.194 
  Lymphoma   -0.279 0.239 0.757 -0.259 0.239 0.772 -0.259 0.239 0.772 
Fluid and electrolyte  
disorders   0.050 0.034 1.051 0.054 0.035 1.055 0.054 0.035 1.055 
  Metastatic cancer   0.094 0.269 1.098 0.099 0.269 1.104 0.100 0.269 1.105 
Other neurological  
disorders   0.068 0.045 1.070 0.068 0.045 1.070 0.068 0.045 1.071 
  Obesity   -0.090 0.075 0.914 -0.075 0.075 0.928 -0.076 0.075 0.927 
  Paralysis   0.016 0.088 1.016 0.008 0.088 1.008 0.008 0.088 1.008 
Peripheral vascular  
disorders   0.067 0.058 1.069 0.081 0.058 1.084 0.081 0.058 1.084 
  Psychoses   0.122 0.077 1.130 0.104 0.077 1.109 0.103 0.077 1.109 
Pulmonary circulation  
disorders   0.077 0.075 1.080 0.092 0.075 1.097 0.093 0.075 1.097 
  Renal failure   0.122** 0.045 1.129** 0.125** 0.045 1.133** 0.124** 0.045 1.132** 
Solid tumor without  
metastasis   -0.044 0.091 0.957 -0.039 0.091 0.962 -0.038 0.091 0.963 
  Peptic ulcer disease    0.628 0.527 1.873 0.614 0.526 1.849 0.614 0.527 1.847 
  Valvular disease   -0.024 0.055 0.977 -0.004 0.055 0.996 -0.004 0.055 0.996 
  Weight loss   0.168* 0.072 1.183* 0.169* 0.072 1.184* 0.170* 0.072 1.185* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.115* 0.052 0.892* -0.111* 0.052 0.895* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.043 0.068 1.044 0.053 0.068 1.054 
  Private, for-profit      -0.032 0.078 0.968 -0.032 0.078 0.968 
System affiliation      0.060 0.054 1.061 0.060 0.054 1.062 
Cardiac catherization facility      -0.084 0.062 0.920 -0.072 0.063 0.930 
Magnet hospital      -0.197* 0.100 0.822* -0.223* 0.101 0.800* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.059 0.070 1.061 0.058 0.070 1.060 
  Medium      -0.072 0.076 0.931 -0.069 0.076 0.933 
  High      0.046 0.113 1.047 0.049 0.113 1.050 
Hospital location (Ref: Rural)             
  Micro/Division      0.024 0.106 1.024 0.023 0.106 1.023 
  Metro      -0.085 0.099 0.918 -0.084 0.099 0.919 
Disproportionate Share 
Hospital (DSH) Index       -0.003 0.163 0.997 -0.041 0.165 0.960 
Mean number of Elixhauser 
comorbid conditions      -0.103
* 0.050 0.902* -0.098* 0.050 0.907* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.186** 0.688 8.899** 2.174** 0.687 8.791** 
Hospital PN Volume      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%): Discharge 
Composite Measure      -0.002
* 0.001 0.998* -0.005* 0.002 0.995* 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.111***  0.096***   0.062***   0.062***   
  ICC 0.033  0.028   0.018   0.018   
  MOR 1.375  1.345   1.267   1.267   
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n: level-1 (patients) 36374  36374   36374   36374   
n: level-2 (hospitals) 424  424   424   424   
AIC 27090  26210   26177   26177   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 16:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Global Composite Measure) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.127*** 0.034 0.881*** -0.132*** 0.034 0.877*** -0.131*** 0.034 0.877*** 
  Race (Ref: White)            
   Black   0.076 0.076 1.079 0.053 0.077 1.054 0.052 0.077 1.053 
   Hispanic   0.037 0.057 1.038 -0.011 0.057 0.989 -0.010 0.058 0.990 
   Others   -0.070 0.071 0.932 -0.149* 0.072 0.861* -0.146* 0.072 0.865* 
  Disposition (Ref=Routine)            
   Home Health Care   0.288*** 0.049 1.334*** 0.299*** 0.049 1.348*** 0.299*** 0.049 1.349*** 
   Nursing Home    0.760*** 0.040 2.137*** 0.754*** 0.040 2.126*** 0.754*** 0.040 2.126*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.065 0.047 0.937 -0.064 0.047 0.938 -0.064 0.047 0.938 
   3rd quartile   -0.007 0.049 0.993 -0.002 0.049 0.998 -0.001 0.049 0.999 
   4th quartile   -0.018 0.054 0.982 -0.010 0.055 0.990 -0.008 0.055 0.992 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.097 0.170 1.101 0.083 0.170 1.086 0.082 0.170 1.086 
Prior admission (1y) for  
PN   0.367
*** 0.036 1.444*** 0.365*** 0.036 1.441*** 0.365*** 0.036 1.440*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.644*** 0.057 1.904*** 0.619*** 0.058 1.856*** 0.618*** 0.058 1.856*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.208 0.125 1.231 0.201 0.125 1.222 0.200 0.125 1.221 
  Deficiency anemias   0.027 0.037 1.027 0.028 0.037 1.028 0.028 0.037 1.028 
  Rheumatoid arthritis   0.226** 0.082 1.254** 0.236** 0.082 1.267** 0.236** 0.082 1.266** 
  Chronic blood loss anemia   -0.011 0.158 0.989 0.004 0.158 1.004 0.005 0.158 1.005 
  Congest Heart Failure   0.199*** 0.037 1.220*** 0.192*** 0.036 1.212*** 0.193*** 0.037 1.212*** 
  Chronic pulmonary disease   0.161*** 0.034 1.175*** 0.172*** 0.034 1.187*** 0.172*** 0.034 1.188*** 
  Coagulopathy   -0.174 0.098 0.840 -0.166 0.097 0.847 -0.166 0.097 0.847 
  Depression   -0.095 0.054 0.910 -0.085 0.054 0.918 -0.086 0.054 0.918 
  Diabetes, uncomplicated   0.065 0.039 1.067 0.068 0.039 1.070 0.068 0.039 1.071 
Diabetes w/ chronic  
complications   0.121 0.076 1.129 0.120 0.076 1.127 0.120 0.076 1.128 
  Drug abuse   0.136 0.234 1.146 0.133 0.234 1.143 0.134 0.234 1.144 
  Hypertension   -0.032 0.036 0.968 -0.018 0.036 0.982 -0.019 0.036 0.982 
  Hypothyroidism   -0.012 0.044 0.988 -0.007 0.044 0.993 -0.007 0.044 0.993 
  Liver disease   0.173 0.135 1.189 0.176 0.135 1.192 0.177 0.135 1.194 
  Lymphoma   -0.279 0.239 0.757 -0.257 0.239 0.773 -0.258 0.239 0.773 
Fluid and electrolyte  
disorders   0.049 0.034 1.051 0.054 0.034 1.055 0.054 0.035 1.055 
  Metastatic cancer   0.094 0.269 1.098 0.101 0.269 1.107 0.103 0.269 1.109 
Other neurological  
disorders   0.068 0.045 1.070 0.068 0.045 1.070 0.068 0.045 1.070 
  Obesity   -0.090 0.075 0.914 -0.075 0.075 0.928 -0.075 0.075 0.927 
  Paralysis   0.016 0.088 1.016 0.008 0.088 1.008 0.008 0.088 1.008 
Peripheral vascular  
disorders   0.066 0.058 1.069 0.081 0.058 1.084 0.081 0.058 1.084 
  Psychoses   0.122 0.077 1.130 0.103 0.077 1.108 0.102 0.077 1.107 
Pulmonary circulation  
disorders   0.077 0.075 1.080 0.093 0.075 1.097 0.093 0.075 1.097 
  Renal failure   0.121** 0.045 1.129** 0.125** 0.045 1.133** 0.124** 0.045 1.132** 
Solid tumor without  
metastasis   -0.044 0.091 0.957 -0.039 0.091 0.962 -0.038 0.091 0.963 
  Peptic ulcer disease    0.628 0.527 1.873 0.618 0.526 1.856 0.620 0.526 1.859 
  Valvular disease   -0.024 0.055 0.976 -0.004 0.055 0.996 -0.004 0.055 0.996 
  Weight loss   0.168* 0.072 1.183* 0.168* 0.072 1.182* 0.168* 0.072 1.183* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.119* 0.052 0.888* -0.113* 0.052 0.893* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.038 0.068 1.039 0.041 0.068 1.042 
  Private, for-profit      -0.043 0.078 0.958 -0.047 0.079 0.954 
System affiliation      0.069 0.054 1.071 0.066 0.054 1.068 
Cardiac catherization facility      -0.081 0.062 0.922 -0.071 0.063 0.932 
Magnet hospital      -0.190 0.100 0.827 -0.217* 0.102 0.805* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.067 0.070 1.069 0.065 0.070 1.067 
  Medium      -0.068 0.076 0.934 -0.066 0.076 0.936 
  High      0.047 0.112 1.048 0.047 0.112 1.048 
Hospital location (Ref: Rural)             
  Micro/Division      0.024 0.106 1.025 0.024 0.106 1.024 
  Metro      -0.084 0.099 0.919 -0.082 0.099 0.921 
Disproportionate Share 
Hospital (DSH) Index       -0.022 0.163 0.979 -0.051 0.165 0.951 
Mean number of Elixhauser 
comorbid conditions      -0.105
* 0.049 0.901* -0.100* 0.049 0.905* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.200** 0.685 9.022** 2.188** 0.685 8.915** 
Hospital PN Volume      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%): Global Composite 
Measure      -0.008
* 0.003 0.992* -0.014* 0.005 0.986* 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.111***  0.096***   0.061***   0.061***   
  ICC 0.033  0.028   0.018   0.018   
  MOR 1.375  1.345   1.265   1.265   
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n: level-1 (patients) 36378  36378   36378   36378   
n: level-2 (hospitals) 425  425   425   425   
AIC 27095  26215   26179   26179   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 17:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Assessed and Given Influenza Vaccination) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.128*** 0.034 0.880*** -0.133*** 0.034 0.876*** -0.133*** 0.034 0.876*** 
  Race (Ref: White)            
   Black   0.081 0.077 1.084 0.055 0.077 1.057 0.056 0.077 1.057 
   Hispanic   0.043 0.057 1.044 -0.008 0.058 0.992 -0.008 0.058 0.992 
   Others   -0.067 0.072 0.936 -0.149* 0.073 0.861* -0.146* 0.073 0.864* 
  Disposition (Ref=Routine)            
   Home Health Care   0.293*** 0.049 1.340*** 0.304*** 0.049 1.355*** 0.305*** 0.049 1.356*** 
   Nursing Home    0.764*** 0.041 2.147*** 0.760*** 0.041 2.139*** 0.760*** 0.041 2.139*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.063 0.048 0.939 -0.064 0.047 0.938 -0.063 0.047 0.939 
   3rd quartile   -0.006 0.049 0.994 -0.007 0.049 0.993 -0.006 0.049 0.994 
   4th quartile   -0.024 0.054 0.976 -0.022 0.056 0.978 -0.020 0.056 0.980 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.101 0.170 1.106 0.087 0.170 1.090 0.086 0.170 1.090 
Prior admission (1y) for  
PN   0.363
*** 0.036 1.438*** 0.361*** 0.036 1.435*** 0.361*** 0.036 1.435*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.645*** 0.058 1.907*** 0.620*** 0.058 1.859*** 0.620*** 0.058 1.859*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.222 0.125 1.249 0.215 0.125 1.240 0.214 0.125 1.239 
  Deficiency anemias   0.024 0.037 1.024 0.025 0.037 1.025 0.024 0.037 1.025 
  Rheumatoid arthritis   0.228** 0.082 1.256** 0.237** 0.082 1.267** 0.237** 0.082 1.267** 
  Chronic blood loss anemia   -0.002 0.158 0.998 0.011 0.158 1.011 0.011 0.158 1.012 
  Congest Heart Failure   0.193*** 0.037 1.213*** 0.188*** 0.037 1.206*** 0.188*** 0.037 1.207*** 
  Chronic pulmonary disease   0.164*** 0.035 1.179*** 0.175*** 0.035 1.191*** 0.175*** 0.035 1.191*** 
  Coagulopathy   -0.187 0.099 0.829 -0.180 0.099 0.835 -0.181 0.099 0.834 
  Depression   -0.096 0.054 0.908 -0.087 0.054 0.917 -0.087 0.054 0.917 
  Diabetes, uncomplicated   0.066 0.039 1.068 0.068 0.039 1.070 0.068 0.039 1.070 
Diabetes w/ chronic  
complications   0.123 0.076 1.130 0.120 0.076 1.127 0.120 0.076 1.127 
  Drug abuse   0.090 0.238 1.094 0.085 0.238 1.089 0.087 0.238 1.091 
  Hypertension   -0.031 0.036 0.969 -0.018 0.036 0.982 -0.018 0.036 0.982 
  Hypothyroidism   -0.014 0.044 0.987 -0.009 0.044 0.991 -0.009 0.044 0.991 
  Liver disease   0.175 0.135 1.192 0.177 0.135 1.193 0.178 0.135 1.195 
  Lymphoma   -0.258 0.240 0.773 -0.239 0.240 0.787 -0.239 0.240 0.787 
Fluid and electrolyte  
disorders   0.051 0.035 1.052 0.055 0.035 1.057 0.055 0.035 1.057 
  Metastatic cancer   0.016 0.284 1.016 0.022 0.284 1.022 0.023 0.284 1.024 
Other neurological  
disorders   0.069 0.045 1.071 0.069 0.045 1.071 0.069 0.045 1.071 
  Obesity   -0.091 0.076 0.913 -0.076 0.076 0.927 -0.076 0.076 0.927 
  Paralysis   0.017 0.088 1.018 0.008 0.088 1.008 0.008 0.088 1.008 
Peripheral vascular  
disorders   0.068 0.058 1.071 0.082 0.058 1.085 0.082 0.058 1.085 
  Psychoses   0.127 0.077 1.135 0.109 0.078 1.115 0.108 0.078 1.114 
Pulmonary circulation  
disorders   0.080 0.076 1.083 0.095 0.076 1.099 0.095 0.076 1.100 
  Renal failure   0.127** 0.046 1.135** 0.129** 0.046 1.138** 0.129** 0.046 1.137** 
Solid tumor without  
metastasis   -0.047 0.092 0.954 -0.042 0.092 0.959 -0.041 0.092 0.959 
  Peptic ulcer disease    0.629 0.527 1.876 0.607 0.527 1.836 0.609 0.527 1.839 
  Valvular disease   -0.021 0.055 0.979 -0.002 0.055 0.998 -0.001 0.055 0.999 
  Weight loss   0.165* 0.073 1.179* 0.164* 0.073 1.178* 0.165* 0.073 1.179* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.111* 0.053 0.895* -0.106* 0.053 0.899* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.047 0.069 1.048 0.053 0.069 1.054 
  Private, for-profit      -0.042 0.079 0.959 -0.041 0.079 0.960 
System affiliation      0.068 0.055 1.071 0.066 0.055 1.068 
Cardiac catherization facility      -0.092 0.063 0.913 -0.084 0.063 0.919 
Magnet hospital      -0.203* 0.100 0.816* -0.217* 0.101 0.805* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.060 0.071 1.062 0.061 0.071 1.063 
  Medium      -0.087 0.076 0.917 -0.082 0.076 0.921 
  High      0.054 0.118 1.056 0.044 0.119 1.045 
Hospital location (Ref: Rural)             
  Micro/Division      0.051 0.108 1.053 0.049 0.108 1.050 
  Metro      -0.061 0.102 0.941 -0.062 0.102 0.940 
Disproportionate Share 
Hospital (DSH) Index       0.001 0.165 1.002 -0.026 0.166 0.974 
Mean number of Elixhauser 
comorbid conditions      -0.101
* 0.050 0.904* -0.098* 0.050 0.907* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.263** 0.705 9.616** 2.276** 0.704 9.739** 
Hospital PN Volume      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%): Assessed and 
Given Influenza Vaccination      -0.003
* 0.001 0.997* -0.005* 0.002 0.995* 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.113***  0.098***   0.062***   0.062***   
  ICC 0.033  0.029   0.018   0.018   
  MOR 1.379  1.348   1.267   1.267   
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n: level-1 (patients) 35964  35964   35964   35964   
n: level-2 (hospitals) 411  411   411   411   
AIC 26776  25904   25870   25871   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 18:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Assessed and Given Pneumococcal Vaccination) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.128*** 0.034 0.880*** -0.132*** 0.034 0.877*** -0.132*** 0.034 0.877*** 
  Race (Ref: White)            
   Black   0.076 0.076 1.079 0.055 0.077 1.057 0.055 0.077 1.057 
   Hispanic   0.037 0.057 1.038 -0.012 0.058 0.988 -0.011 0.058 0.989 
   Others   -0.070 0.071 0.933 -0.150* 0.072 0.861* -0.145* 0.072 0.865* 
  Disposition (Ref=Routine)            
   Home Health Care   0.287*** 0.049 1.332*** 0.297*** 0.049 1.346*** 0.297*** 0.049 1.346*** 
   Nursing Home    0.760*** 0.040 2.138*** 0.755*** 0.040 2.128*** 0.755*** 0.040 2.128*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.065 0.047 0.937 -0.067 0.047 0.935 -0.067 0.047 0.935 
   3rd quartile   -0.007 0.049 0.993 -0.005 0.049 0.995 -0.003 0.049 0.997 
   4th quartile   -0.018 0.054 0.982 -0.013 0.055 0.987 -0.012 0.055 0.989 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.096 0.170 1.101 0.084 0.170 1.087 0.084 0.170 1.088 
Prior admission (1y) for  
PN   0.367
*** 0.036 1.443*** 0.365*** 0.036 1.440*** 0.365*** 0.036 1.440*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.644*** 0.057 1.904*** 0.619*** 0.058 1.857*** 0.619*** 0.058 1.857*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.207 0.125 1.230 0.200 0.125 1.221 0.198 0.125 1.218 
  Deficiency anemias   0.027 0.037 1.027 0.028 0.037 1.028 0.028 0.037 1.028 
  Rheumatoid arthritis   0.227** 0.082 1.254** 0.236** 0.082 1.266** 0.235** 0.082 1.265** 
  Chronic blood loss anemia   -0.011 0.158 0.989 0.005 0.158 1.005 0.006 0.158 1.006 
  Congest Heart Failure   0.198*** 0.037 1.219*** 0.192*** 0.037 1.211*** 0.192*** 0.037 1.211*** 
  Chronic pulmonary disease   0.162*** 0.034 1.175*** 0.172*** 0.034 1.188*** 0.172*** 0.034 1.188*** 
  Coagulopathy   -0.174 0.098 0.841 -0.167 0.097 0.847 -0.167 0.097 0.846 
  Depression   -0.095 0.054 0.910 -0.086 0.054 0.918 -0.086 0.054 0.917 
  Diabetes, uncomplicated   0.065 0.039 1.068 0.067 0.039 1.070 0.068 0.039 1.070 
Diabetes w/ chronic  
complications   0.121 0.076 1.129 0.121 0.076 1.129 0.122 0.076 1.130 
  Drug abuse   0.136 0.234 1.146 0.130 0.234 1.139 0.132 0.234 1.141 
  Hypertension   -0.032 0.036 0.969 -0.019 0.036 0.982 -0.018 0.036 0.982 
  Hypothyroidism   -0.011 0.044 0.989 -0.007 0.044 0.993 -0.007 0.044 0.993 
  Liver disease   0.173 0.135 1.189 0.175 0.135 1.192 0.177 0.135 1.194 
  Lymphoma   -0.279 0.239 0.757 -0.259 0.239 0.772 -0.259 0.239 0.772 
Fluid and electrolyte  
disorders   0.050 0.034 1.051 0.054 0.035 1.055 0.054 0.035 1.055 
  Metastatic cancer   0.094 0.269 1.098 0.098 0.269 1.103 0.100 0.269 1.105 
Other neurological  
disorders   0.068 0.045 1.070 0.068 0.045 1.070 0.069 0.045 1.071 
  Obesity   -0.090 0.075 0.914 -0.075 0.075 0.928 -0.076 0.075 0.927 
  Paralysis   0.016 0.088 1.016 0.008 0.088 1.008 0.008 0.088 1.008 
Peripheral vascular  
disorders   0.067 0.058 1.069 0.081 0.058 1.084 0.081 0.058 1.084 
  Psychoses   0.122 0.077 1.130 0.104 0.077 1.110 0.104 0.077 1.109 
Pulmonary circulation  
disorders   0.077 0.075 1.080 0.092 0.075 1.097 0.092 0.075 1.097 
  Renal failure   0.122** 0.045 1.129** 0.125** 0.045 1.133** 0.124** 0.045 1.132** 
Solid tumor without  
metastasis   -0.044 0.091 0.957 -0.039 0.091 0.962 -0.038 0.091 0.963 
  Peptic ulcer disease    0.628 0.527 1.873 0.615 0.526 1.850 0.614 0.526 1.847 
  Valvular disease   -0.024 0.055 0.977 -0.004 0.055 0.996 -0.004 0.055 0.996 
  Weight loss   0.168* 0.072 1.183* 0.169* 0.072 1.184* 0.170* 0.072 1.185* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.115* 0.052 0.892* -0.112* 0.052 0.894* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.044 0.068 1.045 0.055 0.068 1.056 
  Private, for-profit      -0.029 0.078 0.971 -0.030 0.078 0.970 
System affiliation      0.056 0.054 1.058 0.057 0.054 1.059 
Cardiac catherization facility      -0.084 0.062 0.920 -0.071 0.063 0.932 
Magnet hospital      -0.198* 0.100 0.820* -0.226* 0.102 0.797* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.058 0.070 1.059 0.055 0.070 1.057 
  Medium      -0.070 0.076 0.932 -0.069 0.076 0.933 
  High      0.053 0.112 1.054 0.056 0.112 1.058 
Hospital location (Ref: Rural)             
  Micro/Division      0.026 0.106 1.026 0.025 0.106 1.025 
  Metro      -0.083 0.099 0.920 -0.081 0.099 0.922 
Disproportionate Share 
Hospital (DSH) Index       0.002 0.164 1.002 -0.038 0.166 0.963 
Mean number of Elixhauser 
comorbid conditions      -0.103
* 0.050 0.902* -0.097 0.050 0.908 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.183** 0.688 8.872** 2.166** 0.687 8.725** 
Hospital PN Volume)      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%):Assessed and 
Given Pneumococcal 
Vaccination 
     -0.002 0.001 0.998 -0.005* 0.002 0.995* 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.111***  0.096***   0.062***   0.062***   
  ICC 0.033  0.028   0.019   0.018   
  MOR 1.375  1.345   1.268   1.268   
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n: level-1 (patients) 36374  36374   36374   36374   
n: level-2 (hospitals) 424  424   424   424   
AIC 27090  26210   26178   26177   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 19:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Initial Antibiotic(s) within 6h After Arrival) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.002 0.002 1.002 0.002 0.002 1.002 0.002 0.002 1.002 
  Female   -0.120*** 0.035 0.887*** -0.125*** 0.035 0.882*** -0.125*** 0.035 0.882*** 
  Race (Ref: White)            
   Black   0.069 0.078 1.071 0.041 0.078 1.042 0.041 0.078 1.042 
   Hispanic   0.023 0.058 1.023 -0.030 0.059 0.971 -0.030 0.059 0.971 
   Others   -0.046 0.073 0.955 -0.127 0.074 0.881 -0.127 0.074 0.881 
  Disposition (Ref=Routine)            
   Home Health Care   0.297*** 0.049 1.346*** 0.307*** 0.049 1.359*** 0.307*** 0.049 1.359*** 
   Nursing Home    0.761*** 0.041 2.140*** 0.758*** 0.041 2.134*** 0.758*** 0.041 2.135*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.081 0.048 0.922 -0.084 0.048 0.919 -0.084 0.048 0.919 
   3rd quartile   -0.028 0.050 0.973 -0.027 0.050 0.974 -0.028 0.050 0.973 
   4th quartile   -0.031 0.055 0.970 -0.033 0.056 0.967 -0.034 0.056 0.966 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.114 0.173 1.120 0.100 0.173 1.105 0.100 0.173 1.106 
Prior admission (1y) for  
PN   0.352
*** 0.036 1.422*** 0.351*** 0.036 1.421*** 0.351*** 0.036 1.421*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.639*** 0.059 1.894*** 0.617*** 0.059 1.854*** 0.617*** 0.059 1.854*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.209 0.127 1.232 0.196 0.127 1.217 0.197 0.127 1.218 
  Deficiency anemias   0.028 0.037 1.028 0.027 0.037 1.027 0.027 0.037 1.027 
  Rheumatoid arthritis   0.223** 0.083 1.250** 0.233** 0.083 1.262** 0.233** 0.083 1.262** 
  Chronic blood loss anemia   -0.022 0.161 0.979 -0.007 0.161 0.993 -0.007 0.161 0.993 
  Congest Heart Failure   0.200*** 0.037 1.221*** 0.192*** 0.037 1.212*** 0.192*** 0.037 1.212*** 
  Chronic pulmonary disease   0.169*** 0.035 1.184*** 0.178*** 0.035 1.195*** 0.178*** 0.035 1.195*** 
  Coagulopathy   -0.176 0.099 0.839 -0.166 0.099 0.847 -0.166 0.099 0.847 
  Depression   -0.082 0.054 0.922 -0.074 0.054 0.929 -0.074 0.054 0.929 
  Diabetes, uncomplicated   0.062 0.040 1.064 0.064 0.040 1.066 0.064 0.040 1.066 
Diabetes w/ chronic  
complications   0.102 0.078 1.107 0.099 0.078 1.104 0.099 0.078 1.104 
  Drug abuse   0.059 0.243 1.061 0.043 0.243 1.044 0.043 0.243 1.044 
  Hypertension   -0.018 0.037 0.982 -0.009 0.037 0.991 -0.009 0.037 0.991 
  Hypothyroidism   -0.013 0.045 0.987 -0.010 0.045 0.990 -0.009 0.045 0.991 
  Liver disease   0.188 0.136 1.206 0.187 0.136 1.205 0.187 0.136 1.205 
  Lymphoma   -0.294 0.245 0.745 -0.273 0.245 0.761 -0.273 0.245 0.761 
Fluid and electrolyte  
disorders   0.053 0.035 1.054 0.057 0.035 1.059 0.057 0.035 1.059 
  Metastatic cancer   0.040 0.284 1.041 0.049 0.284 1.050 0.048 0.284 1.049 
Other neurological  
disorders   0.070 0.046 1.072 0.068 0.046 1.070 0.068 0.046 1.070 
  Obesity   -0.119 0.077 0.888 -0.104 0.077 0.902 -0.104 0.077 0.902 
  Paralysis   0.042 0.089 1.042 0.033 0.089 1.033 0.033 0.089 1.034 
Peripheral vascular  
disorders   0.074 0.059 1.077 0.087 0.059 1.091 0.087 0.059 1.091 
  Psychoses   0.137 0.079 1.147 0.125 0.079 1.133 0.125 0.079 1.133 
Pulmonary circulation  
disorders   0.081 0.076 1.085 0.095 0.076 1.099 0.095 0.076 1.099 
  Renal failure   0.123** 0.046 1.131** 0.124** 0.046 1.132** 0.124** 0.046 1.132** 
Solid tumor without  
metastasis   -0.044 0.093 0.957 -0.039 0.093 0.962 -0.039 0.093 0.961 
  Peptic ulcer disease    0.629 0.526 1.875 0.606 0.526 1.834 0.604 0.526 1.830 
  Valvular disease   -0.023 0.056 0.977 -0.006 0.056 0.994 -0.006 0.056 0.994 
  Weight loss   0.149* 0.074 1.160* 0.149* 0.074 1.161* 0.149* 0.074 1.161* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.145** 0.053 0.865** -0.149** 0.054 0.862** 
Ownership (Ref: Public)            
  Private, not-for-profit      0.036 0.070 1.037 0.036 0.070 1.037 
  Private, for-profit      -0.010 0.081 0.990 -0.007 0.081 0.993 
System affiliation      0.060 0.056 1.062 0.059 0.056 1.061 
Cardiac catherization facility      -0.101 0.064 0.904 -0.099 0.064 0.906 
Magnet hospital      -0.182 0.100 0.834 -0.173 0.102 0.841 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.032 0.071 1.033 0.031 0.071 1.031 
  Medium      -0.075 0.076 0.928 -0.078 0.076 0.925 
  High      0.039 0.121 1.040 0.049 0.122 1.051 
Hospital location (Ref: Rural)             
  Micro/Division      0.076 0.112 1.079 0.076 0.112 1.079 
  Metro      -0.046 0.105 0.955 -0.047 0.105 0.954 
Disproportionate Share 
Hospital (DSH) Index       -0.020 0.172 0.980 -0.017 0.172 0.983 
Mean number of Elixhauser 
comorbid conditions      -0.086 0.051 0.917 -0.085 0.051 0.918 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.100** 0.729 8.168** 2.090** 0.729 8.082** 
Hospital PN Volume      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%): Initial 
Antibiotic(s) within 6h After 
Arrival 
     -0.007 0.004 0.993 -0.004 0.006 0.996 
            
Interaction  
(Volume ൈ PQM)         -0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.109***  0.093***   0.060***   0.060***   
  ICC 0.032  0.027   0.018   0.018   
  MOR 1.370  1.337   1.262   1.262   
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n: level-1 (patients) 35202  35202   35202   35202   
n: level-2 (hospitals) 394  394   394   394   
AIC 26028  25201   25177   25179   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 20:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Oxygenation Assessment) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.128*** 0.034 0.880*** -0.131*** 0.034 0.877*** -0.131*** 0.034 0.877*** 
  Race (Ref: White)            
   Black   0.076 0.076 1.079 0.058 0.076 1.059 0.056 0.076 1.057 
   Hispanic   0.041 0.056 1.041 -0.007 0.057 0.993 -0.003 0.057 0.997 
   Others   -0.070 0.071 0.933 -0.148* 0.072 0.863* -0.147* 0.072 0.863* 
  Disposition (Ref=Routine)            
   Home Health Care   0.287*** 0.049 1.332*** 0.297*** 0.049 1.345*** 0.296*** 0.049 1.345*** 
   Nursing Home    0.758*** 0.040 2.134*** 0.754*** 0.040 2.124*** 0.753*** 0.040 2.124*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.063 0.047 0.939 -0.063 0.047 0.939 -0.066 0.047 0.937 
   3rd quartile   -0.006 0.049 0.994 -0.001 0.049 0.999 -0.006 0.049 0.994 
   4th quartile   -0.018 0.054 0.982 -0.009 0.055 0.991 -0.012 0.055 0.988 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.095 0.170 1.100 0.082 0.170 1.086 0.083 0.170 1.086 
Prior admission (1y) for  
PN   0.366
*** 0.036 1.442*** 0.365*** 0.036 1.441*** 0.365*** 0.036 1.440*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.642*** 0.057 1.901*** 0.616*** 0.058 1.852*** 0.616*** 0.058 1.852*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.207 0.125 1.231 0.200 0.125 1.221 0.199 0.125 1.220 
  Deficiency anemias   0.027 0.037 1.028 0.029 0.037 1.029 0.029 0.037 1.029 
  Rheumatoid arthritis   0.226** 0.082 1.253** 0.236** 0.082 1.266** 0.235** 0.082 1.264** 
  Chronic blood loss anemia   -0.011 0.158 0.989 0.006 0.158 1.006 0.005 0.158 1.005 
  Congest Heart Failure   0.198*** 0.037 1.219*** 0.191*** 0.036 1.210*** 0.191*** 0.036 1.210*** 
  Chronic pulmonary disease   0.160*** 0.034 1.173*** 0.172*** 0.034 1.187*** 0.172*** 0.034 1.188*** 
  Coagulopathy   -0.174 0.098 0.840 -0.167 0.097 0.846 -0.168 0.097 0.846 
  Depression   -0.095 0.054 0.909 -0.087 0.054 0.917 -0.087 0.054 0.917 
  Diabetes, uncomplicated   0.066 0.039 1.068 0.069 0.039 1.072 0.069 0.039 1.072 
Diabetes w/ chronic  
complications   0.121 0.076 1.129 0.122 0.076 1.130 0.122 0.076 1.130 
  Drug abuse   0.136 0.234 1.146 0.128 0.234 1.137 0.128 0.234 1.136 
  Hypertension   -0.033 0.036 0.968 -0.020 0.036 0.980 -0.020 0.036 0.981 
  Hypothyroidism   -0.008 0.044 0.992 -0.003 0.044 0.997 -0.003 0.044 0.997 
  Liver disease   0.172 0.135 1.188 0.174 0.135 1.190 0.174 0.135 1.190 
  Lymphoma   -0.279 0.239 0.756 -0.260 0.239 0.771 -0.259 0.239 0.772 
Fluid and electrolyte  
disorders   0.050 0.034 1.051 0.055 0.034 1.056 0.054 0.034 1.056 
  Metastatic cancer   0.094 0.269 1.098 0.099 0.269 1.104 0.100 0.269 1.105 
Other neurological  
disorders   0.067 0.045 1.069 0.068 0.045 1.070 0.068 0.045 1.070 
  Obesity   -0.090 0.075 0.914 -0.074 0.075 0.928 -0.075 0.075 0.928 
  Paralysis   0.016 0.088 1.016 0.008 0.088 1.008 0.008 0.088 1.008 
Peripheral vascular  
disorders   0.066 0.058 1.069 0.080 0.058 1.084 0.081 0.058 1.084 
  Psychoses   0.122 0.077 1.130 0.106 0.077 1.112 0.109 0.077 1.116 
Pulmonary circulation  
disorders   0.077 0.075 1.080 0.093 0.075 1.097 0.092 0.075 1.097 
  Renal failure   0.121** 0.045 1.129** 0.123** 0.045 1.131** 0.122** 0.045 1.130** 
Solid tumor without  
metastasis   -0.044 0.091 0.957 -0.039 0.091 0.962 -0.039 0.091 0.962 
  Peptic ulcer disease    0.628 0.527 1.874 0.611 0.526 1.843 0.608 0.526 1.836 
  Valvular disease   -0.024 0.055 0.976 -0.005 0.055 0.995 -0.004 0.055 0.996 
  Weight loss   0.173* 0.072 1.189* 0.174* 0.072 1.190* 0.175* 0.072 1.192* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.122* 0.052 0.885* -0.114* 0.052 0.892* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.037 0.068 1.037 0.042 0.068 1.043 
  Private, for-profit      -0.046 0.079 0.955 -0.041 0.079 0.960 
System affiliation      0.049 0.053 1.050 0.042 0.053 1.043 
Cardiac catherization facility      -0.085 0.062 0.918 -0.084 0.062 0.919 
Magnet hospital      -0.222* 0.099 0.801* -0.227* 0.099 0.797* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.049 0.070 1.051 0.043 0.070 1.043 
  Medium      -0.071 0.076 0.932 -0.068 0.075 0.935 
  High      0.083 0.111 1.087 0.083 0.111 1.086 
Hospital location (Ref: Rural)             
  Micro/Division      0.039 0.106 1.040 0.051 0.106 1.052 
  Metro      -0.071 0.099 0.931 -0.063 0.099 0.939 
Disproportionate Share 
Hospital (DSH) Index       0.019 0.162 1.019 0.009 0.161 1.009 
Mean number of Elixhauser 
comorbid conditions      -0.105
* 0.049 0.900* -0.098* 0.049 0.906* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.318*** 0.687 10.154*** 2.292*** 0.684 9.898*** 
Hospital PN Volume      -0.001 0.000 0.999 -0.001 0.000 0.999 
PQM (%): Oxygenation 
Assessment      -0.033 0.017 0.967 -0.056
* 0.024 0.946* 
            
Interaction  
(Volume ൈ PQM)         0.001 0.001 1.001 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.111***  0.096***   0.061***   0.060***   
  ICC 0.033  0.028   0.018   0.018   
  MOR 1.375  1.345   1.267   1.263   
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n: level-1 (patients) 36384  36384   36384   36384   
n: level-2 (hospitals) 426  426   426   426   
AIC 27104  26227   26193   26193   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 21:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (the Most Appropriate Initial Antibiotic(s)) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.003 0.002 1.003 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.130*** 0.034 0.878*** -0.133*** 0.034 0.875*** -0.133*** 0.034 0.875*** 
  Race (Ref: White)            
   Black   0.079 0.076 1.082 0.060 0.077 1.062 0.060 0.077 1.062 
   Hispanic   0.040 0.057 1.041 -0.003 0.058 0.997 -0.003 0.058 0.997 
   Others   -0.068 0.071 0.934 -0.148* 0.072 0.863* -0.149* 0.072 0.862* 
  Disposition (Ref=Routine)            
   Home Health Care   0.289*** 0.049 1.335*** 0.300*** 0.049 1.349*** 0.300*** 0.049 1.349*** 
   Nursing Home    0.760*** 0.041 2.139*** 0.756*** 0.041 2.129*** 0.756*** 0.041 2.130*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.064 0.047 0.938 -0.065 0.047 0.937 -0.064 0.047 0.938 
   3rd quartile   -0.007 0.049 0.993 -0.002 0.049 0.998 -0.001 0.049 0.999 
   4th quartile   -0.020 0.054 0.980 -0.007 0.055 0.993 -0.006 0.055 0.994 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.097 0.170 1.102 0.084 0.170 1.088 0.084 0.170 1.088 
Prior admission (1y) for  
PN   0.365
*** 0.036 1.441*** 0.363*** 0.036 1.438*** 0.363*** 0.036 1.438*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.644*** 0.057 1.904*** 0.619*** 0.058 1.857*** 0.619*** 0.058 1.857*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.214 0.125 1.239 0.210 0.125 1.234 0.210 0.125 1.234 
  Deficiency anemias   0.025 0.037 1.025 0.026 0.037 1.026 0.026 0.037 1.026 
  Rheumatoid arthritis   0.227** 0.082 1.255** 0.238** 0.082 1.269** 0.238** 0.082 1.269** 
  Chronic blood loss anemia   -0.008 0.158 0.992 0.005 0.158 1.005 0.005 0.158 1.005 
  Congest Heart Failure   0.197*** 0.037 1.217*** 0.189*** 0.037 1.208*** 0.189*** 0.037 1.208*** 
  Chronic pulmonary disease   0.166*** 0.034 1.181*** 0.176*** 0.035 1.192*** 0.176*** 0.035 1.192*** 
  Coagulopathy   -0.173 0.098 0.841 -0.163 0.098 0.849 -0.163 0.098 0.849 
  Depression   -0.092 0.054 0.912 -0.083 0.054 0.920 -0.083 0.054 0.921 
  Diabetes, uncomplicated   0.067 0.039 1.069 0.070 0.039 1.072 0.070 0.039 1.072 
Diabetes w/ chronic  
complications   0.120 0.076 1.127 0.116 0.076 1.123 0.116 0.076 1.124 
  Drug abuse   0.085 0.238 1.089 0.079 0.238 1.082 0.079 0.238 1.082 
  Hypertension   -0.033 0.036 0.968 -0.019 0.036 0.981 -0.019 0.036 0.981 
  Hypothyroidism   -0.015 0.044 0.985 -0.010 0.044 0.990 -0.010 0.044 0.990 
  Liver disease   0.172 0.135 1.187 0.172 0.135 1.187 0.171 0.135 1.186 
  Lymphoma   -0.275 0.239 0.760 -0.256 0.239 0.774 -0.256 0.239 0.774 
Fluid and electrolyte  
disorders   0.052 0.035 1.053 0.057 0.035 1.059 0.057 0.035 1.059 
  Metastatic cancer   0.051 0.276 1.053 0.060 0.276 1.062 0.060 0.276 1.061 
Other neurological  
disorders   0.071 0.045 1.073 0.072 0.045 1.074 0.072 0.045 1.074 
  Obesity   -0.095 0.076 0.909 -0.080 0.076 0.923 -0.080 0.076 0.923 
  Paralysis   0.020 0.088 1.020 0.013 0.088 1.013 0.013 0.088 1.013 
Peripheral vascular  
disorders   0.069 0.058 1.071 0.085 0.058 1.089 0.085 0.058 1.088 
  Psychoses   0.124 0.077 1.132 0.102 0.077 1.108 0.102 0.077 1.108 
Pulmonary circulation  
disorders   0.076 0.076 1.079 0.094 0.076 1.099 0.094 0.076 1.099 
  Renal failure   0.126** 0.046 1.134** 0.130** 0.046 1.139** 0.131** 0.046 1.139** 
Solid tumor without  
metastasis   -0.038 0.092 0.963 -0.033 0.091 0.968 -0.033 0.091 0.968 
  Peptic ulcer disease    0.628 0.527 1.874 0.604 0.526 1.830 0.603 0.526 1.828 
  Valvular disease   -0.024 0.055 0.976 -0.007 0.055 0.993 -0.007 0.055 0.993 
  Weight loss   0.169* 0.072 1.184* 0.165* 0.072 1.180* 0.165* 0.072 1.180* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.128* 0.052 0.880* -0.129* 0.052 0.879* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.038 0.068 1.039 0.040 0.068 1.040 
  Private, for-profit      -0.061 0.079 0.941 -0.059 0.079 0.942 
System affiliation      0.070 0.054 1.073 0.073 0.054 1.076 
Cardiac catherization facility      -0.075 0.062 0.928 -0.078 0.062 0.925 
Magnet hospital      -0.209* 0.099 0.811* -0.206* 0.100 0.814* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.067 0.070 1.069 0.068 0.070 1.070 
  Medium      -0.064 0.075 0.938 -0.065 0.075 0.937 
  High      0.085 0.117 1.089 0.086 0.117 1.090 
Hospital location (Ref: Rural)             
  Micro/Division      0.029 0.106 1.029 0.030 0.106 1.031 
  Metro      -0.077 0.099 0.926 -0.076 0.099 0.927 
Disproportionate Share 
Hospital (DSH) Index       0.004 0.161 1.004 0.015 0.163 1.015 
Mean number of Elixhauser 
comorbid conditions      -0.103
* 0.049 0.902* -0.104* 0.049 0.901* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.095** 0.685 8.123** 2.101** 0.685 8.175** 
Hospital PN Volume      -0.001 0.000 0.999 -0.000 0.000 1.000 
PQM (%):the Most 
Appropriate Initial 
Antibiotic(s) 
     -0.008** 0.003 0.992** -0.007 0.005 0.993 
            
Interaction  
(Volume ൈ PQM)         -0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.112***  0.097***   0.059***   0.059***   
  ICC 0.033  0.029   0.018   0.018   
  MOR 1.377  1.347   1.261   1.261   
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n: level-1 (patients) 36172  36172   36172   36172   
n: level-2 (hospitals) 422  422   422   422   
AIC 26945  26068   26031   26033   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
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Appendix Table 22:  
Association of PN-PPR with individual- and hospital-level characteristics using 
hierarchical logistic regression (Initial ER Blood Culture Performed Prior To First Hospital Dose Of Antibiotics) 
 
Parameter Model 1 Model 2 Model 3 Model 4 
 Coef SE Coef SE aOR Coef SE aOR Coef SE aOR 
Fixed effects            
Level 1: Patient Characteristics           
 Socio-Demographic & 
Post-discharge             
  Age   0.002 0.002 1.002 0.003 0.002 1.003 0.003 0.002 1.003 
  Female   -0.126*** 0.034 0.882*** -0.130*** 0.034 0.878*** -0.130*** 0.034 0.878*** 
  Race (Ref: White)            
   Black   0.052 0.077 1.053 0.029 0.078 1.030 0.029 0.078 1.029 
   Hispanic   0.029 0.057 1.029 -0.016 0.058 0.984 -0.016 0.058 0.984 
   Others   -0.072 0.072 0.931 -0.148* 0.072 0.862* -0.148* 0.072 0.862* 
  Disposition (Ref=Routine)            
   Home Health Care   0.281*** 0.049 1.325*** 0.291*** 0.049 1.338*** 0.291*** 0.049 1.338*** 
   Nursing Home    0.749*** 0.041 2.116*** 0.747*** 0.041 2.110*** 0.747*** 0.041 2.110*** 
  Median Income Quartile  
  (Ref=1st quartile: Poorest)             
   2nd quartile   -0.075 0.048 0.928 -0.076 0.047 0.927 -0.076 0.047 0.927 
   3rd quartile   -0.007 0.049 0.993 -0.004 0.049 0.996 -0.005 0.049 0.995 
   4th quartile   -0.015 0.054 0.985 -0.012 0.055 0.988 -0.012 0.055 0.988 
Severity            
Prior admission (1y)     
(Ref=No)            
Prior admission (1y) other   
than PN   0.105 0.170 1.111 0.090 0.170 1.094 0.090 0.170 1.094 
Prior admission (1y) for  
PN   0.365
*** 0.036 1.440*** 0.364*** 0.036 1.439*** 0.364*** 0.036 1.439*** 
Prior admission (1y) for  
both PN and other  
conditions 
  0.641*** 0.058 1.898*** 0.617*** 0.058 1.853*** 0.617*** 0.058 1.853*** 
Comorbidities            
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  AIDS            
  Alcohol abuse   0.219 0.125 1.245 0.211 0.125 1.235 0.211 0.125 1.235 
  Deficiency anemias   0.024 0.037 1.024 0.024 0.037 1.024 0.024 0.037 1.024 
  Rheumatoid arthritis   0.229** 0.082 1.257** 0.238** 0.082 1.268** 0.238** 0.082 1.268** 
  Chronic blood loss anemia   -0.006 0.158 0.994 0.010 0.158 1.010 0.010 0.158 1.010 
  Congest Heart Failure   0.201*** 0.037 1.223*** 0.195*** 0.037 1.215*** 0.195*** 0.037 1.215*** 
  Chronic pulmonary disease   0.166*** 0.035 1.180*** 0.176*** 0.035 1.193*** 0.176*** 0.035 1.192*** 
  Coagulopathy   -0.165 0.098 0.848 -0.156 0.098 0.855 -0.156 0.098 0.855 
  Depression   -0.088 0.054 0.916 -0.080 0.054 0.923 -0.080 0.054 0.923 
  Diabetes, uncomplicated   0.071 0.039 1.074 0.073 0.039 1.075 0.073 0.039 1.075 
Diabetes w/ chronic  
complications   0.115 0.076 1.122 0.116 0.076 1.123 0.116 0.076 1.123 
  Drug abuse   0.141 0.234 1.151 0.131 0.234 1.140 0.131 0.234 1.140 
  Hypertension   -0.032 0.036 0.968 -0.020 0.036 0.980 -0.020 0.036 0.980 
  Hypothyroidism   -0.011 0.044 0.989 -0.008 0.044 0.992 -0.008 0.044 0.992 
  Liver disease   0.173 0.135 1.189 0.173 0.135 1.188 0.173 0.135 1.189 
  Lymphoma   -0.275 0.239 0.760 -0.257 0.239 0.773 -0.257 0.239 0.773 
Fluid and electrolyte  
disorders   0.052 0.035 1.054 0.057 0.035 1.058 0.057 0.035 1.058 
  Metastatic cancer   0.116 0.269 1.123 0.123 0.269 1.131 0.123 0.269 1.131 
Other neurological  
disorders   0.074 0.045 1.077 0.073 0.045 1.076 0.073 0.045 1.076 
  Obesity   -0.090 0.076 0.914 -0.075 0.076 0.928 -0.075 0.076 0.928 
  Paralysis   0.016 0.088 1.016 0.009 0.088 1.009 0.009 0.088 1.009 
Peripheral vascular  
disorders   0.069 0.058 1.071 0.082 0.058 1.086 0.082 0.058 1.086 
  Psychoses   0.129 0.078 1.137 0.114 0.078 1.121 0.114 0.078 1.121 
Pulmonary circulation  
disorders   0.071 0.076 1.074 0.087 0.076 1.090 0.086 0.076 1.090 
  Renal failure   0.122** 0.046 1.130** 0.124** 0.046 1.132** 0.124** 0.046 1.132** 
Solid tumor without  
metastasis   -0.033 0.091 0.967 -0.030 0.091 0.971 -0.030 0.091 0.971 
  Peptic ulcer disease    0.631 0.526 1.879 0.612 0.526 1.844 0.611 0.526 1.842 
  Valvular disease   -0.018 0.055 0.982 0.000 0.055 1.000 0.000 0.055 1.000 
  Weight loss   0.168* 0.073 1.183* 0.169* 0.073 1.184* 0.169* 0.073 1.185* 
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Level 2: Hospital Characteristics           
California (Ref: Florida)      -0.128* 0.053 0.880* -0.127* 0.053 0.881* 
Ownership (Ref: Public)            
  Private, not-for-profit      0.055 0.068 1.057 0.054 0.068 1.056 
  Private, for-profit      -0.017 0.078 0.983 -0.018 0.078 0.982 
System affiliation      0.054 0.055 1.056 0.053 0.055 1.055 
Cardiac catherization facility      -0.080 0.062 0.923 -0.078 0.062 0.925 
Magnet hospital      -0.198* 0.100 0.820* -0.203* 0.101 0.816* 
Teaching intensity  
(Ref: non-teaching)            
  Low      0.052 0.069 1.054 0.052 0.069 1.053 
  Medium      -0.064 0.075 0.938 -0.066 0.075 0.936 
  High      0.063 0.112 1.066 0.058 0.114 1.059 
Hospital location (Ref: Rural)             
  Micro/Division      0.039 0.107 1.039 0.039 0.107 1.040 
  Metro      -0.081 0.100 0.922 -0.080 0.100 0.923 
Disproportionate Share 
Hospital (DSH) Index       0.016 0.163 1.017 0.014 0.163 1.014 
Mean number of Elixhauser 
comorbid conditions      -0.101
* 0.050 0.904* -0.100* 0.050 0.905* 
Proportion of patients with 
prior hospitalization for both 
PN and other conditions 
     2.072** 0.700 7.943** 2.066** 0.701 7.894** 
Hospital PN Volume      -0.000 0.000 1.000 -0.001 0.000 0.999 
PQM (%): Initial ER Blood 
Culture Performed Prior To 
First Hospital Dose Of 
Antibiotics 
     -0.005 0.004 0.995 -0.007 0.007 0.993 
            
Interaction  
(Volume ൈ PQM)         0.000 0.000 1.000 
            
Random effects            
  Hospital (intercept)            
  Variance between hospitals 0.105***  0.092***   0.058***   0.058***   
  ICC 0.031  0.027   0.017   0.017   
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  MOR 1.362  1.335   1.259   1.259   
            
n: level-1 (patients) 36118  36118   36118   36118   
n: level-2 (hospitals) 415  415   415   415   
AIC 26863  26002   25976   25978   
 
* p < 0.05, ** p < 0.01, *** p < 0.001 
ICC: Intraclass Correlation; Level-1 variance of hierarchical logistic model is π2/3 =3.29. 
MOR: Median Odds Ratio; = exp൛ඥሺ2 ൈ ߪ௨మሻ ൈ 0.6745ൟ 
PQM: Process Quality Measure 
Model 1 is a null model; Model 2 includes patient-level factors (level-1); Model 3 includes Model 2 plus hospital-level factors; Model 4 includes interaction 
based on Model 3. 
 
 
 
 
 
